var title_f23_35_24112="Hypopion 3";
var content_f23_35_24112=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F53237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F53237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypopyon in a contact wearer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 316px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Corneal ulcer and hypophion (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baskin MN. Opthalmic and otolaryngologic emergencies. In: Atlas of Pediatric Emergency Medicine, Fleisher GR, Ludwig S, Baskin MN (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24112=[""].join("\n");
var outline_f23_35_24112=null;
var title_f23_35_24113="AIDS-related Kaposis sarcoma - multiple plaques";
var content_f23_35_24113=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74359&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74359&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    AIDS-related Kaposi's sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple oval, violaceous plaques are present on the upper extremities and trunk in this patient with AIDS-related Kaposi's sarcoma. Lesions tend to follow skin relaxed tension lines.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24113=[""].join("\n");
var outline_f23_35_24113=null;
var title_f23_35_24114="Patient information: Brachytherapy (The Basics)";
var content_f23_35_24114=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16302\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/32/37382\">",
"         Prostate gland",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"          Female reproductive anatomy",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?17/27/17842\">",
"         Patient information: Hair loss from cancer treatment (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/40/1667\">",
"         Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/36/579\">",
"         Patient information: Managing pain when you have cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/57/19346\">",
"         Patient information: Nausea and vomiting with cancer treatment (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/32/40450\">",
"         Patient information: Radiation therapy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/4/29762\">",
"         Patient information: When your cancer treatment makes you tired (The Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Brachytherapy (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/brachytherapy-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H25056374\">",
"      <span class=\"h1\">",
"       What is brachytherapy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Brachytherapy is a type of cancer treatment. It uses high doses of X-rays, called radiation, to kill cancer cells. There are 2 types of radiation therapy, depending on where the source of the radiation is.",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        In &ldquo;external-beam radiation therapy,&rdquo; the radiation comes from a machine that is outside the body.",
"       </li>",
"       <li>",
"        In &ldquo;internal radiation therapy,&rdquo; the radiation comes from a source, such as tiny seeds or capsules, that is put inside the body. Brachytherapy is another name for internal radiation therapy.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      In brachytherapy, a doctor puts the source of radiation into or right next to the cancer. The radiation affects only the cancer, and sometimes the area right around the cancer. The radiation does not affect other parts of the body.",
"     </p>",
"     <p>",
"      There are 2 types of brachytherapy:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Low-dose rate (LDR) &mdash; A doctor puts the radiation source into the cancer and leaves it there. The source gives off radiation for weeks to months. After that, it doesn&rsquo;t give off any more radiation.",
"       </li>",
"       <li>",
"        High-dose rate (HDR) &mdash; A doctor puts the radiation source into the cancer for a short time (hours to days) and then removes it from the body.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Doctors can use brachytherapy to treat different types of cancers. These often include cancers of the prostate (",
"      <a class=\"graphic graphic_figure graphicRef65675 \" href=\"UTD.htm?36/32/37382\">",
"       figure 1",
"      </a>",
"      ), breast, cervix, and lining of the uterus (endometrium) (",
"      <a class=\"graphic graphic_figure graphicRef80271 \" href=\"UTD.htm?14/52/15171\">",
"       figure 2",
"      </a>",
"      ). Some people have brachytherapy along with external-beam radiation therapy or other cancer treatments.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25056381\">",
"      <span class=\"h1\">",
"       What happens during brachytherapy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor will do a procedure to put the radiation source into your body. He or she will give you medicines to make you feel sleepy or numb. He or she will put a thin tube into your body near the area with the cancer. Then he or she will put the radiation through the tube and into the cancer.",
"     </p>",
"     <p>",
"      For LDR brachytherapy, the doctor will remove the tube and leave the radiation in place. People can then usually leave the hospital.",
"     </p>",
"     <p>",
"      To get HDR brachytherapy, people need to stay in the hospital. During treatment, people get a certain number of radiation doses, depending on their cancer. For each dose, the doctor will put the radiation through the tube and into the cancer. After a certain amount of time, the doctor will take the radiation out. He or she will repeat this as many times as needed over days or weeks. The tube might stay in place for the whole treatment, or it might come out and go back in each time.",
"     </p>",
"     <p>",
"      People who get brachytherapy might need to avoid others, especially children, at certain times during treatment. That&rsquo;s because people can give off radiation when they have a source of radiation in their body. Your doctor or nurse will tell you if and when you need to stay away from other people.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25056388\">",
"      <span class=\"h1\">",
"       What are the side effects of brachytherapy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People can have different side effects from brachytherapy. The side effects will depend on the type of brachytherapy, the radiation dose, and the body part involved. Depending on your treatment, your doctor will tell you the side effects you are likely to have.",
"     </p>",
"     <p>",
"      Common side effects from brachytherapy can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Swelling inside the body in the area around the radiation",
"       </li>",
"       <li>",
"        Redness or soreness where the tube was put in on the outside of the body",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your doctor can treat the side effects in different ways, depending on your symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25056395\">",
"      <span class=\"h1\">",
"       What else should I do?",
"      </span>",
"      &nbsp;&mdash;&nbsp;When you get brachytherapy, it&rsquo;s important to:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Follow all of your doctor&rsquo;s instructions about treatments and visits.",
"       </li>",
"       <li>",
"        Let your doctor or nurse know about any side effects or problems you have during treatment, or if your health changes.",
"       </li>",
"       <li>",
"        Take care of yourself by eating well, getting enough sleep, and exercising. To keep your energy up, try to eat foods and drinks with a lot of protein and calories.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H25056402\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/32/40450?source=see_link\">",
"       Patient information: Radiation therapy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/40/1667?source=see_link\">",
"       Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/27/17842?source=see_link\">",
"       Patient information: Hair loss from cancer treatment (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/57/19346?source=see_link\">",
"       Patient information: Nausea and vomiting with cancer treatment (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/4/29762?source=see_link\">",
"       Patient information: When your cancer treatment makes you tired (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/36/579?source=see_link\">",
"       Patient information: Managing pain when you have cancer (The Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?23/35/24114?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16302 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-02DD474397-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24114=[""].join("\n");
var outline_f23_35_24114=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25056374\">",
"      What is brachytherapy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25056381\">",
"      What happens during brachytherapy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25056388\">",
"      What are the side effects of brachytherapy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25056395\">",
"      What else should I do?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25056402\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16302\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/32/37382\">",
"      Prostate gland",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"       Female reproductive anatomy",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/27/17842?source=related_link\">",
"      Patient information: Hair loss from cancer treatment (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/40/1667?source=related_link\">",
"      Patient information: Managing loss of appetite and weight loss with cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/36/579?source=related_link\">",
"      Patient information: Managing pain when you have cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/57/19346?source=related_link\">",
"      Patient information: Nausea and vomiting with cancer treatment (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/32/40450?source=related_link\">",
"      Patient information: Radiation therapy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/4/29762?source=related_link\">",
"      Patient information: When your cancer treatment makes you tired (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_35_24115="Dobutamine: Patient drug information";
var content_f23_35_24115=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dobutamine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     see \"Dobutamine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/48/25348?source=see_link\">",
"     see \"Dobutamine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F161958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dobutamine Injection, USP;",
"     </li>",
"     <li>",
"      Dobutrex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025576\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691384",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to help a weak heart.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025575\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701968",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dobutamine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697143",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfite allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025580\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025578\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11939 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-91.202.164.29-7B7E1375F2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24115=[""].join("\n");
var outline_f23_35_24115=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161958\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025576\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025575\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025580\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025581\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025583\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025578\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025585\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=related_link\">",
"      Dobutamine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/48/25348?source=related_link\">",
"      Dobutamine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_35_24116="Halobetasol: Patient drug information";
var content_f23_35_24116=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Halobetasol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/44/9925?source=see_link\">",
"     see \"Halobetasol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/37/43603?source=see_link\">",
"     see \"Halobetasol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F178409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Halonate&trade;;",
"     </li>",
"     <li>",
"      Ultravate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F178410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ultravate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin rashes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702231",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to halobetasol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697930",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Burning.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698659",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired, weak, or touchy; trembling; having a fast heartbeat, confusion, sweating, or dizziness if you missed a dose or recently stopped this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014845\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014851\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014852\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12528 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-704953041C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24116=[""].join("\n");
var outline_f23_35_24116=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178409\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178410\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014843\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014842\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014847\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014848\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014850\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014845\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014846\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014851\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014852\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/44/9925?source=related_link\">",
"      Halobetasol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/37/43603?source=related_link\">",
"      Halobetasol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_35_24117="Paraldehyde: Drug information";
var content_f23_35_24117=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Paraldehyde: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F14280478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Paraldahyde Injection BP",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F14280312\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anticonvulsant, Miscellaneous;",
"     </li>",
"     <li>",
"      Anxiolytics, Sedatives, and Hypnotics, Miscellaneous",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F14280362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Canadian labeling: Second- or third-line therapy:",
"     <b>",
"      Note:",
"     </b>",
"     Do not administer &gt;5 mL per injection site.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Alcohol withdrawal:",
"     </b>",
"     I.M.: 5 mL every 4-6 hours for 24 hours (maximum: 30 mL on day 1), followed by every 6 hours (maximum: 20 mL/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypnotic:",
"     </b>",
"     I.M.: 10 mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Sedative:",
"     </b>",
"     I.M.: 5 mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Seizure associated with status epilepticus, tetanus, or poisoning:",
"     </b>",
"     I.M.: 5-10 mL",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F14280361\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Canadian labeling: Second- or third-line therapy:",
"     <b>",
"      Note:",
"     </b>",
"     Do not administer &gt;5 mL per injection site.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypnotic:",
"     </b>",
"     I.M.: 0.3 mL/kg/daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Sedative:",
"     </b>",
"     I.M.: 0.15 mL/kg/daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Seizure associated with status epilepticus:",
"     </b>",
"     I.M.: 0.1-0.15 mL/kg/dose every 4-8 hours",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F14280363\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F14280364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mild-to-moderate impairment: No dosage adjustment provided in manufacturer's labeling; however, undergoes extensive hepatic metabolism and should be used with extreme caution. Consider dose reductions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Severe impairment: Use contraindicated.",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F14280372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F245799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Administer by I.M. injection only; avoid injecting near nerve trunks (permanent nerve damage may occur). I.M. injection is associated with extreme pain and serious injection site reactions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Do",
"     <b>",
"      not",
"     </b>",
"     administer intravenously (life-threatening effects may result) or SubQ.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Do",
"     <b>",
"      not",
"     </b>",
"     use any use plastic syringes or rubber for administration; glass syringes are recommended for administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Do",
"     <b>",
"      not",
"     </b>",
"     use if solution is brownish or has an odor of acetic acid. Use immediately after opening vial (paraldehyde decomposes to acetic acid causing toxicity).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F245798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Alternative agent (only when conventional treatment is ineffective, inappropriate, or unavailable) in the treatment of convulsive seizure episodes associated with status epilepticus, tetanus, and convulsant drug toxicity. Historically, has also been used as a sedative/hypnotic, as an anxiolytic during withdrawal from narcotics or barbiturates, and in the management of acute agitation or delirium due to alcohol withdrawal; however, these uses are not recommended due to the availability of safer and more efficacious agents.",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F14280323\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Drowsiness, dizziness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Metabolic acidosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Strong, unpleasant breath odor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Hepatitis (toxic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site pain, injection site reactions (sterile skin abscesses, skin sloughing, fat necrosis, muscle irritation, nerve damage [including permanent damage])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Muscle cramps, trembling",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Nephrosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, psychological and physical dependence with prolonged use",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F245802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to paraldehyde or any component of the formulation; severe hepatic insufficiency; bronchopulmonary disease; pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F245785\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; CNS depression: May cause CNS depression, which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatic effects: Toxic hepatitis has been reported following prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Metabolic acidosis: Has been reported following prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal effects: Nephrosis has been reported following prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Cardiovascular disease: Avoid or use with caution in patients with cardiovascular disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Drug abuse: Use with caution in patients with a history of drug abuse or acute alcoholism; potential for drug dependency exists. Tolerance, psychological and physical dependence may occur with prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatic impairment: Use with extreme caution and monitor closely for toxicity; large portions of the dose are metabolized via the liver; use is contraindicated in severe hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Respiratory disease:  The lungs are responsible for a significant portion of elimination of unchanged paraldehyde. Avoid or use caution in patients with respiratory disease; use is contraindicated in patients with bronchopulmonary disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Sedatives: Effects with other sedative drugs or ethanol may be potentiated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Administration: Per Canadian manufacturer's labeling, product is intended for I.M. administration only; avoid injecting I.M. near nerve trucks due to potential for severe and permanent nerve damage. I.M. administration is associated with severe pain and may also cause skin reactions (eg, sterile skin abscesses, skin sloughing), fat necrosis, and muscle irritation. Subcutaneous injections are",
"     <b>",
"      not",
"     </b>",
"     recommended; paraldehyde is a tissue irritant. In addition, do",
"     <b>",
"      not",
"     </b>",
"     inject intravenously due to potential for thrombophlebitis, pulmonary edema and hemorrhage, respiratory distress, cyanosis, hypotension and cardiac dilatation, and circulatory collapse.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use: Not appropriate as a first-line agent for any indication. Limited published information exists for paraldehyde use compared to more conventional agents with more published safety and efficacy data. If used as a hypnotic/sedative agent, therapy should be limited to short-term use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Decomposition: Paraldehyde decomposes when opened; prepare using only freshly opened vials. Use of partly decomposed paraldehyde is hazardous and may result in metabolic acidosis; use of decomposed paraldehyde has resulted in death from corrosive poisoning. If solution is a brownish color or smells of acetic acid, it should",
"     <b>",
"      not",
"     </b>",
"     be used.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Irritant/solvent: Avoid contact with skin, eyes, and clothing. Since paraldehyde is a solvent, contact with plastic (eg, plastic syringes) or rubber should be avoided.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Withdrawal: Use caution when withdrawing therapy after prolonged use in physically dependent patients; decrease slowly and monitor for withdrawal symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F245789\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Disulfiram: May increase the serum concentration of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May diminish the therapeutic effect of Anticonvulsants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mefloquine: May diminish the therapeutic effect of Anticonvulsants. Mefloquine may decrease the serum concentration of Anticonvulsants. Management: Mefloquine is contraindicated for malaria prophylaxis in persons with a history of convulsions.  Monitor anticonvulsant concentrations and treatment response closely with concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F245805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: Avoid ethanol (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14280313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Paraldehyde crosses the placenta; use in pregnancy is contraindicated. Use in obstetric anesthesia is not appropriate due to potential respiratory depression in neonates. Pregnancy should be excluded prior to initiating in females of childbearing potential.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F14280314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14280315\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to the potential for serious adverse reactions in the nursing infant, breast-feeding is not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F245783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Paraldehyde, a cyclic trimer of acetaldehyde, has an unknown mechanism of action; causes CNS depression, including the ascending reticular activating system to provide sedation/hypnosis and anticonvulsant activity (at slightly lower doses than those required to produce hypnosis). It has no analgesic properties at sub-anesthetic doses and may cause excitement or delirium in the presence of pain.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F245801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of sedation/hypnosis: I.M.: 5-15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M.: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Tissue distribution not extensively studied; diffuses into CSF with concentrations in CSF ~25% to 30% lower than that of serum concentrations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: ~80% to 90% of the dose metabolized in the liver to acetaldehyde, then oxidized via aldehyde dehydrogenase to acetic acid, and further metabolized to carbon dioxide and water",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Adults: ~3.5-9.5 hours (mean: 7.5 hours [in patients with normal hepatic function])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: I.M.: Serum: 20-60 minutes; CSF: 30-60 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Significant portion excreted as unchanged drug in expired air via the lungs; trace amounts excreted in urine unchanged",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Ahmad S, Ellis JC, Kamwendo H, et al, &ldquo;Efficacy and Safety of Intranasal Lorazepam Versus Intramuscular Paraldehyde for Protracted Convulsions in Children: An Open Randomised Trial,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2006, 367(9522):1591-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/35/24117/abstract-text/16698412/pubmed\" id=\"16698412\" target=\"_blank\">",
"        16698412",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Guthrie SK, &ldquo;The Treatment of Alcohol Withdrawal,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1989, 9(3):131-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/35/24117/abstract-text/2666958/pubmed\" id=\"2666958\" target=\"_blank\">",
"        2666958",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Health and Clinical Excellence (NICE), &ldquo;The Epilepsies: The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care,&rdquo; 2012. Available at  file://guidance.nice.org.uk/CG137/Guidance/pdf/English",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rossetti AO, &ldquo;Novel Anesthetics and Other Treatment Strategies for Refractory Status Epilepticus,&rdquo;",
"      <i>",
"       Epilepsia",
"      </i>",
"      , 2009, 50(Suppl 12):51-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/35/24117/abstract-text/19941525/pubmed\" id=\"19941525\" target=\"_blank\">",
"        19941525",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rowland AG, Gill AM, Stewart AB, et al, &ldquo;Review of the Efficacy of Rectal Paraldehyde in the Management of Acute and Prolonged Tonic-Clonic Convulsions,&rdquo;",
"      <i>",
"       Arch Dis Child",
"      </i>",
"      , 2009, 94(9):720-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/35/24117/abstract-text/19357123/pubmed\" id=\"19357123\" target=\"_blank\">",
"        19357123",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yoong M, Chin RF, and Scott RC, &ldquo;Management of Convulsive Status Epilepticus in Children,&rdquo;",
"      <i>",
"       Arch Dis Child Educ Pract Ed",
"      </i>",
"      , 2009, 94(1):1-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?23/35/24117/abstract-text/19158332/pubmed\" id=\"19158332\" target=\"_blank\">",
"        19158332",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 83875 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-2E861B2D37-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24117=[""].join("\n");
var outline_f23_35_24117=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280478\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280312\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280362\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280361\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280363\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280364\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280372\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F245799\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F245798\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280323\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F245802\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F245785\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299823\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F245789\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F245805\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280313\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280314\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14280315\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F245783\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F245801\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/83875\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/83875|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_35_24118="US guided carpal tunnel puncture";
var content_f23_35_24118=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F67723&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F67723&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 611px\">",
"   <div class=\"ttl\">",
"    Ultrasound guided carpal tunnel puncture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 591px; height: 507px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A, B) Patient and paperclip positioning for puncture of carpal tunnel.",
"    <br>",
"     (C) Transverse US scan showing the reverberation of the paperclip and the median nerve right between the two echoes of the paperclip.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: George AW Bruyn, MD, PhD.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24118=[""].join("\n");
var outline_f23_35_24118=null;
var title_f23_35_24119="Atrial flutter Type II";
var content_f23_35_24119=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F68846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F68846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electrocardiogram in type II atrial flutter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 435px; height: 175px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There are three findings that distinguish this arrhythmia from type I atrial flutter: the flutter rate is faster at 375 beats/min; there is no isoelectric interval between the flutter waves; and there is more apparent positivity in leads II, III, and avF. The high degree of AV block is due to digoxin and some underlying AV nodal disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24119=[""].join("\n");
var outline_f23_35_24119=null;
var title_f23_35_24120="Salt intake, salt restriction, and essential hypertension";
var content_f23_35_24120=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Salt intake, salt restriction, and essential hypertension",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/35/24120/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/35/24120/contributors\">",
"     Norman M Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/35/24120/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/35/24120/contributors\">",
"     George L Bakris, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/35/24120/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/35/24120/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/35/24120/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between sodium intake and blood pressure, and the effects of sodium restriction in patients with uncomplicated essential hypertension are discussed in this topic review. The restriction of sodium intake and fluid removal with diuretics play an even more central role in the therapy of hypertension in those with hypertension associated with acute or chronic kidney disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/10/7337?source=see_link&amp;anchor=H17855216#H17855216\">",
"     \"Overview of hypertension in acute and chronic kidney disease\", section on 'Benefits of sodium restriction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relationship of other factors to the development of hypertension, the evaluation of the hypertensive patient, and the management of hypertension in general and in specific subpopulations are discussed elsewhere. (See appropriate topic reviews).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SODIUM INTAKE AND HYPERTENSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Essential hypertension is seen primarily in societies with average sodium intakes above 100",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    (2.3 g sodium); however, it is rare in societies with average sodium intakes of less than 50",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    (1.2 g sodium) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. These observations suggest that the development of hypertension requires a threshold level of sodium intake. This effect appears to be independent of other risk factors for hypertension, such as obesity.",
"   </p>",
"   <p>",
"    In addition to sodium, chloride (the accompanying anion in salt) also appears to be important in the pathogenesis of essential hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/3\">",
"     3",
"    </a>",
"    ]. Increasing sodium chloride intake in sodium-sensitive patients leads to volume expansion and a rise in BP; neither of these findings is seen if sodium is given with another anion (such as citrate [which is metabolized to bicarbonate]) or chloride with another cation (such as ammonium) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Reducing salt intake from 170 to 100",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    lowers the mean blood pressure (BP) in normotensive adults by approximately",
"    <span class=\"nowrap\">",
"     2/1",
"    </span>",
"    mmHg and in hypertensive adults by",
"    <span class=\"nowrap\">",
"     5/3",
"    </span>",
"    mmHg [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/4\">",
"     4",
"    </a>",
"    ]. However, over the course of 30 years, the fall in BP may be greater, in part because salt restriction minimizes the normal rise in BP associated with aging [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Sodium-sensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The BP responsiveness to variations in salt intake is known as salt-sensitivity. The extent of BP change after abrupt changes in salt intake varies considerably from individual to individual and in the same individual tested at different times [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Salt-sensitivity also increases with age, and is more marked in African-Americans, obese individuals, and patients with metabolic syndrome or chronic kidney disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Thus, excess salt intake over many years probably plays a greater role in the development of hypertension in these groups.",
"   </p>",
"   <p>",
"    The terms, salt-sensitive and salt-resistant, as used in the setting of short-term studies of hypertensive patients do not apply to the long term effects of dietary salt restriction, which take four to five weeks to alter systemic blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Salt-sensitive normotensive people may be more likely to develop hypertension. In one study with an average follow-up of 15 years, hypertension developed in 14 of 16 subjects who had originally been shown to be salt-sensitive compared to 10 of 20 subjects originally shown to be sodium-insensitive [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANISMS OF SODIUM-SENSITIVITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanisms of sodium-sensitivity are incompletely understood. Various abnormalities in sodium",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chloride handling may lead to volume expansion and hypertension. By comparison, a lesser activation of the renin-aldosterone mechanism may explain the greater falls in BP with reductions in sodium intake among the elderly, African-Americans, and patients with chronic kidney disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Sodium retention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The traditional view of sodium sensitivity has been that impaired renal sodium excretion can lead to initial volume expansion and then hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. This elevation in BP can be viewed as being physiologically appropriate, since the associated increase in renal perfusion pressure can, via the phenomenon of pressure natriuresis, directly enhance sodium excretion and restore normovolemia. Normal subjects can excrete a sodium load without an elevation in BP by suppressing the release of renin and increasing that of atrial natriuretic peptide. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6744?source=see_link&amp;anchor=H6#H6\">",
"     \"Chapter 8C: Regulation of renal Na+ excretion\", section on 'Pressure natriuresis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanisms of increased sodium reabsorption are not well understood. Possibilities include increased activity of the proximal tubular Na-H exchanger, the thick ascending limb Na-K-2Cl cotransporter, the distal tubular Na-Cl cotransporter, and the collecting duct epithelial sodium channel (ENaC) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/14-23\">",
"     14-23",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Both experimental and human evidence support an association between hypertension and the activity of the proximal Na-H exchanger [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/16,17\">",
"       16,17",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/2/24617?source=see_link\">",
"       \"Chapter 3A: Cell model for proximal transport\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Increased activity of the epithelial sodium channel in the collecting tubule is responsible for the hypertension in Liddle syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/20\">",
"       20",
"      </a>",
"      ], and genetic variants in this channel may explain salt sensitive hypertension in certain populations [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/21-23\">",
"       21-23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6744?source=see_link\">",
"       \"Chapter 8C: Regulation of renal Na+ excretion\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/60/9159?source=see_link\">",
"       \"Genetic factors in the pathogenesis of essential hypertension\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    On the other hand, loss-of-function mutations in the distal tubule Na-Cl cotransporter in Gitelman syndrome are associated with lower blood pressures than in normal individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=see_link\">",
"     \"Bartter and Gitelman syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Signaling and vascular tone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence in transgenic mice and sodium-sensitive hypertensive rats suggests that abnormalities in a bidirectional",
"    <span class=\"nowrap\">",
"     sodium/calcium",
"    </span>",
"    exchanger result in increased calcium entry into vascular smooth muscle in response to excessive sodium intake. Increased calcium entry causes vasoconstriction and hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. In addition, G protein-mediated signaling regulates vascular tone. In particular, G proteins, G 12-13, and their major effector, the leukemia-associated Rho guanine nucleotide exchange factor (LARG) may play a role in salt-mediated hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Genes associated with salt sensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple genes have been implicated in the pathogenesis of hypertension, including those genes that regulate sodium absorption. These are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/60/9159?source=see_link\">",
"     \"Genetic factors in the pathogenesis of essential hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Failure of normal vasodilatation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some evidence suggests that increased blood pressure from sodium-sensitivity results directly from impaired vascular dilatation. One study of 23 normotensive black subjects compared the effects of sodium loading among those who were sodium sensitive or resistant [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/28\">",
"     28",
"    </a>",
"    ]. Sodium-sensitive and -insensitive subjects had similar changes in sodium balance, body weight, plasma volume and cardiac output. However, whereas the sodium-insensitive subjects had a robust decrease in systemic vascular resistance during sodium loading, the sodium sensitive group did not. The failure of systemic vascular resistant to decrease in the sodium sensitive subjects may have been due, in part, to an increase in asymmetrical dimethylarginine, an endogenous inhibitor vascular relaxation, induced by sodium loading [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/29\">",
"     29",
"    </a>",
"    ]. In sodium resistant subjects, sodium loading had no effect on asymmetrical dimethylarginine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sodium-sensitivity has been associated with a number of other abnormalities that might contribute to the development of hypertension, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Insulin resistance, dyslipidemia, and microalbuminuria, results in an atherogenic predisposition that could also induce or aggravate hypertension [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dietary potassium deficiency induces sodium-sensitivity in African-Americans via an uncertain mechanism [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/31\">",
"       31",
"      </a>",
"      ]. One possibility is increased activity of the WNK kinase1 gene, resulting in enhanced sodium reabsorption via activation of the",
"      <span class=\"nowrap\">",
"       sodium/chloride",
"      </span>",
"      cotransporter [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/32\">",
"       32",
"      </a>",
"      ]. Conversely, the response to sodium is reduced with potassium supplementation.",
"     </li>",
"     <li>",
"      Subtle renal injury, perhaps due to tubulointerstitial injury, may lead to increased renal vasoconstriction, and decreased sodium excretion [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     EFFECTS OF DIETARY SODIUM RESTRICTION ON BLOOD PRESSURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A low salt diet is recommended in all international and national guidelines as a component of nonpharmacologic therapy of essential hypertension. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Major society recommendations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Blood pressure reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary sodium reduction can reduce BP in normotensive, prehypertensive, and hypertensive individuals, including the elderly [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/34\">",
"     34",
"    </a>",
"    ]. An estimate of the amount of BP lowering was illustrated in a 2004 meta-analysis of 17 trials of patients with hypertension and 11 in patients with normal BP [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/35\">",
"     35",
"    </a>",
"    ]. A decrease in sodium intake of approximately 75",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    for four or more weeks resulted in a fall in BP of",
"    <span class=\"nowrap\">",
"     5/3",
"    </span>",
"    mmHg among hypertensives and",
"    <span class=\"nowrap\">",
"     2/1",
"    </span>",
"    mmHg among normotensives. In many other trials, however, sodium reduction was either too short-lived or too moderate to fully ascertain the antihypertensive potential of sodium restriction.",
"   </p>",
"   <p>",
"    Although the reductions in BP observed in normotensive patients are small, they could, if sustained over long periods, provide considerable protection against cardiovascular events (",
"    <a class=\"graphic graphic_table graphicRef75065 \" href=\"UTD.htm?4/48/4875\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Response to antihypertensive drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to its direct effect on blood pressure, lowering the extracellular volume by limiting sodium intake can enhance the response to most antihypertensive drugs, except possibly calcium channel blockers [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Sodium restriction may also diminish the degree of potassium depletion following treatment with a diuretic [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dietary sodium reduction, by increasing renin release, makes the BP more angiotensin II-dependent and therefore more responsive to therapy with an ACE inhibitor or angiotensin II receptor blocker [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/15\">",
"     15",
"    </a>",
"    ]. A less responsive renin-angiotensin system may be one reason why blacks appear to be more sensitive to sodium restriction than whites [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/16\">",
"     16",
"    </a>",
"    ]. Even patients being treated with the combination of a diuretic and an ACE inhibitor benefit from a reduction in sodium intake (eg, from 195 to 105",
"    <span class=\"nowrap\">",
"     meq/day).",
"    </span>",
"    In this setting, the BP has been shown to fall by an average of",
"    <span class=\"nowrap\">",
"     9/3",
"    </span>",
"    mmHg [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with proteinuric chronic kidney disease who are already treated with ACE inhibitors, reducing sodium intake substantially decreases both BP and proteinuria to a degree greater than achieved by addition of an angiotensin receptor blocker to the ACE inhibitor [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link&amp;anchor=H10#H10\">",
"     \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\", section on 'Importance of salt intake'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/10/7337?source=see_link&amp;anchor=H17855216#H17855216\">",
"     \"Overview of hypertension in acute and chronic kidney disease\", section on 'Benefits of sodium restriction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Calcium channel blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sodium intake does not appear to have an important influence on the degree of BP control achieved by calcium channel blockers [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. In addition, in some, but not all studies, calcium channel blockers provided no additional antihypertensive effect to diuretics [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. A possible mechanism is that initial therapy with calcium channel blockers is often associated with a natriuresis similar to that seen with a diuretic [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. This effect appears to be mediated by reductions in proximal and distal tubular sodium reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/46\">",
"     46",
"    </a>",
"    ]. The calcium channel blocker-induced sodium loss is reversed with cessation of therapy, as approximately 40 to 150 meq of sodium are retained in the first week [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The natriuretic effect of calcium channel blockade may appear surprising in view of the not uncommon complication of peripheral edema in patients treated with dihydropyridine calcium channel blockers. However, the edema in this setting results from redistribution of fluid from the vascular space into the interstitium rather than sodium retention [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32966?source=see_link\">",
"     \"Major side effects and safety of calcium channel blockers\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H187520963\">",
"    <span class=\"h1\">",
"     EFFECTS OF DIETARY SALT RESTRICTION ON CARDIOVASCULAR DISEASE AND MORTALITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is evidence supporting a cardiovascular benefit of salt restriction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/49\">",
"     49",
"    </a>",
"    ]. However, the literature does not, and probably never will, provide a definitive answer for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Unlike changes in blood pressure, which can be assessed over short periods of time, the effects of sodium reduction on cardiovascular disease and mortality require large sample sizes and long-term follow-up. Several investigators have argued that an adequately powered randomized trial of sodium restriction to prevent cardiovascular disease and mortality would require more than 20,000 patients followed for five years [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/50,51\">",
"       50,51",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Participants in trials of dietary sodium restriction typically resume a regular (or high) sodium intake once the intervention period of the trial ends. Thus, any benefits of sodium restriction that could be deduced from analyzing the extended follow-up of existing trials are likely to be diluted by resumption of a high sodium diet.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The best available data come from two meta-analyses of randomized trials with intervention periods of at least six months. One meta-analysis separately analyzed trials of patients who were normotensive at baseline or hypertensive at baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/51\">",
"     51",
"    </a>",
"    ]. Outcomes were better with sodium restriction but the effect was not statistically significant. The second meta-analysis combined the results in normotensive and hypertensive patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/50\">",
"     50",
"    </a>",
"    ]. With the larger number of patients, sodium restriction was associated with a significant reduction in cardiovascular events (8.0 versus 10.1 percent) but the benefit in mortality was still not significant. This benefit, if real, may be due at least in part to lower attained blood pressures with sodium restriction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Numerous prospective population studies are also available, most of which support the conclusion that a high sodium intake independently increases the risk of cardiovascular disease and death [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/52-54\">",
"     52-54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     OTHER BENEFITS OF SALT RESTRICTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of other potential adverse consequences of a high salt intake that may be ameliorated by dietary sodium restriction, independent of blood pressure (",
"    <a class=\"graphic graphic_table graphicRef76832 \" href=\"UTD.htm?8/28/8651\">",
"     table 2",
"    </a>",
"    ). These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lowering of urinary calcium excretion, which may protect against calcium stones and the development of osteoporosis with age [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased antiproteinuric effect of angiotensin inhibitors in patients with chronic kidney disease [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/56\">",
"       56",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=see_link&amp;anchor=H10#H10\">",
"       \"Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults\", section on 'Importance of salt intake'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Regression of left ventricular hypertrophy [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MAJOR SOCIETY RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the potential benefits and low risk, moderate dietary sodium restriction is recommended as part of the nonpharmacologic therapy of hypertension by almost all national and international organizations. In 2010, the United States Departments of Agriculture and of Health and Human Services recommended that adults in general consume 2.3 g or less of sodium per day (approximately 6 g of sodium chloride [one gram of sodium = 44 meq; one gram of sodium chloride contains 17 meq of sodium]) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/58\">",
"     58",
"    </a>",
"    ]. However, they recommended that individuals who meet one or more of the following criteria should consume no more than 1.5 g of sodium per day:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age 51 years and older",
"     </li>",
"     <li>",
"      Black race",
"     </li>",
"     <li>",
"      Diagnosed hypertension",
"     </li>",
"     <li>",
"      Diagnosed diabetes mellitus",
"     </li>",
"     <li>",
"      Diagnosed chronic kidney disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Previous major guidelines had similar or slightly different recommendations. The 2003 Seventh Joint National Committee (JNC-7) guidelines recommends reducing dietary sodium intake from the usual 150 to 200",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    down to 100",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    (approximately 2.3 g of sodium) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/59\">",
"     59",
"    </a>",
"    ]. The 2007 European Society of Hypertension recommends less than 85",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    (2.0 g of sodium) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since 80 percent of dietary salt is derived from the salt added in food and drink processing, the easiest way to achieve meaningful, population-wide reduction is by lowering the amount of salt added by food processors [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. A regulatory intervention promoting a population-wide reduction in salt intake could provide substantial savings in quality-adjusted life-years and in health care costs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/63-65\">",
"     63-65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study, the projected benefits were estimated using the Coronary Heart Disease Model, a computer simulation of the incidence and prevalence of coronary heart disease and the associated mortality and costs in United States adults [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/63\">",
"     63",
"    </a>",
"    ]. The projected benefits of a reduction in salt by 3",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A reduction in the number of new cases of coronary heart disease by up to 120,000; stroke by up to 66,000 and myocardial infarctions by up to 99,000 annually.",
"     </li>",
"     <li>",
"      A reduction in the number of deaths from any cause by up to 92,000 annually.",
"     </li>",
"     <li>",
"      A savings in health care costs of up to 24 billion annually.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The projected cardiovascular benefits are similar to those of population-wide reductions in smoking, obesity and cholesterol levels [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     POTENTIAL SIDE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although marked sodium restriction (less than 20",
"    <span class=\"nowrap\">",
"     meq/day)",
"    </span>",
"    can cause an approximate 10 percent elevation in total and LDL-cholesterol levels, this is a probable reflection of hemoconcentration [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/67\">",
"     67",
"    </a>",
"    ]. However, the more common goal of sodium intake of 80 to 100",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    does not unfavorably alter lipid levels [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/68\">",
"     68",
"    </a>",
"    ]. Concerns about activation of the renin-angiotensin system by a moderately restricted sodium intake also do not appear to be warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/69\">",
"     69",
"    </a>",
"    ]. However, sodium reduction with a low-sodium, high-potassium salt substitute may induce hyperkalemia in patients with chronic kidney disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24120/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/61/39890?source=see_link\">",
"       \"Patient information: Low sodium diet (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A high dietary intake of sodium is associated with the development of hypertension. Some individuals are particularly sensitive to sodium in the diet, and are referred to as being sodium-sensitive. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Sodium intake and hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sodium-sensitive individuals obtain a greater degree of blood pressure reduction with dietary sodium restriction. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Sodium-sensitivity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dietary sodium reduction can lower blood pressure in both hypertensive and normotensive individuals, and enhances the response to most antihypertensive therapies. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Blood pressure reduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Response to antihypertensive drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dietary sodium reduction may decrease the risk of cardiovascular disease, potentially though, in part, a reduction in blood pressure. (See",
"      <a class=\"local\" href=\"#H187520963\">",
"       'Effects of dietary salt restriction on cardiovascular disease and mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In all hypertensive individuals, we recommend reducing dietary sodium intake (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). A reasonable goal is to reduce daily sodium intake to &lt;100",
"      <span class=\"nowrap\">",
"       meq/day",
"      </span>",
"      (2.3 g of sodium or 6 g of sodium chloride [one gram of sodium = 44 meq; one gram of sodium chloride contains 17 meq of sodium]). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Major society recommendations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest reducing dietary sodium intake to similar levels in the general population with the goal of preventing hypertension and decreasing the risk of adverse cardiovascular events (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/1\">",
"      Adrogu&eacute; HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 2007; 356:1966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/2\">",
"      Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ 1996; 312:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/3\">",
"      Kurtz TW, Al-Bander HA, Morris RC Jr. \"Salt-sensitive\" essential hypertension in men. Is the sodium ion alone important? N Engl J Med 1987; 317:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/4\">",
"      He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003; 42:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/5\">",
"      Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/6\">",
"      Obarzanek E, Proschan MA, Vollmer WM, et al. Individual blood pressure responses to changes in salt intake: results from the DASH-Sodium trial. Hypertension 2003; 42:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/7\">",
"      Chen J, Gu D, Huang J, et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet 2009; 373:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/8\">",
"      Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. BMJ 1991; 302:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/9\">",
"      Barba G, Galletti F, Cappuccio FP, et al. Incidence of hypertension in individuals with different blood pressure salt-sensitivity: results of a 15-year follow-up study. J Hypertens 2007; 25:1465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/10\">",
"      Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 1994; 23:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/11\">",
"      van Paassen P, de Zeeuw D, de Jong PE, Navis G. Renin inhibition improves pressure natriuresis in essential hypertension. J Am Soc Nephrol 2000; 11:1813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/12\">",
"      Aviv A, Hollenberg NK, Weder AB. Sodium glomerulopathy: tubuloglomerular feedback and renal injury in African Americans. Kidney Int 2004; 65:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/13\">",
"      de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int 2004; 66:2454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/14\">",
"      Capasso G, Cantone A, Evangelista C, et al. Channels, carriers, and pumps in the pathogenesis of sodium-sensitive hypertension. Semin Nephrol 2005; 25:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/15\">",
"      Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic. Hypertension 2005; 46:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/16\">",
"      Siffert W, D&uuml;sing R. Sodium-proton exchange and primary hypertension. An update. Hypertension 1995; 26:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/17\">",
"      Kuro-o M, Hanaoka K, Hiroi Y, et al. Salt-sensitive hypertension in transgenic mice overexpressing Na(+)-proton exchanger. Circ Res 1995; 76:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/18\">",
"      Capasso G, Rizzo M, Evangelista C, et al. Altered expression of renal apical plasma membrane Na+ transporters in the early phase of genetic hypertension. Am J Physiol Renal Physiol 2005; 288:F1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/19\">",
"      Nakagawa K, Holla VR, Wei Y, et al. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J Clin Invest 2006; 116:1696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/20\">",
"      Freundlich M, Ludwig M. A novel epithelial sodium channel beta-subunit mutation associated with hypertensive Liddle syndrome. Pediatr Nephrol 2005; 20:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/21\">",
"      Pratt JH, Ambrosius WT, Agarwal R, et al. Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension 2002; 40:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/22\">",
"      Hannila-Handelberg T, Kontula K, Tikkanen I, et al. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension. BMC Med Genet 2005; 6:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/23\">",
"      Saha C, Eckert GJ, Ambrosius WT, et al. Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension 2005; 46:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/24\">",
"      Cruz DN, Simon DB, Nelson-Williams C, et al. Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 2001; 37:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/25\">",
"      Iwamoto T, Kita S, Zhang J, et al. Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle. Nat Med 2004; 10:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/26\">",
"      Huang BS, Leenen FH. Brain \"ouabain\" mediates the sympathoexcitatory and hypertensive effects of high sodium intake in Dahl salt-sensitive rats. Circ Res 1994; 74:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/27\">",
"      Wirth A, Beny&oacute; Z, Lukasova M, et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 2008; 14:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/28\">",
"      Schmidlin O, Sebastian AF, Morris RC Jr. What initiates the pressor effect of salt in salt-sensitive humans? Observations in normotensive blacks. Hypertension 2007; 49:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/29\">",
"      Schmidlin O, Forman A, Leone A, et al. Salt sensitivity in blacks: evidence that the initial pressor effect of NaCl involves inhibition of vasodilatation by asymmetrical dimethylarginine. Hypertension 2011; 58:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/30\">",
"      Bigazzi R, Bianchi S, Baldari G, Campese VM. Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin. Am J Hypertens 1996; 9:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/31\">",
"      Morris RC Jr, Sebastian A, Forman A, et al. Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 1999; 33:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/32\">",
"      Huang CL, Kuo E. Mechanisms of disease: WNK-ing at the mechanism of salt-sensitive hypertension. Nat Clin Pract Nephrol 2007; 3:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/33\">",
"      Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 2002; 346:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/34\">",
"      Appel LJ, Espeland MA, Easter L, et al. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med 2001; 161:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/35\">",
"      He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 2004; :CD004937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/36\">",
"      Cook NR, Cohen J, Hebert PR, et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995; 155:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/37\">",
"      Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/38\">",
"      Slagman MC, Waanders F, Hemmelder MH, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ 2011; 343:d4366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/39\">",
"      Boudville N, Ward S, Benaroia M, House AA. Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens 2005; 18:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/40\">",
"      Ram CV, Garrett BN, Kaplan NM. Moderate sodium restriction and various diuretics in the treatment of hypertension. Arch Intern Med 1981; 141:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/41\">",
"      Singer DR, Markandu ND, Sugden AL, et al. Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide. Hypertension 1991; 17:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/42\">",
"      Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens 2003; 17:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/43\">",
"      Weir MR, Hall PS, Behrens MT, Flack JM. Salt and blood pressure responses to calcium antagonism in hypertensive patients. Hypertension 1997; 30:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/44\">",
"      Nicholson JP, Resnick LM, Laragh JH. Hydrochlorothiazide is not additive to verapamil in treating essential hypertension. Arch Intern Med 1989; 149:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/45\">",
"      Frishman WH, Zawada ET Jr, Smith LK, et al. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension. Am J Cardiol 1987; 59:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/46\">",
"      Larochelle P. Renal tubular effects of calcium antagonists. Kidney Int Suppl 1992; 36:S49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/47\">",
"      Cappuccio FP, Markandu ND, Sagnella GA, et al. Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Med 1991; 91:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/48\">",
"      Pedrinelli R, Dell'Omo G, Mariani M. Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension. J Hum Hypertens 2001; 15:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/49\">",
"      Rodriguez CJ, Bibbins-Domingo K, Jin Z, et al. Association of sodium and potassium intake with left ventricular mass: coronary artery risk development in young adults. Hypertension 2011; 58:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/50\">",
"      He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 2011; 378:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/51\">",
"      Taylor RS, Ashton KE, Moxham T, et al. Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens 2011; 24:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/52\">",
"      Yang Q, Liu T, Kuklina EV, et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2011; 171:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/53\">",
"      Strazzullo P, D'Elia L, Kandala NB, Cappuccio FP. Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ 2009; 339:b4567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/54\">",
"      O'Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011; 306:2229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/55\">",
"      Hoon DS, Okun E, Neuwirth H, et al. Aberrant expression of gangliosides in human renal cell carcinomas. J Urol 1993; 150:2013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/56\">",
"      Weir MR. Dietary salt, blood pressure, and microalbuminuria. J Clin Hypertens (Greenwich) 2004; 6:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/57\">",
"      Jula AM, Karanko HM. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation 1994; 89:1023.",
"     </a>",
"    </li>",
"    <li>",
"     US Dept of Agriculture and US Dept Health and Human Services. Dietary Guidelines for Americans 2010. US Govt Printing Office; US Dept of Agriculture and US Dept Health and Human Services, Washington, DC, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/59\">",
"      Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/60\">",
"      Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/61\">",
"      Engstrom A, Tobelmann RC, Albertson AM. Sodium intake trends and food choices. Am J Clin Nutr 1997; 65:704S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/62\">",
"      Cappuccio FP, Capewell S, Lincoln P, McPherson K. Policy options to reduce population salt intake. BMJ 2011; 343:d4995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/63\">",
"      Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/64\">",
"      Smith-Spangler CM, Juusola JL, Enns EA, et al. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med 2010; 152:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/65\">",
"      Wang G, Labarthe D. The cost-effectiveness of interventions designed to reduce sodium intake. J Hypertens 2011; 29:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/66\">",
"      Coxson PG, Cook NR, Joffres M, et al. Mortality benefits from US population-wide reduction in sodium consumption: projections from 3 modeling approaches. Hypertension 2013; 61:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/67\">",
"      Graudal NA, Gall&oslash;e AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 1998; 279:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/68\">",
"      de Wardener HE, Kaplan NM. On the assertion that a moderate restriction of sodium intake may have adverse health effects. Am J Hypertens 1993; 6:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/69\">",
"      He J, Ogden LG, Vupputuri S, et al. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999; 282:2027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24120/abstract/70\">",
"      Dent A, Walmsley D, Dhandapani S. Hyperkalaemia is a risk with low sodium salt in vulnerable patients. BMJ 2011; 343:d4514.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3877 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.150.3.100-F1EFE81ED1-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24120=[""].join("\n");
var outline_f23_35_24120=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SODIUM INTAKE AND HYPERTENSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Sodium-sensitivity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANISMS OF SODIUM-SENSITIVITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Sodium retention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Signaling and vascular tone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Genes associated with salt sensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Failure of normal vasodilatation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      EFFECTS OF DIETARY SODIUM RESTRICTION ON BLOOD PRESSURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Blood pressure reduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Response to antihypertensive drugs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H187520963\">",
"      EFFECTS OF DIETARY SALT RESTRICTION ON CARDIOVASCULAR DISEASE AND MORTALITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      OTHER BENEFITS OF SALT RESTRICTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MAJOR SOCIETY RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      POTENTIAL SIDE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3877\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3877|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/48/4875\" title=\"table 1\">",
"      Expected reduction CHD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/28/8651\" title=\"table 2\">",
"      Other effects of high salt",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41130?source=related_link\">",
"      Antihypertensive therapy and progression of nondiabetic chronic kidney disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23226?source=related_link\">",
"      Bartter and Gitelman syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/2/24617?source=related_link\">",
"      Chapter 3A: Cell model for proximal transport",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/37/6744?source=related_link\">",
"      Chapter 8C: Regulation of renal Na+ excretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/60/9159?source=related_link\">",
"      Genetic factors in the pathogenesis of essential hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32966?source=related_link\">",
"      Major side effects and safety of calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/10/7337?source=related_link\">",
"      Overview of hypertension in acute and chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/61/39890?source=related_link\">",
"      Patient information: Low sodium diet (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_35_24121="Secondary spontaneous pneumothorax in adults";
var content_f23_35_24121=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Secondary spontaneous pneumothorax in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/35/24121/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/35/24121/contributors\">",
"     Richard W Light, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/35/24121/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/35/24121/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/35/24121/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/35/24121/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/35/24121/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A secondary spontaneous pneumothorax (SSP) is defined as a pneumothorax that occurs as a complication of underlying lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In contrast, primary spontaneous pneumothorax occurs without a precipitating event in the absence of clinical lung disease.",
"   </p>",
"   <p>",
"    The causes, clinical manifestations, diagnosis, and management of secondary spontaneous pneumothorax will be reviewed here. Primary spontaneous pneumothorax and catamenial pneumothorax (due to thoracic endometriosis) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link\">",
"     \"Primary spontaneous pneumothorax in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25254?source=see_link\">",
"     \"Thoracic endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly every lung disease can be complicated by secondary spontaneous pneumothorax (SSP), although the most commonly associated diseases are chronic obstructive pulmonary disease, cystic fibrosis, primary or metastatic lung malignancy, and necrotizing pneumonia (eg, bacterial or fungal pneumonia, Pneumocystis jirovecii pneumonia, tuberculosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Chronic obstructive pulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic obstructive pulmonary disease (COPD) is the most common cause of SSP, with 50 to 70 percent of SSP in case series attributed to COPD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Rupture of apical blebs is the usual cause. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30954?source=see_link\">",
"     \"Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severity of COPD correlates with the likelihood of developing SSP. As an example, more than 30 percent of patients with SSP due to COPD have a forced expiratory volume in one second (FEV1) less than one liter and an FEV1 to forced vital capacity",
"    <span class=\"nowrap\">",
"     (FEV1/FVC)",
"    </span>",
"    ratio less than 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cystic fibrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSP is relatively common in cystic fibrosis (CF). Approximately 3 to 4 percent of all patients with CF will have an episode of SSP, which increases to 16 to 20 percent among those patients who survive to age 18 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. CF-related SSP is usually due to rupture of apical subpleural cysts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39274?source=see_link&amp;anchor=H33#H33\">",
"     \"Cystic fibrosis: Overview of the treatment of lung disease\", section on 'Spontaneous pneumothorax'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=see_link&amp;anchor=H8#H8\">",
"     \"Cystic fibrosis: Clinical manifestations and diagnosis\", section on 'Respiratory tract involvement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of pneumothorax in CF is inversely related to the forced expiratory volume in one second (FEV1). In one report, nearly half of all patients with CF who had an FEV1 less than 20 percent of predicted experienced at least one SSP [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/6\">",
"     6",
"    </a>",
"    ]. Other factors associated with an increased risk of pneumothorax included infection with Pseudomonas aeruginosa, Burkholderia cepacia complex, or Aspergillus species, as well as a prior episode of massive hemoptysis. These factors may reflect disease severity, rather than being independent risk factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91030897\">",
"    <span class=\"h2\">",
"     Lung malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both primary and metastatic lung malignancy have been associated with SSP. Among 168 patients with SSP, malignancy was the underlying cause in 16 percent, more commonly primary lung cancer than metastatic disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/3\">",
"     3",
"    </a>",
"    ]. Potential mechanisms include tumor necrosis and endobronchial obstruction with air trapping. As COPD often co-exists with lung malignancy, COPD may contribute to the risk of pneumothorax in these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91030916\">",
"    <span class=\"h2\">",
"     Necrotizing pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSP can complicate the course of necrotizing pneumonia due to bacterial infection, Pneumocystis jirovecii, tuberculosis, and less often fungi [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/3\">",
"     3",
"    </a>",
"    ]. The relative frequency of these etiologies depends on the frequency of these diseases in the population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91030949\">",
"    <span class=\"h3\">",
"     Bacterial pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSP has been associated with bacterial pneumonias caused by Staphylococcus, Klebsiella, Pseudomonas, Streptococcus pneumoniae, and anaerobic organisms. Among 168 patients with SSP, bacterial pneumonia was the etiology in 11 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/3\">",
"     3",
"    </a>",
"    ]. In this setting, SSP can be associated with extension of bacterial infection into the pleura and development of empyema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91030752\">",
"    <span class=\"h3\">",
"     Pneumocystis jirovecii",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with acquired immunodeficiency syndrome (AIDS) who develop SSP, greater than 80 percent have current or previous P. jirovecii pneumonia (PCP). In the era of potent antiretroviral therapy (ART), the frequency of pneumothorax complicating PCP is approximately 5 to 10 percent, although data are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/8\">",
"     8",
"    </a>",
"    ]. The pathogenesis of SSP in PCP is likely alveolar and pleural tissue invasion and rupture of large subpleural cysts that are caused by tissue necrosis. The clinical presentation, diagnosis and management of Pneumocystis pneumonia and pneumothorax are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7577?source=see_link\">",
"     \"Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20678?source=see_link&amp;anchor=H3#H3\">",
"     \"Pneumothorax in HIV-infected patients\", section on 'Pneumocystis jirovecii'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Tuberculosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSP occurs in 1 to 3 percent of patients hospitalized with pulmonary tuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/9\">",
"     9",
"    </a>",
"    ]. The pneumothorax is usually due to rupture of a tuberculous cavity into the pleural space. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=see_link\">",
"     \"Diagnosis of pulmonary tuberculosis in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39673?source=see_link&amp;anchor=H22#H22\">",
"     \"Clinical manifestations and evaluation of pulmonary tuberculosis\", section on 'Pneumothorax'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H185836\">",
"    <span class=\"h2\">",
"     Catamenial pneumothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Catamenial pneumothorax refers to a pneumothorax occurring in association with menses due to thoracic endometriosis and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25254?source=see_link\">",
"     \"Thoracic endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H185829\">",
"    <span class=\"h2\">",
"     Less common causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Less common causes of SSP include ankylosing spondylitis, asthma, histiocytosis X, interstitial lung disease (eg, idiopathic pulmonary fibrosis), lymphangioleiomyomatosis, Marfan syndrome, metastatic sarcoma, rheumatoid arthritis, and sarcoidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/2,10-12\">",
"     2,10-12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=see_link\">",
"     \"Clinical manifestations of ankylosing spondylitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/30/4586?source=see_link\">",
"     \"Pulmonary lymphangioleiomyomatosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20538?source=see_link\">",
"     \"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26969?source=see_link\">",
"     \"Overview of lung disease associated with rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of sarcoidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation of SSP depends upon the volume of air in the pleural space, rapidity of onset, tension within the pleural space, and the patient's age and respiratory reserve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91031076\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with secondary spontaneous pneumothorax (SSP) complain of dyspnea and report chest pain on the same side as the pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/13\">",
"     13",
"    </a>",
"    ]. Symptoms due to SSP are generally more severe than those associated with primary spontaneous pneumothorax, presumably because patients with SSP have less pulmonary reserve due to underlying lung disease. Thus, any impairment of pulmonary function has a more noticeable effect. The intensity of dyspnea can range from a mild increase over baseline to impending cardiopulmonary failure when a tension pneumothorax develops. Patients with an infectious cause of SSP may also have cough, fever, chills, or fatigue.",
"   </p>",
"   <p>",
"    Usually, the patient has a known underlying lung disease, although occasionally the SSP is the presenting manifestation, as with a malignancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91031069\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with a small SSP, physical examination findings may be limited to those of the underlying lung disease. In contrast, characteristic physical findings of a large pneumothorax include decreased chest excursion, diminished breath sounds, absent fremitus, and hyperresonance to percussion on the affected side. Subcutaneous emphysema may be present. Labored breathing and hemodynamic compromise (eg, tachycardia, hypotension) may suggest a possible tension pneumothorax, which necessitates emergency decompression. Tracheal deviation from the midline is a rare and typically late finding in pneumothorax. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91031083\">",
"    <span class=\"h2\">",
"     Arterial blood gases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial blood gases are typically obtained when a patient demonstrates tachypnea, accessory muscle use, a pulse oxygen saturation &lt;92 percent, or has a history of hypercapnia. In patients with SSP, arterial blood gases are frequently abnormal. In one study, the arterial oxygen tension (PaO",
"    <sub>",
"     2",
"    </sub>",
"    ) was below 55 mmHg in 17 percent of patients and below 45 mmHg in 4 percent, while the arterial tension of carbon dioxide (PaCO",
"    <sub>",
"     2",
"    </sub>",
"    ) exceeded 50 mmHg in 16 percent and exceeded 60 mmHg in 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     IMAGING AND DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;An upright chest radiograph is typically obtained as part of the evaluation of new or worsening dyspnea or chest discomfort in a patient with underlying lung disease. The chest radiograph provides the diagnosis of secondary spontaneous pneumothorax (SSP) with the finding of a visceral pleural line, which defines the interface of the lung and pleural air (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56589 \" href=\"UTD.htm?40/52/41797\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71341 \" href=\"UTD.htm?28/47/29430\">",
"     image 2",
"    </a>",
"    ). If the diagnosis of SSP is unclear on the conventional chest radiograph, chest computed tomography is the best modality for determining the presence, size and location of intrapleural air. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22838?source=see_link&amp;anchor=H26874535#H26874535\">",
"     \"Imaging of pneumothorax\", section on 'Chest radiographs'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22838?source=see_link&amp;anchor=H19124390#H19124390\">",
"     \"Imaging of pneumothorax\", section on 'Computed tomography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4333687\">",
"    <span class=\"h2\">",
"     Diagnosing pneumothorax in patients with emphysema",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of a pneumothorax can be challenging in patients with severe emphysema for the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pleural line may be difficult to visualize because the emphysematous lung appears hyperlucent, resulting in minimal difference in the radiodensity of the lung and the pneumothorax.",
"     </li>",
"     <li>",
"      A pneumothorax may be difficult to distinguish from a large, thin-walled, air-containing bulla (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef82207 \" href=\"UTD.htm?20/54/21349\">",
"       image 3",
"      </a>",
"      ). In general, the pleural line associated with a pneumothorax is convex relative to the lateral chest wall, whereas the pleural line associated with a large bulla is usually concave relative to the lateral chest wall. The two conditions can be easily differentiated by computed tomography of the chest [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/60/8136?source=see_link&amp;anchor=H7#H7\">",
"       \"Evaluation and medical management of giant bullae in COPD\", section on 'Imaging'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4333695\">",
"    <span class=\"h2\">",
"     Assessing the size of a pneumothorax",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to confirming the presence of a pneumothorax, the chest radiograph is used to assess the size of the pneumothorax, which is important for management decisions. The size of the pneumothorax is generally determined based on the interpleural distance, which is the distance between the lung margin (visceral pleura) and the chest wall (parietal pleura) at the level of the hilum on a conventional, upright posterior-anterior chest radiograph [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ]. A distance of 2 cm roughly correlates with a 50 percent pneumothorax, which is considered a large pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ]. Other methods for estimating the size of a pneumothorax are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22838?source=see_link&amp;anchor=H26873522#H26873522\">",
"     \"Imaging of pneumothorax\", section on 'Size of pneumothorax'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of SSP includes supplemental oxygen, cardiopulmonary stabilization, and removing air from the pleural space, with subsequent management directed at treating prolonged air leaks and preventing recurrence. In the discussion that follows, we expand upon published clinical consensus statements [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Initial management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost all patients with secondary spontaneous pneumothorax (SSP) should be hospitalized because the underlying lung disease increases the risk for an adverse outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15,17,18\">",
"     15,17,18",
"    </a>",
"    ]. An exception would be stable patients with cystic fibrosis and a small SSP (&lt;1 cm), who may be observed in the outpatient setting if follow-up and ease of access to health care are good [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1029692\">",
"    <span class=\"h3\">",
"     Supplemental oxygen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supplemental oxygen is administered to virtually all patients with SSP to treat hypoxemia and facilitate absorption of air from the pleural space [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ]. However, the concentration of inspired oxygen (FIO",
"    <sub>",
"     2",
"    </sub>",
"    ) should be increased cautiously in patients who have or are at risk for hypercapnia (eg, moderate to severe COPD) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/63/3064?source=see_link&amp;anchor=H12669889#H12669889\">",
"     \"Use of oxygen in patients with hypercapnia\", section on 'Safe administration of oxygen to hypercapnic patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13193876\">",
"    <span class=\"h3\">",
"     Indications for pleural drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of SSP is more complicated than that of primary spontaneous pneumothorax due to the presence of underlying lung disease, which increases the likelihood of persistent air leakage and further expansion of the pneumothorax. Thus, most patients with a SSP will require pleural drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15,20\">",
"     15,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following factors are used to determine the necessity for and type of pleural drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the patient is breathless or the SSP is large (pleural line &gt;2 cm from chest wall), prompt drainage by tube thoracostomy (chest tube placement) is indicated, because of the risk of progressive respiratory impairment or tension pneumothorax [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/21\">",
"       21",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H3139368\">",
"       'Thoracostomy tube size'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=see_link\">",
"       \"Placement and management of thoracostomy tubes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with a pleural line 1 to 2 cm from chest wall, we typically place a small bore chest tube in the pleural space for ongoing drainage. However, centers with experience performing needle aspiration under ultrasound guidance may choose this option. (See",
"      <a class=\"local\" href=\"#H3139394\">",
"       'Tube thoracostomy versus needle aspiration'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Stable, asymptomatic patients with a very small pneumothorax (pleural line &lt;1 cm from chest wall) may be treated with supplemental oxygen and observed for any deterioration in cardiopulmonary status or enlargement of the pneumothorax on a chest radiograph repeated in 12 to 24 hours, or sooner if symptoms worsen. (See",
"      <a class=\"local\" href=\"#H1029692\">",
"       'Supplemental oxygen'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3139394\">",
"    <span class=\"h3\">",
"     Tube thoracostomy versus needle aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tube thoracostomy is generally preferred over needle aspiration for drainage of SSP because it is more likely to be successful [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15,22\">",
"     15,22",
"    </a>",
"    ]. In one trial, 28 patients with SSP were randomly assigned to receive tube thoracostomy and 33 patients to needle aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/23\">",
"     23",
"    </a>",
"    ]. The tube thoracostomy group was more likely to have their pleural air completely evacuated than the needle aspiration group (93 versus 67 percent). The lower success rate of pleural aspiration in SSP than primary spontaneous pneumothorax may be due to a higher rate of persistent air leakage [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/24\">",
"     24",
"    </a>",
"    ]. The technique of needle aspiration of a pneumothorax is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=see_link&amp;anchor=H13#H13\">",
"     \"Primary spontaneous pneumothorax in adults\", section on 'Aspiration'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=see_link\">",
"     \"Placement and management of thoracostomy tubes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the decision is made to proceed with pleural needle aspiration, removal of more than 2.5 L of pleural air suggests a persistent air leak and is an indication for placement of a thoracostomy tube [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H91031239\">",
"    <span class=\"h3\">",
"     Guidance by ultrasound or other imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound or other imaging modalities (eg, fluoroscopy, computed tomography) are used to guide chest tube placement when the pneumothorax is small (but symptomatic) or loculated. However, if the patient has impending respiratory failure due to SSP, tube thoracostomy should not be delayed while waiting for imaging availability. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26408?source=see_link&amp;anchor=H165837042#H165837042\">",
"     \"Thoracic ultrasound: Indications, advantages, and technique\", section on 'Identification of pneumothorax'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=see_link&amp;anchor=H6#H6\">",
"     \"Imaging of pleural effusions in adults\", section on 'Computed tomography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3139368\">",
"    <span class=\"h3\">",
"     Thoracostomy tube size",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small bore catheters have advantages over larger tubes in terms of ease of insertion and patient comfort and also appear to be equally efficacious in most patients in retrospective studies. One retrospective study included 91 patients, 22 of whom were treated with a large bore (20 to 28 Fr) tube and 69 with a small bore (10 to 14 Fr) tube [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/25\">",
"     25",
"    </a>",
"    ]. Successful treatment was reported in 72 percent of both patient groups. No significant differences were noted in terms of length of hospital stay, extubation time, recurrence rate, and complications. In a separate case series that included 114 patients with SSP, placement of a small bore catheter (12 Fr) was associated with a low (7 percent) overall failure rate and a mean duration of drainage of 4.42 days [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One possible exception to the use of small bore tubes for SSP would be patients receiving mechanical ventilation. The choice is generally made on a case-by-case basis, depending on the severity of the underlying lung disease and the anticipated rate of air leakage. Traditionally, large bore tubes (24 to 28 Fr) have been used to decompress pneumothoraces in patients receiving mechanical ventilation, because of concerns about small bore tubes not being adequate for large volume air leaks during positive pressure ventilation. However, in a retrospective study of 62 patients with pneumothoraces complicating mechanical ventilation, small bore tubes were successful in 69 percent of pneumothoraces [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/27\">",
"     27",
"    </a>",
"    ]. In this study, small bore tubes were less likely to be successful when treating barotrauma-induced pneumothoraces, when compared with pneumothoraces caused by lung puncture during procedures such as central line insertion. Thus, patients who are clinically unstable (eg, tension pneumothorax) or who have barotrauma complicating mechanical ventilation are generally managed with a 24 to 28 French (Fr) chest tube, due to the increased risk for a large air leak.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3139375\">",
"    <span class=\"h3\">",
"     Chest tube management",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest tube or catheter should be connected to a water seal device, generally without application of suction due to the risk of re-expansion pulmonary edema [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ]. Failure of the pneumothorax to resolve should lead to the initiation of suction if it was not initially applied. A Heimlich valve can also be used, although a water seal device is preferable as it allows monitoring of the rate of air leakage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=see_link&amp;anchor=H254981216#H254981216\">",
"     \"Placement and management of thoracostomy tubes\", section on 'Drainage system'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In general, the chest tube should remain in place until a procedure is performed to prevent recurrent SSP. However, patients who decline preventive interventions can have their chest tube clamped twelve hours after the lung has expanded radiographically and no further air leak is detected via the chest tube. A chest radiograph should be performed 12 to 24 hours after the chest tube is clamped and, if the pneumothorax has not recurred, the chest tube can be removed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=see_link&amp;anchor=H254981706#H254981706\">",
"     \"Placement and management of thoracostomy tubes\", section on 'Removal'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An alternative approach for stable patients whose lung is at least 90 percent expanded, but who have a persistent air leak, is to attach a Heimlich valve to the chest tube and discharge the patient to home [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. The advantage of this regimen is that it allows the patient to avoid a long-term hospitalization. However, a separate procedure to prevent a recurrent SSP is typically performed in patients who are surgical candidates. (See",
"    <a class=\"local\" href=\"#H1032463\">",
"     'Preventing recurrence'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     After initial stabilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;After initial stabilization of the SSP, some patients will need an additional intervention to treat a persistent air leak and most will need a procedure to prevent recurrence (eg, stapling of blebs, mechanical or chemical pleurodesis) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ]. For those who require an intervention for prolonged air leakage, the two procedures are typically performed at the same time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1032319\">",
"    <span class=\"h3\">",
"     Persistent air leakage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Persistent air leaks are more common and tend to persist longer in SSP, compared to primary spontaneous pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/30\">",
"     30",
"    </a>",
"    ]. Persistent air leaks may be due to subpleural bullae or cysts (eg, COPD, Pneumocystis pneumonia) or to necrotic lung (eg, pneumonia) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/31\">",
"     31",
"    </a>",
"    ]. For patients who have a persistent air leak after three days of tube thoracostomy drainage or failure of the lung to re-expand fully, it becomes progressively less likely that spontaneous closure of the leak will occur and additional interventions may be appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15,21\">",
"     15,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Video-assisted thoracoscopic surgery",
"      </strong>",
"       For surgical candidates with a persistent leak",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      incomplete lung expansion (&lt;90 percent), the preferred procedure is stapling or resection of blebs and mechanical pleurodesis via video-assisted thoracoscopic surgery (VATS) or open thoracotomy. As an alternative, VATS with",
"      <span class=\"nowrap\">",
"       stapling/resection",
"      </span>",
"      of blebs and intraoperative chemical pleurodesis can be performed. As pleurodesis is performed as part of the procedure, the two goals of closure of the air leak and prevention of recurrence are accomplished with one operation. Additional details of VATS and thoracotomy are discussed below. (See",
"      <a class=\"local\" href=\"#H1032463\">",
"       'Preventing recurrence'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Blood patch or chemical pleurodesis",
"      </strong>",
"       For patients who have a persistent or refractory air leak, but are not candidates for surgery, we suggest bedside application of a blood patch or chemical pleurodesis. A few case series have described the successful use of a pleural blood patch (also known as blood patch pleurodesis) for patients with a persistent air leak complicating acute respiratory distress syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/32-36\">",
"       32-36",
"      </a>",
"      ]. Blood patch pleurodesis is performed by drawing approximately 100 mL of the patient's venous blood under sterile conditions and instilling it into the pleural space through the chest tube. However, empyema complicated 9 percent of blood pleurodesis cases in one report [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/35\">",
"       35",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Chemical pleurodesis via the chest tube with a",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"       tetracycline",
"      </a>",
"      derivative or size-calibrated talc is another option for management of a persistent air leak, although success is much lower than with VATS. The technique is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36232?source=see_link&amp;anchor=H15#H15\">",
"       \"Chemical pleurodesis\", section on 'Technique'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Conservative management",
"      </strong>",
"       Some patients with severe underlying lung disease who are poor surgical candidates may prefer a longer period of conservative management with supplemental oxygen and chest tube drainage. Spontaneous resolution has been described with conservative management after as long as 14 days [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15,20\">",
"       15,20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1032463\">",
"    <span class=\"h3\">",
"     Preventing recurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;We advocate performing an intervention to prevent recurrence in almost all patients treated for an initial SSP once the patient has been stabilized and initial drainage of pleural air established [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ]. This advice is based on the observation that recurrence of SSP is common and frequently life-threatening. One study reported a 50 percent likelihood of recurrent SSP over three years among patients with a SSP due to COPD, who did not have an intervention to prevent recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As noted above, for patients with a persistent air leak, an intervention to control the leak and prevent recurrence (pleurodesis) is performed within a few (eg, 3 to 5) days of hospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ]. For patients with full re-expansion and no evidence of persistent air leak, surgery to prevent recurrence is typically performed during the same hospitalization prior to removal of the chest tube, as recurrence tends to occur relatively early.",
"   </p>",
"   <p>",
"    The three main options are thoracotomy, video-assisted thoracoscopic surgery (VATS), and chemical pleurodesis. The decision among these options depends on the preferences of the surgical team and whether the patient is an operative candidate at present or a lung transplant candidate in the future. (See",
"    <a class=\"local\" href=\"#H1032988\">",
"     'Lung transplant candidates'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Surgical options",
"      </strong>",
"      &ndash; Meta-analyses comparing open thoracotomy with VATS have shown lower recurrence rates with open procedures (approximately 1 percent with open versus 5 percent with VATS), but greater blood loss, more postoperative pain, and longer hospital stays [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15,37,38\">",
"       15,37,38",
"      </a>",
"      ]. Due to the potential for lower morbidity, VATS with stapling of blebs followed by obliteration of the pleural space is the preferred intervention in most patients [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15,39,40\">",
"       15,39,40",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Several methods are available for obliteration of the pleural space, including pleural abrasion with dry gauze [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/41\">",
"       41",
"      </a>",
"      ], apical pleurectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/42\">",
"       42",
"      </a>",
"      ], intraoperative insufflation of talc [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/43\">",
"       43",
"      </a>",
"      ], and laser abrasion of the parietal pleura [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/44,45\">",
"       44,45",
"      </a>",
"      ]. We prefer mechanical pleurodesis, using pleural abrasion with gauze, since it is effective and simple to perform.",
"      <br/>",
"      <br/>",
"      For surgical candidates who have a persistent air leak, the optimal surgical techniques to ensure closure of the air leak(s) are uncertain. Most surgeons recommend stapling of blebs, since recurrence rates are substantially higher if the blebs are not closed [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/46,47\">",
"       46,47",
"      </a>",
"      ]. In contrast, one study of patients with AIDS-related pulmonary infections reported success in seven out of eight patients using VATS-directed insufflation of talc without direct treatment of the air leak [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/48\">",
"       48",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      For patients with emphysema who meet inclusion and exclusion criteria for lung volume reduction surgery (LVRS), it may be appropriate to perform LVRS at the time of surgical pleurodesis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link&amp;anchor=H7#H7\">",
"       \"Lung volume reduction surgery in COPD\", section on 'Patient selection'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      <strong>",
"       Nonsurgical chemical pleurodesis",
"      </strong>",
"      &ndash; For patients who refuse VATS or are not operative candidates, we suggest chemical pleurodesis, rather than no further intervention [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"       15",
"      </a>",
"      ]. However, this technique is not as effective as the VATS with pleurodesis procedure described above [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/5,49\">",
"       5,49",
"      </a>",
"      ]. Chemical pleurodesis administered via the chest tube reduces the SSP recurrence rate from 40 to 50 percent to approximately 15 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/5,15,50\">",
"       5,15,50",
"      </a>",
"      ]. It is performed by instilling a sclerosant into the pleural space. Although the choice of a sclerosant is controversial, we prefer",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      over talc, because we believe it is the safer option [",
"      <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/51-53\">",
"       51-53",
"      </a>",
"      ]. The usual intrapleural dose of doxycycline is 500 mg. Technical aspects of chemical pleurodesis are discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36232?source=see_link\">",
"       \"Chemical pleurodesis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30615?source=see_link\">",
"       \"Talc pleurodesis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1032988\">",
"    <span class=\"h3\">",
"     Lung transplant candidates",
"    </span>",
"    &nbsp;&mdash;&nbsp;For lung transplant candidates, we avoid chemical pleurodesis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/54\">",
"     54",
"    </a>",
"    ]. Chemical pleurodesis increases the risk of excessive bleeding during transplantation, although it does not preclude future lung transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"     15",
"    </a>",
"    ]. Instead, VATS-directed mechanical abrasion of the apical pleural surface is performed to achieve apical pleurodesis. This partial pleurodesis usually prevents large pneumothoraces without creating full pleurodesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=see_link&amp;anchor=H8#H8\">",
"     \"Lung transplantation: General guidelines for recipient selection\", section on 'Previous cardiothoracic surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8057763\">",
"    <span class=\"h3\">",
"     Air travel",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal length of time to wait after resolution of a secondary pneumothorax before travelling by air is not known. The type of treatment the patient received (eg, simple drainage versus pleurodesis) likely influences the risk of recurrence during air travel, although this has not been studied. In general, air travel is postponed for at least two weeks following radiographic resolution of a spontaneous pneumothorax. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35271?source=see_link&amp;anchor=H228050519#H228050519\">",
"     \"Pneumothorax and air travel\", section on 'Disease-specific management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should be assessed for potential in-flight hypoxemia and supplemental oxygen supplied when necessary. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/10/28840?source=see_link&amp;anchor=H5#H5\">",
"     \"Traveling with oxygen aboard commercial air carriers\", section on 'Screening for in-flight hypoxemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/30/40418?source=see_link\">",
"       \"Patient information: Pneumothorax (collapsed lung) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H959384\">",
"    <span class=\"h2\">",
"     Etiologies and clinical features",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A secondary spontaneous pneumothorax (SSP) is a pneumothorax that occurs as a complication of underlying lung disease, most commonly chronic obstructive pulmonary disease (COPD). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiologies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with SSP usually complain of dyspnea and also chest pain on the same side as the pneumothorax. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of SSP is established by detection of a visceral pleural line on the chest radiograph of a patient with underlying lung disease. If the diagnosis is unclear based on a conventional chest radiograph (eg, due to underlying bullae, emphysema), chest computed tomography (CT) is obtained for clarification. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Imaging and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The size of the pneumothorax is estimated on the chest radiograph based on the distance between the visceral pleural line and the chest wall at the level of the hilum. A pneumothorax is considered large if the pleural line is more than 2 cm from the chest wall. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Imaging and diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Initial management",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We advise initial hospitalization of all patients with SSP because the underlying lung disease increases the risk for an adverse outcome. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinically unstable patients with SSP require a chest tube regardless of the size of the pneumothorax. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For clinically stable patients with a large SSP (pleural line &gt;2 cm from chest wall), we recommend insertion of a chest tube, rather than observation or simple aspiration, regardless of the presence of symptoms (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). This recommendation is based on the risk of rapid progression to respiratory failure or tension pneumothorax in these patients. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Initial management'",
"      </a>",
"      above.)",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who have a small pneumothorax (pleural line &lt;2 cm from chest wall) and are minimally breathless, we suggest drainage of pleural air, rather than observation (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). In the setting of SSP, placement of a small bore catheter (10 to 14 Fr) is generally preferred over needle aspiration. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For clinically stable, asymptomatic patients with a very small SSP (ie, pleural line &lt;1 cm from chest wall), close observation may be an acceptable alternative to immediate pleural drainage. Onset of symptoms or an enlarging pneumothorax would be indications for pleural drainage. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We believe that patients who are clinically unstable or who may have a large air leak (eg, patients with barotrauma due to mechanical ventilation) are best managed with a 24 to 28 French (Fr) chest tube. For the majority of other patients who require pleural drainage, a 10 to 14 Fr chest tube should be sufficient. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When managing SSP, the chest tube is usually connected to a water seal device, rather than a Heimlich valve. Suction is usually NOT applied to the chest tube initially, but should be applied if the pneumothorax fails to resolve. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Initial management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For surgical candidates who have an air leak that persists for more than three days, we suggest video assisted thoracoscopy (VATS) with stapling or resection of blebs and pleurodesis, rather than ongoing management with a chest tube (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Alternative approaches for patients who are not surgical candidates include the performance of a blood patch, chemical pleurodesis through the chest tube, or a longer period of pleural drainage. (See",
"      <a class=\"local\" href=\"#H1032319\">",
"       'Persistent air leakage'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Preventing recurrence",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend that patients undergo a preventive intervention after their initial SSP, rather than waiting until a second SSP occurs (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). For recurrence prevention, we recommend thoracotomy or VATS with stapling of blebs and pleural abrasion, rather than nonsurgical chemical pleurodesis via the chest tube (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Thoracotomy is associated with a slightly lower rate of recurrence than VATS, but greater initial morbidity. (See",
"      <a class=\"local\" href=\"#H1032463\">",
"       'Preventing recurrence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who are not operative candidates or who refuse VATS, we recommend chemical pleurodesis via the chest tube, rather than forgoing an intervention (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1032463\">",
"       'Preventing recurrence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For potential lung transplant candidates, the preferred procedure is VATS-directed mechanical abrasion of the apical pleural surface to achieve apical pleurodesis without generalized pleurodesis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1032988\">",
"       'Lung transplant candidates'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/1\">",
"      Sahn SA, Heffner JE. Spontaneous pneumothorax. N Engl J Med 2000; 342:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/2\">",
"      Noppen M, De Keukeleire T. Pneumothorax. Respiration 2008; 76:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/3\">",
"      Chen CH, Liao WC, Liu YH, et al. Secondary spontaneous pneumothorax: which associated conditions benefit from pigtail catheter treatment? Am J Emerg Med 2012; 30:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/4\">",
"      Guo Y, Xie C, Rodriguez RM, Light RW. Factors related to recurrence of spontaneous pneumothorax. Respirology 2005; 10:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/5\">",
"      Light RW, O'Hara VS, Moritz TE, et al. Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax. Results of a Department of Veterans Affairs cooperative study. JAMA 1990; 264:2224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/6\">",
"      Flume PA, Strange C, Ye X, et al. Pneumothorax in cystic fibrosis. Chest 2005; 128:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/7\">",
"      Flume PA. Pneumothorax in cystic fibrosis. Chest 2003; 123:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/8\">",
"      Radhi S, Alexander T, Ukwu M, et al. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003. BMC Infect Dis 2008; 8:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/9\">",
"      WILDER RJ, BEACHAM EG, RAVITCH MM. Spontaneous pneumothorax complicating cavitary tuberculosis. J Thorac Cardiovasc Surg 1962; 43:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/10\">",
"      Rigante D, Segni G, Bush A. Persistent spontaneous pneumothorax in an adolescent with Marfan's syndrome and pulmonary bullous dysplasia. Respiration 2001; 68:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/11\">",
"      Hoag JB, Sherman M, Fasihuddin Q, Lund ME. A comprehensive review of spontaneous pneumothorax complicating sarcoma. Chest 2010; 138:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/12\">",
"      Karpman C, Aughenbaugh GL, Ryu JH. Pneumothorax and bullae in Marfan syndrome. Respiration 2011; 82:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/13\">",
"      Dines DE, Clagett OT, Payne WS. Spontaneous pneumothorax in emphysema. Mayo Clin Proc 1970; 45:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/14\">",
"      Bourgouin P, Cousineau G, Lemire P, H&eacute;bert G. Computed tomography used to exclude pneumothorax in bullous lung disease. J Can Assoc Radiol 1985; 36:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/15\">",
"      MacDuff A, Arnold A, Harvey J, BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 Suppl 2:ii18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/16\">",
"      Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/17\">",
"      Flume PA, Mogayzel PJ Jr, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med 2010; 182:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/18\">",
"      Tschopp JM, Rami-Porta R, Noppen M, Astoul P. Management of spontaneous pneumothorax: state of the art. Eur Respir J 2006; 28:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/19\">",
"      O'Driscoll BR, Howard LS, Davison AG, British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax 2008; 63 Suppl 6:vi1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/20\">",
"      Chee CB, Abisheganaden J, Yeo JK, et al. Persistent air-leak in spontaneous pneumothorax--clinical course and outcome. Respir Med 1998; 92:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/21\">",
"      Schoenenberger RA, Haefeli WE, Weiss P, Ritz RF. Timing of invasive procedures in therapy for primary and secondary spontaneous pneumothorax. Arch Surg 1991; 126:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/22\">",
"      Light RW. Pleural controversy: optimal chest tube size for drainage. Respirology 2011; 16:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/23\">",
"      Andrivet P, Djedaini K, Teboul JL, et al. Spontaneous pneumothorax. Comparison of thoracic drainage vs immediate or delayed needle aspiration. Chest 1995; 108:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/24\">",
"      Kiely DG, Ansari S, Davey WA, et al. Bedside tracer gas technique accurately predicts outcome in aspiration of spontaneous pneumothorax. Thorax 2001; 56:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/25\">",
"      Tsai WK, Chen W, Lee JC, et al. Pigtail catheters vs large-bore chest tubes for management of secondary spontaneous pneumothoraces in adults. Am J Emerg Med 2006; 24:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/26\">",
"      Cafarotti S, Dall'Armi V, Cusumano G, et al. Small-bore wire-guided chest drains: safety, tolerability, and effectiveness in pneumothorax, malignant effusions, and pleural empyema. J Thorac Cardiovasc Surg 2011; 141:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/27\">",
"      Lin YC, Tu CY, Liang SJ, et al. Pigtail catheter for the management of pneumothorax in mechanically ventilated patients. Am J Emerg Med 2010; 28:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/28\">",
"      Vricella LA, Trachiotis GD. Heimlich valve in the management of pneumothorax in patients with advanced AIDS. Chest 2001; 120:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/29\">",
"      Choi SH, Lee SW, Hong YS, et al. Can spontaneous pneumothorax patients be treated by ambulatory care management? Eur J Cardiothorac Surg 2007; 31:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/30\">",
"      Mathur R, Cullen J, Kinnear WJ, Johnston ID. Time course of resolution of persistent air leak in spontaneous pneumothorax. Respir Med 1995; 89:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/31\">",
"      Sepkowitz KA, Telzak EE, Gold JW, et al. Pneumothorax in AIDS. Ann Intern Med 1991; 114:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/32\">",
"      Rinaldi S, Felton T, Bentley A. Blood pleurodesis for the medical management of pneumothorax. Thorax 2009; 64:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/33\">",
"      Ando M, Yamamoto M, Kitagawa C, et al. Autologous blood-patch pleurodesis for secondary spontaneous pneumothorax with persistent air leak. Respir Med 1999; 93:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/34\">",
"      Mart&iacute;nez-Escobar S, Ruiz-Bail&eacute;n M, Lorente-Acosta MJ, et al. Pleurodesis using autologous blood: a new concept in the management of persistent air leak in acute respiratory distress syndrome. J Crit Care 2006; 21:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/35\">",
"      Cagirici U, Sahin B, Cakan A, et al. Autologous blood patch pleurodesis in spontaneous pneumothorax with persistent air leak. Scand Cardiovasc J 1998; 32:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/36\">",
"      Aihara K, Handa T, Nagai S, et al. Efficacy of blood-patch pleurodesis for secondary spontaneous pneumothorax in interstitial lung disease. Intern Med 2011; 50:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/37\">",
"      Barker A, Maratos EC, Edmonds L, Lim E. Recurrence rates of video-assisted thoracoscopic versus open surgery in the prevention of recurrent pneumothoraces: a systematic review of randomised and non-randomised trials. Lancet 2007; 370:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/38\">",
"      Vohra HA, Adamson L, Weeden DF. Does video-assisted thoracoscopic pleurectomy result in better outcomes than open pleurectomy for primary spontaneous pneumothorax? Interact Cardiovasc Thorac Surg 2008; 7:673.",
"     </a>",
"    </li>",
"    <li>",
"     Light, RW. Pleural Diseases, Lippincott, Williams and Wilkins, Philadelphia 2007. p.306.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/40\">",
"      Shaikhrezai K, Thompson AI, Parkin C, et al. Video-assisted thoracoscopic surgery management of spontaneous pneumothorax--long-term results. Eur J Cardiothorac Surg 2011; 40:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/41\">",
"      Fosse E, Fjeld NB, Brockmeier V, Buanes T. Thoracoscopic pleurodesis. Scand J Thorac Cardiovasc Surg 1993; 27:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/42\">",
"      Waller, DA, Yoruk, Y, Morritt, GN, et al. Videothoracoscopy in the treatment of spontaneous pneumothorax: An initial experience. Ann Royal College Surg Eng 1993; 75:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/43\">",
"      Milanez JR, Vargas FS, Filomeno LT, et al. Intrapleural talc for the prevention of recurrent pneumothorax. Chest 1994; 106:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/44\">",
"      Torre M, Grassi M, Nerli FP, et al. Nd-YAG laser pleurodesis via thoracoscopy. Endoscopic therapy in spontaneous pneumothorax Nd-YAG laser pleurodesis. Chest 1994; 106:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/45\">",
"      Bobbio A, Ampollini L, Internullo E, et al. Thoracoscopic parietal pleural argon beam coagulation versus pleural abrasion in the treatment of primary spontaneous pneumothorax. Eur J Cardiothorac Surg 2006; 29:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/46\">",
"      Horowitz MD, Oliva H. Pneumothorax in AIDS patients: operative management. Am Surg 1993; 59:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/47\">",
"      Naunheim KS, Mack MJ, Hazelrigg SR, et al. Safety and efficacy of video-assisted thoracic surgical techniques for the treatment of spontaneous pneumothorax. J Thorac Cardiovasc Surg 1995; 109:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/48\">",
"      Wait MA, Dal Nogare AR. Treatment of AIDS-related spontaneous pneumothorax. A decade of experience. Chest 1994; 106:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/49\">",
"      Alfageme I, Moreno L, Huertas C, et al. Spontaneous pneumothorax. Long-term results with tetracycline pleurodesis. Chest 1994; 106:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/50\">",
"      Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/51\">",
"      Sahn SA. Talc should be used for pleurodesis. Am J Respir Crit Care Med 2000; 162:2023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/52\">",
"      Light RW. Talc should not be used for pleurodesis. Am J Respir Crit Care Med 2000; 162:2024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/53\">",
"      Ghio AJ, Roggli V, Light RW. Talc should not be used for pleurodesis in patients with nonmalignant pleural effusions. Am J Respir Crit Care Med 2001; 164:1741; author reply 1741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/35/24121/abstract/54\">",
"      Noyes BE, Orenstein DM. Treatment of pneumothorax in cystic fibrosis in the era of lung transplantation. Chest 1992; 101:1187.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6691 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-41.196.66.12-20F8DF7B33-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24121=[""].join("\n");
var outline_f23_35_24121=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Chronic obstructive pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H91030897\">",
"      Lung malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H91030916\">",
"      Necrotizing pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H91030949\">",
"      - Bacterial pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H91030752\">",
"      - Pneumocystis jirovecii",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H185836\">",
"      Catamenial pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H185829\">",
"      Less common causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H91031076\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H91031069\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H91031083\">",
"      Arterial blood gases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      IMAGING AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4333687\">",
"      Diagnosing pneumothorax in patients with emphysema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4333695\">",
"      Assessing the size of a pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Initial management",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1029692\">",
"      - Supplemental oxygen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13193876\">",
"      - Indications for pleural drainage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3139394\">",
"      - Tube thoracostomy versus needle aspiration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H91031239\">",
"      - Guidance by ultrasound or other imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3139368\">",
"      - Thoracostomy tube size",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3139375\">",
"      - Chest tube management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      After initial stabilization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1032319\">",
"      - Persistent air leakage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1032463\">",
"      - Preventing recurrence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1032988\">",
"      - Lung transplant candidates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8057763\">",
"      - Air travel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H959384\">",
"      Etiologies and clinical features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Initial management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Preventing recurrence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6691\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6691|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/52/41797\" title=\"diagnostic image 1\">",
"      Chest Xray of pneumothorax after stab wound",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/47/29430\" title=\"diagnostic image 2\">",
"      Atypical pneumothorax PA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/54/21349\" title=\"diagnostic image 3\">",
"      Giant bilateral bullae PA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36232?source=related_link\">",
"      Chemical pleurodesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30954?source=related_link\">",
"      Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39673?source=related_link\">",
"      Clinical manifestations and evaluation of pulmonary tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/9/151?source=related_link\">",
"      Clinical manifestations of ankylosing spondylitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/53/21338?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7577?source=related_link\">",
"      Clinical presentation and diagnosis of Pneumocystis infection in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/49/28442?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39274?source=related_link\">",
"      Cystic fibrosis: Overview of the treatment of lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/56/9098?source=related_link\">",
"      Diagnosis of pulmonary tuberculosis in HIV-negative patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/60/8136?source=related_link\">",
"      Evaluation and medical management of giant bullae in COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20538?source=related_link\">",
"      Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=related_link\">",
"      Imaging of pleural effusions in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/19/22838?source=related_link\">",
"      Imaging of pneumothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=related_link\">",
"      Lung transplantation: General guidelines for recipient selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=related_link\">",
"      Lung volume reduction surgery in COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/21/26969?source=related_link\">",
"      Overview of lung disease associated with rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/30/40418?source=related_link\">",
"      Patient information: Pneumothorax (collapsed lung) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/12/1226?source=related_link\">",
"      Placement and management of thoracostomy tubes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35271?source=related_link\">",
"      Pneumothorax and air travel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20678?source=related_link\">",
"      Pneumothorax in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/3/10297?source=related_link\">",
"      Primary spontaneous pneumothorax in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/30/4586?source=related_link\">",
"      Pulmonary lymphangioleiomyomatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30615?source=related_link\">",
"      Talc pleurodesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/42/25254?source=related_link\">",
"      Thoracic endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/50/26408?source=related_link\">",
"      Thoracic ultrasound: Indications, advantages, and technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/10/28840?source=related_link\">",
"      Traveling with oxygen aboard commercial air carriers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/63/3064?source=related_link\">",
"      Use of oxygen in patients with hypercapnia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_35_24122="Lichen sclers lost archectectur";
var content_f23_35_24122=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57562%7EOBGYN%2F54149%7EOBGYN%2F70014&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57562%7EOBGYN%2F54149%7EOBGYN%2F70014&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Loss of architecture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 258px; height: 393px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGJAQIDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDg7i4aV5NzgEEqAnPT0I6g461NbX3lvEkxSOUuEBHQDOCOOpweTXO2F1KWkMcaK7c7pPlCr26e1OurmaRAFktfs7fNuEJMm1eSyg9uB9feqSutBOSWrO4jvACY40ZtoAIGCasrMNhMjFNowQxwfxzXBprlxaQSRwIiIqqWLEu0jEcsDgEdOmSB2qhc+Jb2WSYXSr5SYUrMo2jPcd8n16Cp9kk9R+07HoMt/GUCrIp6fdOazr2cNECzdWHBrjNK1y1upTFMhtnZSYzs27jngBvf344NW2uruSdCSkycndndgd8ke9Ty6hzHSC5B3SOrbFBORzTY7gBd+3GT3PHt+v8AnpXOS6wbhgoEi54RVwwIHPWr6XZjABkw+OuOc0NWBSuacd1HcIY0kXzOcgNz6jjrUJuIktw8r+Ww44yM/hWI97Bc3DAHOMKcrg/UY6Gs+XUUiMU8tztfnHPUAnB49sc01GwcyaNjUNVxCxEcqqv/AC0A9+9VrjVWMUU0ISRN2AysMn2rJk1iK4gMZlRUzkgt97BrHOow/aN8R2JG3AbnPoOKpIhs6y3uo7tGLMxkzznnHt/9eqV66w/MygRydJPf0rGv7h4WeRp2jlODgDbn8COlQwXrXYZCQTjJBGMj1p2sK6ZoS3BVWG8so5DcZH+fWqjTl1yGJB/HFRyAh12Esvf5uKjnJWRAuAWPIqtCbEczMVJDH8Ov41UckqCWq/PkrhwFJ5BPf8Ko3ETqsbOpVJBuUZ5I9fpS9QsuhX3tg4b+dIWbHWkYcsVzt9R2prNjleAe5o0GkO3OV4J9TzTd7DuaQ+xJNJjgc8UirI6Xw34rudJQW8ym5s858vdtZD6qf6V6noevhoYdQsrjMYwu84Kn1SRT29R+XrXhH41Ysb24sZS9rM8TkYbb3HoR3pONzoo4h09HsfZdnJZ6/o0up6KiI9mqjUNM3Ey2x7Mn96M9QfTPcEDnQqt4iidmJt5E+VhyMZ6/pXlHgLx8YNVtJ4Zl03V48Ikpb9zMP4kb/ZOPunj0IOK9eaCPUILvV9NDK6kvdWROTasepX1jPUHHHNZyjzK3X8zvpVVHVPT8v6/rodc9zEsaxDO4r0x2rNvFFwxwCE25x1P6fSuY069lu542jctG3DNnjA7Z+tdjauZ1HygHjHH+eKwafU3i+V6GfFZoVRlRIoh6jDNn2qotsdRvSScWcbfvCWxuPYVc1K5aSV4sYgDZ4P49P5VFetLdWsdpaQuIxweME4/xqkdtJyWrLU2vO8b6fpSm3tf43B2qQO2c81d02FvsKysnlWagHaW2mXHUZ7cdx/SqGk2cduDE1q95eYwsfQL2Ga6W4t/7KjjfW5RdX7j9zZKwOwDuc8AfWtYty1FUlGPuQ6/e/wCu5kpb3qIqwrZmIDCGWJi5HbcQeT60VaF1ORlpbdSeq7+ntRU38/wC8uyPlu1W4vrphAwRGzja6OUT3AHXt6fWnalaNbC082eT94/zlgCSBjgbcH8qtX4KSb0tbaK6YfNJyGkUgnPHsP1rmLnUX3O3lzQ3MhAAZTlWDcLhueMY4rZas+Xehd1SZbC2fyYkhikG5MyEbvw647896qX16lvbyMZCjhPLCqxV0k6lie/X3FZT2+owag0t6Cs0MuWjldVZG+9gqTkc80976KzgkaO2tXmlY5lZxNnucDoCCf8A9fWqSsTe461hu7yBbaKEXZKl1kBYmNVXczZzwoAJbI4xnNWdGupI7RI7eOJSu+ZJdxUuq/e3AnB4BIxg1XTWGucxM115kyiKXyiFLrtAKcdmIGRj+EUyYhbu2WOXbFHJtUyqUVGBxyo5B9SR2pk7E0upQ/bYkLgGJt4lQ5Vm9vTr396v3epedIyyPJFtPygL9/v0NYsMKyq8k8RidG3LvG2NY9wzjPXk4/SjUY5Ut0vD50cczsE8xcAkddmSSAOOp70kru4N9ELdXzLM0MErorHk4xg9z7CriF/tQRrSMSRxjHygg++OpPTI/lWVbGMWzGW5VXY9dpJX1BOOp/SpYYiyTC3uVmgVN4OxjtORwOBjr171XKmLbQRIHLySiJ5AoLHYuSCeOQMgdarzxywr9lkkYRgiRlUZXJA/XHFW4r17C6WNbmaIrhZHibcTj0HT8+eKilkLTvE8jOxO1WdDkZ5yfcmnYB1vmSykaYM0ULYWTf8AxHooHfgE8elROBNL5kjuFzzIEwGHTIHFEEsCXIEssgiVWICAHL7eB1AAJ4z2HOD0qSdYXZmkZixDN5WQFVvr36jmhbWC2pZsLO5vQIoEluneTZGkXVuMsdvVsDsKhMc0l2BG8vlNJgKozjJwFG7qeO9QQG4uomREkkWENMQnYDGWOOgHrUpMs8cSWyuCG2Asf9Yx6cHqeg47AUrhbuRyF7PUWjkhc+U5Uxyfe79cfnxReXP2hIQuxSsYQgew/TNWobC4s7m2mvSixtIwAck79hG8FQCw/EVHMykl5IVnjDts2yhsKM4BA6HpycUupXQzjt+z8Bw2eQTxTry1ubKTyLuCeCQgExzRlDg9Dg1ZYOtnG8e3yCW2grkkd8mi7u77UhCbu8nvWij2RrNIzlFH8K57D0FJagV7W1aW8htjIqmUhQwOQC3QH8cfSmXVvJayPDP8k8btHJEQdyMDgg1oWujXE8M1xdH7NaQgbppOhOMhQM5LYxwOmecDmo51glvv9FEs8SjlrgrG0mO+ATg/ifXNCQ79TPGcZ5xTS2c5/P1rZtHggaaHcXhuYzFLGVzsbPyspB5wQD9CR3rKmheGR45kKyIxDAjoRQMYG56cd667wr4+1nQL21nhuXka2IETOcui91B7qR1U5FcnsO4qo3H2GfxqWG0uJkleGCR1gTzJSq8Rr0yx7DJA+pxUtXHGbjqmfTng7xPpfjPU76x0G0aC7WJrpUXiOeRcF1RD0yMnH+ya6eC88uUxyA+bzkAct3H6GvlTwb4ku/C+vW2pWUkiPFIHPlkA5HQjPGR+oyDwTX1VLqlp4j0618R2CxKJv3dxHE24JNj5tuD91hyO4rOpHm9T0cLW6P8Ar/gFh4d8A3qxbOdx5x+A71Lpu2JQIQqKeZJmOMDP59KqJqFvMdqBpXH3Yx/F2PtWrY2wUI9y5Dn5vLA+VeOmBWB6HPZal63upLdtuk25jlIwbiRdoHuAetR7E3sdhknPzSSucFz35+vanFjKApYAN2HGRUtttV9jo7lhgJkAsPduwq1K+glNLUqpZ2xRSyvuxziQYz+dFdFHIVjVVu7FAAAFW0LBfYHv9aKrkXdC+sy/q/8AkfGuoa4ttpsoto5pZrpEjBDkrCp6kZXJkbA+bIC843HkZl1o08Gni/1GynO6Qb/LODET91W3HO456kHp3Ocdx/wjMVuAsl19hm5G4OzByeD8w45GRxyBx6ip7HwM0YjFhqi27hi26GyNtKoK7MtM5DBWBI25AOSTW3OrnheznY8we2SO1d7qOdFYebBE8jA4JxkjGOfXIz2rPhkKQSIrrAxBDsc5Yf3e/v8AWvUZ/CU7wXENjqVjcGzI4W9XfGQdoy2HJ/2VzhSc/LnnkX8NQW8pEuobmjJG5FcbSvVWBUFec8npjPtVc3UjkaMJLe7sbhAhEUmchllX5QQCMMD3GOR/jWjBcLbNbSLezz3gYDFouXRDnO2Qg4bJ7dMk8mtu68NeTBl9M1FVdvk2W4Y4zj7+Px5IOT3plnp0V/ILWzsnkdpPLihxmUvk43MAA7de2FCknFF1YTi76lK91SZdEGky3UcUUM5leyy0hdgCELsPl3IGIyCOvIGKztQs7ZLpY4tQfVXC7tioxUHHzLuzyVxyVyOOCRzWpLZRPCXt4U8qBVWWZ0EZctnG1VI42jrtyec9RUUGmpDd3q2lo82cpBIGdNik8SE7SAMf7Q/GnsFn0MV38i5Et9CDHIgJiiYIzIw65AOD0PPP1zVU3IHkq6RusShSrKRu+YsQT174yMcVvfYfsc5xbOW2tIyQll8oDgFmkXHoeAevY8VDbCXyYYYbZFnQsTcMjOCQASCNpHGOv64ouJLuU21aQ2kdtMiyRIP3cW/5FDdeF5J6ck5GMe1aNxpDwzzTwWF05gkIuY1QzRW4PRTJ0ycnnPGO9Um06SVkkknhSR2BKxoQwX+8VC5AxzwOf5uttOnn2BftEtmMhivIQDkkjOOMg4469aG+4cvQqr9j+1B1kETcnZLCXjB9M8nH4U6OzK3b2xltXVnCiWHMucjICAc9x2HPB71au7A27KyO4UtgXE0UkRBBxk5GB+Z4Pc1NbLKltE6+YIs4NwzH9wd3ylSuMZA7kgj9E2VylZ5I47IkwvFLDMqOsoYtJkHcrHIAUFM7cZ+Y88VPKtxpms3rQBbnyne1W5tmZEHUZRj93jgdsVrPq1tLc2skNrApSEwh7p2WIMec4AzxuYZBySQTVnQTps012bm2hml8zd5sUbnahAGEQnHJPBBznk8HhJjcdNDm9Khniu2m063ea6QgxllyUcMG46ZbAIxjuat2mk3t9dFpLVjdTEy4iOQVZsnIUEJg5PPGOxxXaaSkt/Y3kzNNeXyOsgyfMEeD8qhpGzuJHCrk85Pyg40LzWvtUFrcXk2pRaDKQkgi+zqrR5w2MEbW3Dg42DaBj+Kk5FKm+5xw0e8lZ9TtL2OSYEGQQ7QjBiFIUY2egK9PrU97arqfmSw21lYzGdUk+xJJFFuwQdqkAK5wRtDAck7QBx6Druux2OjeTYamlzbG93wGeVXkWLGNwMfUKWZ8NjAQE9VBhtNJs9TubeeSC61eztoGHlWZMUG58YklmIJyyA5/5akA4VRgAc2g9kjzeHSby/hkiWG/lgtXMYxENkJYk43/ADDJwe+Wx14q9Y+EL+dGM76jGChZVWUMQm3kNgkj3yMAdcc17NpOi32nulhplhpUsiwC4Gy1/dwREllZozmWVyc7QSMj061c8RfZtKsnbW9b0+KJ2AEEGnpbzSHjgIP3nJ9Mk4/hHNJTZfsV1PILPwasMKahF9ngs0zEHlmUiRymCVaRNuDnuD2KjvVWDwe1oYrtpoLqDBVkNk9wkSYK7nZQMhcnkc5UcHBx6fr2ntJqNlEmg6rZXskqia/uP+PgIQRsEjuxGSVGDjaocAHGa3JtFMR/0Frm8mn3JtCeWwWMKCuApkU7Twp28ZKnrk5+xSopo8hi8G21xaW+5JChGFbT7lZpLhCc/KmM89Mk+v0q5cfDfVrnR/Isra/h0lT5oSd0hAfHJkXBLYAxkk7e3evStL0+8j1fUtL1Gy1dTmOeJ4bmGNYM/K7NKUUqM7Puqepz0zW/feE7orevqKLKhKuWknuLtliyN+3zOFbbljtXpnHrU8w/ZI+V9U8JapZI0otzLbKoYTorKrKejDcASpzwcYPUcVqeA/HM/hCz1C0+yG6hu2XfDJIQgAzu+X+90wcj8a+k7/QLVllhNqbhIerRQtE6HgHBPJ/DIrxn4meBZbVW1qxMSKpBIUfNkHqT03DAyAP60c1wVJw1iz2PQLCKbw1p2rROPNkjIkSIFU6njHrjbmtAB5wATkAcjp/KvN/g98SRqOojRdYQxXdzICCgBWWToWAONpwPmGeeo5HPpFpLsuJF8iVMOQokOTjPHT6VnOKaudcJtvc3dAs7eXzDPetAwAwix/rntW3BY6PFKd011MTjoFGfxrnkjkkcmQgDPQHj16f0rVsZ4LZlbyxK4z16D+tTF20asEk3qmdIlrAUUppNwykcN5h5HrRVc+J7nP8Aq4v++TRWvtafkYctT+mzxYx6gJPOuLSO3SFPKQsVmiLHk4LkAZwoAYZ+XjOQakOkW88aXUennU7VFUBEuoSUOTt2qQwJ+bBGQRgY9K6jW9IF3YxwWEGnJcXaH96I1GUXBcAlSSWBwDjjOetc0+n21vMsM0lncpHnzo1iEiIinG1mCbxjtulyT0yeKXqaNdinfxeGpriVlZC9upje3aNYliA++JC/zZO4bgvYYx1Jw7y90VNMnhhv7W6ECEQi0ZJY2BBUJsUA7gcd24I9CTpSanDB4iFtZ6bZQW6Yguri0JaNuf3ZMcqDySGZVY4J65FTXGs6realpjotzLBE0ggukaOaNxt/5ZyKkbGQEZxkg4wTjIodupC20MR7aUqraJpixoFJlnVj5YPAKlAdrblORjYyhcqeSK57Vbqe9LPc2k0t00SxzTxiOfCkYwiqQ0CED7oUk5OehLd+YZtSshdxx3GrXCOy+bcWmVWRSQViy4XcCAQqgYztz1qK907X96332LTBH5ZLvNCts3m4AyzqxKYK4C8fXmhNg4pnnKnSo9P3tdTYm2F7iawG2OLO05CuWyzlAANo4yQOtRx2Et3KJ9OtbW8cFWiiSdUuFZuVVI5H/e7uuxRk5xzxWjflvtc0+qXrRXxCmVrNo4EmRjuYo5zuHBJd8D/a6VBAl5FbS/ZGiurO0/dOtqzRzIjKCXOdxYcgb0cA7ckHJNVcy5ehHa21pFFJa6pZs8oJiijnhkQOy8+WMbgNu36gMuR1rNbULTRr1re5srm1to0CrLIFmj2MdpTehJKjjkE9wVPArp9I06z12NNOdLtLwBg6R7l3zAHrL5mJGZMuD1GSBkZBivdOFm1151/cJHbQgJ51sC4jZiCblFT5tuDGxEjHjPBIwOTHylKLRbbXpZLa1W8063t13StcWyPMo2BiyBFUgAFS3JOMnAFQan4OjluzBLNZtJbLGsd1IfJSUqCxUPtKLuQqQJBjB4JIYGlqGlaes7FIYooxeL509tsMC7icJBKSQyYUthmKgY5zxXReCGit9JW71CD7RZXMzxvqW8Swx4cof3eCwTG0qSARznAANTzNFKmn0Oft9Pt7O7mSS5Cxsu0bYhcWmN27YfL8zucY5XOeVzxQmt1eWSSxk0NgV+yzKokQyggAgo3Axn5W4b5V75z6do/h6y1aWOS1tnihSNpJGeMm42g7QuWwFRhyu7k7t/HFax8KabaXkFzBawQWbvHDcRvEA4VztWQM2CFDFVJPJVyeCM0ucv2J4fa+Hbi6klmh06YRB9w3JG55I4PzcjcwXO04J7Vor4ZuVtg9lBJd2sjOJYw8eUSMnzGPAyV6EEg8j1Fes6n4ctZLi0tbPTtrSOXa4geUyxMi7VZU2t8wLNxnDcZ44pbDw1bXs99aXsaC4SVPMJDvNtZQBIQCd6sQTjC9edwG2jmtuOVDTQ8PtIbtr1Y9Gju2DL58Uf8ArBGOm45B2jnO48kYHc462fQ7vEMGpyyJNbRG+ljvkSRSrsI12IM/ebIBYlicddwrpdR0KbQNX/tO4Etxo0xMbSxAs1vEjMnzbHUGMMGb+EkbgTg1nSaqE1y11ZDK1olsrNaQzMhaO3YhW3sPnbkuFbIDY5bG6nzNmfs0maugeDYnuYLvUJZ7zToYhFcyxRFPsZxvGAfmVAR90YG0iVlAIB6CHVrTS5raaW1F3EttNNYXHlBA85baGuF3bYyGAX5SQ+07VUrisXw/aNrcMlnq8bytHahoLSKPYEDkGOaSIfwgM5kPOH3buqkN1PxDC2l4m8u2065ZdR8kojSCFsqmIOgcggQo3yjeH91L3WokrOx1KahMy3aTIsWnBnu3ubq4SBJRN8wmmB55AYKpIBBQhcYUR6BpqamZI9Cgn+27Fa51e5mht5RF1AUKXlzsHyjMYUHcQPlBrweFIdGsodQvrCGXWrmQvHbrIkiQsP8AnhGysm5R8pkZVRdrEcfKUtLPVtc02aPxRE7C1nWQ2qrD5ULM27c7KPMa4HGcr8xbAXJyFfuUvI6izt7GX7Rp+gxCSFMRlbHzI7fzMAgySkLHKQcHJLsfU1Y8S3czT2tq9kNP1e5fbayWN2zXEaLy7IfLA27SyZycGVeM9cLUtRvNDtFint9TsYII0MR02SSFChIDboz82cZJ2vjPqSBVnQtcubZp9U1O0urY35SOJzdQ3bm3T7u1HHmSAlt5Kjgso6LT5layKt1ZPodjqlpaeTHZwwSwHz2t94QlWGD+5jXDNyPnaRm3AA44rqtOsLYQJIVKiVAqlZflXAAyuDkAnkg5IJOcZ4xbnxVKlzEk8NxFMoEqGVoI3KDhj5aOxKtnowBPYZFZE3i57rU+Whtn3tGZjcnaSjY+QwsAc5+87gttOxTjkuk9xpX3Ols7aC0083KNc21s11IYx9rkjiWJpcchjtC4+brgBufSsHUGTU767Nhp8V9teRJ55IljjQ7/AJEd3B+UADhFJZsseBzsmVdW0We2i1WXUYp4XEkS3I8yEMuVlTbneoOCNpPXI6YqhbyyN5skcENzoN6qTpcxXCxLBcuP30bnBO5nGS/UbiPlNQ5XQ1Gx4F478Maj4b8TW2r2Qhht4JY5vOgBdIMk8sCcsBhsn8OOlfRWpu1zJcbo9qQ7HinQ7vtCtzvHYA9dvbNUNT0WKVo5V0qJtolaVXHMiFTkKdpYBQN2G5bBxyc0zwVGLSw17TYrlZF0yaKWENlwbeUFVCn0GAQeRVwfR9QlFbrp/wAAu2ReZ9ySc9cZPzfWt7TYZI0PQgnB9vX6VVthDHJsjC7wcHJz0PoKdJeSeeuGwo/hHA9M1jszdQcjbEdvjl4898lv8KKxDfKDhpIgRwQSBRWTwMnrd/gX7FnKaiNQmd4dZ2x2JJnis7WdSlyrH98krdCQjBvLVivzHDHbhVl0qWaONY5BEYQTFbLCH3Aj7sasWHyjH3trEtyQBU2qaZPFYXeq6dHYWlyIvMAit9isFJwwBbJJyQCQvptAOaz38QmddRGvW/2TzwkkH76S2gcgnbhguHQkA53kHpnjnobSZhuif7HpdvcR3V7aiyurQ4tr57B+SvHktHg+Wx3NtVOHOejAGqmoahbW+uPNeJcwSwxMscNyfsC/MY1d2Y4kkGQV+VSSABwc4q3qwXcpvZdOtLXSx/pEirdRRb1aMEYlQblfYCxxziRVHUmsODTpL/V9KubGC1t5ldoUhtk8tZomTOXdz+83hc4DLjgcHmk5JbAoNvUuaHaeICftGlwzxjDpKbi4L+a3zbjJH1QE7XwSvXjg5pj3F1eabNb6vqDWrNJHunjiiMcm9QCcsTsLnptyOeCTV66W20nVFWX7FDeTt8kTK8tsjgALuIwVXsepXjDHpXN20Vpr2qSz2IgFzCBG9k5UxBgCJ1AU7SCTgMmRgEtknNO9tS+W+n+Zj+JNP/sm3lto1hvSiBVnkG2aEkbgoKy8nqWyN2MbuMYz9OBl0+C60y4Saea5YpGoQXMLt87KV4PlkABlcEbsMCc1p3S6jp9mLUTPY2kkLjzxIkoMG8hgX2buGJDEkYABOSBnGnspbea21CLUtLe7JxEsayTSxBU+6Yym1ozGDgDgleAOtUl0OeS12L2kA3kkllLdRi/a1UPYXiOrvMjAL5Tx8I4CKwYA/dIZWw2NKfWVkdPtMwstVje5t7q18k7uEBI3J96MlFw6sChCna3Uclqc9+Z0g1zdpwtZMXMnLzxsVVlYR9SF2p3JweWIPNy01eHUEmt5pFYiORXa2m3PtIAAyOC+WLKeAMFWUAcNkqQ280D7RNNexy2+6P8Afy211tbLclkfaFHzYYYAG0DHAxWtL4o1O3sLmG7sY9KkvbhvtDJHu8wMhy6joqnaqnGfl59SLt/Faajop1K2s54r6yjLz8YVXABZnXqyuQdjHGdwyeKk8EWttb6Tb3S3vkTiNpVhvkySkW4k28u77pwVJUcZ7ZJrPmNYx1uja0bw5eSWJv8AT7kS28uTlbp4YnwSM4jKjPJwwyFJ24Kk47PTLC0utAjW5hBtXMlsbSaRwYmJ2GMrkhW64HJ5Ug45NPQon0bT9La6RYdNNskTPPkOEAXBPPyxs+QoIO0HP3R8uhpkssF2Z7uWZJUVTcKfnbaWzuGMfMrnK9wMj0wr2OinDmvYWzj86N4b25njvLNypeNAisBja5PDAuozxjByMHFaWqWCTXEVxuktZ4kiEU7BSVUl85DcSIQOVb72BjaQCM6SSZb61kldEaT91JJK+5XQksMgckoxBBOSNzgjDZre08Sqs8MqlJyyliOkS4O0e55Y8etCfY0qU2lqc5r9lJatLPNBDElzDKLqOIGWxvFI+Z0bDSQSkANtKlSV/iOSfN9K0+z13Q9QsdQea1vbFGCW87GQ3EYUFc5AO4EluMqGLEEE8+4AGK08u/trloZgY9ixBo298A7h64IFeaePvDHmPHPaalDvtIMwXExeKSKMyYIMvOR0BBHIY8HnNN63RyuCta55dqR1fTLu703WUkuLaS3CksTK8E4jZYxvUgsoLKC2OVX659H8TaLBGul3nh+OK5FjEiMklwz28rEiO2jOSG37vMAYnjJPbjGudaivEN5caZPNc2UMk05NxudVfchjVR8si7CjEKVYAdRk10Hh+LT4bae7RZ72CXyp7FFVIo7ifEsayMigASZDMwzhFbLMzcUMx5dSO71BLeC6NzPPe3lzCyTT+Q8MojVU3icdSAfJjVU5bc2F/eBq0BqOpeGjbWuqafqV9OsRukgt40iWKQkIwbjAjaRzzjK9D5nDLZtrSEXsM+pXWtzanctFqcscEyRwFnPmliPviJGCqMkY2p1art8sMNre3Ulz9kjimhjR4ndIJxFtdFj3YMpErP0bq2T92i/YpR7lGeTVrK0hN54YupLqdmxJNMpXz8cMwb52jALY4UKM4Qk84mjLJpyGW7t7Sa3nVZ3QMZZ4CpIIxhBtbadq54AJcHrU+jX2gT6t9nisbdrkoqxuyNdu0hDkxFVLMSG3YCsN3OG+UYZYx3ul6S39pNGt5M/nQeXG4VA55ARnB3DcgOSxxx0U5Gbx3tc0tOazv7GKGPUFf7bsmAeVBJdZO8ojkIgJUEHCEgLjIGCemTTzFLHaXUb6eLgxFY4HlkiQqg2EMm1A52x4YgAgdjgnnpVutJtpLG1mtbW3nmgeK4lCFEk35xIQxbcMbt2QvzEYHQ7KeKbA6W/kzxQmOOR5IZWEsK4y2QgAZ1HbaFB7kc1LS6l8jWsR2mrdaVcpHZpDd2NveOZo3USshdiQ/wAhyhEoLdc/Px1YV0UOmxWDG6sbYztdIFnH2kxNIRn5wVUhiQRjcoPGcjkVy1tZ22uWyXN1flLiaJlt7i1kaNI1YZCPswyoMjOCUGR8wIBrrNCto20uC9TVr5ZpIV/dXVwsiLKPvxuSMnLBueeORwaE77ETikSrpzyv5kxj81lKkxl1HIPJJwSegzxgDAHJJ4m3iisPGFtMoMdpq9u2kzqfvQuTiNfbZMjJ9JFH8NdfLqMdy8aW2q21sJQDIGKebCTwVQ5OXzwMggfe54rD1/w40s39naWPJiltpdvnH/VOskTK4YjOdyqSckkgt1JNNNboSunZk9hcGSVGZfmAMbKRnDr8rZ/EVHdli0qkglzwCTj04FZsmoG7W31NAFF+C8oBBCXMZ2Tx+g+cbh6hs96kS7Py7gSFUkk8j6gUpo7KUW1caspwN+d3fLqOaKQpE5LFY8tyeaK9iM3yr3vx/wDtTosjesNc027vV8621GO7hxIqtbytHDlmG9dyqoHBGccZ6gGsTxYlpd2jnTrOQ6oXeJEjsXV3jdR5gdgSSu1gwZcrkAc5bMPiTT5Bp8BvrW6vYzEsscUC7LnJ28Kv3SrYIY/LwMncQAYLHw/Y2lpDPNpO+zlVSWh3SpLuJ+6xbnk4IbJ7DHQ+RzN6NHlOCTumV/CmmafqE7NaJcskc08awtarbCFldXffHgfMcpw3GAMLtANaet6gttMskce+3aNYt6qgjToEdiRkrlsBwNvv3rO/s+XS78payXCaq8nmm3uX8yMRmMZikZlJMa+XHjOcYBHQZ2bSCe/0x3urjzpZgkhjMXlKVdcEPkEtt5BPJPHQHbUrsjRJ35mZ+tS21tpU5vY7eaYxCZ7hLxF3SxjcqIrEOE3AgbN31ryG61NIbqW5gv5o7m+hilaReJGdEBCFmUI2d2dxAcYPzHJz6nrUv2T7RaabDb3Fq1rI9zN5Q8qBm+UkBQDs5B2p0PIBGcYdn4as5NAsbNLS4leS2huT5six5bYD5hYbmlwSMBFC4XHJwwtLsJ7HFyS3VwVvrW7e3tbRRHDDPIbebZjc7RqQMDqN2CflBCiqXiG18Qwhnge5u44nBWSa4FwJHYAnEqhX6ADOcH64rt5tVawleGeDSZp2DtcJqMskm4kff5JIYkd/04rktK1JHgggls9HaKCRnZjeKCN+HbKl1VsksArElfmwRxiomM1bcxPDt/e2Ormwt4tOa6luFSGC/R5YwNuCsZXk5DbSCWBBA71Z8V213p5W11CxvIWRA9jCk8YWGReS/wBnCKCGUhWDAs3UselZI1KP7SZNOvljmtyzxRW6yKAjLsGeDlgmB8p6Hqdtdtouq6Xd6m8mrpayiSxRIzG4ZZpB85yRkqxzkbic4wTninKTjoZKEZ6nLxXdvdNZX3nR2byQyC9g2NHGqCfhQygA8srY4UAc4IBrsPD3iY/Z4IM+bDBFDFDJJaRSbXLOdwU5DsTkBshRjJLbQDdPhu0i1q/so43t0KCZPtltkwMcnCiTlypbq20YbpgcyaFogfX7K6uI3WC6ZnjiAB8mFT8vXHzffPb5ielYyl16nVQp3dnsdzpccNtpcrTTMJpmw0aRrLHsPyqgGcSHaMNweSegwKk882+l2sEVzd+XasGjeYLLLKQxKhlbkgdAX5wOmRWytsIJjJavvkQMhRY1+XttBAJ6bQFGQAPel8prmzhN1BCIQFSSQIcsmfy6kjkHOTnrTcXax3U+VO7M++niOivcvKbi6UhpEjGWRjnHzjIJ74GCOnWtvSXuWkfznkWd9hZCMFuBnJ/DJPr+NYVmYYdV2xuiQBh/CFQEZyAeOh7gfjXQmdbhpAUZ1JXaq9BwRz3OPfpQtXdlVlZWsXyIkmkuInG0gRnPJI4xx3GTnj6e1ec/Ek3E0ltplhczw/aR9rVUYbmOTExjUEHgbmAIyD2H3q7/AEsGZJ5bKNrZMY82JM7SSQflOMkYPzZGOfpXMeINNfUvEWmnSnh/tOBpJluWl6xqrH5T0zuY8kZDAZGOtNOxxSio3TPENe0S6j1F9F0xpGso/kktreQxs2ACf4TtwoUNuyA24ZO0V22l6YPDOnNaSSWcV5fgwNb3vmnG8B2YKjkEAJkttGSox05teG2Zda1O8Y7bi7giUbiXLRMTE/z453MpyMfLyOwrK1fV7xDalrucXRaSMRo2z51xGmFIG4bHU5HQFsj1yluKMdEdrJrl5b211L5tuukWMTqPLEr3EsmMiMsx/djnOWAO0HlcGsjVorG/0Wynt4nWC2lWUF2ZbW6dcKu1Bl7nahYFkAGSfnPGeHmvZry7TSIbPTY7OzIu9RuyxiecSEsyXUm7DL/EwGQ2VHanXF/LLf3s9vPqlyki/vppN8MNvktjyVWTIix0GfmJ/iGKvm0J5Ls7zWrm30/T3XV7KeTUP3cUIdicnIaNTHMcxqSnUkkLljyKbKI7+N7md7abU5D5UNsl0wjgcyRkrBlchgq/M3zFh0wDivOrm3eRl1GdZ7aC2kIWW9kAR5M5CyKw/dB/nAzljjNT6PYajPb3MiadeSutuI5LGedkkwzqQGErfNkEAKMDkEDjJpvTYIqzPVLux1p5DLqF4buL7Um+XzTC9uVVWfaVXZtw2N+FYD727rT7uLVLa0M1uVn89XtVMkrRSGMOzEHhdyjazBjs4L/eBrzyBriC7VpNDisJ4mVHjbbHEqRknpnMm4qqgsDvKFgw5Fdz4e1Ka8F5BocNxeNazrM8d9cBFmYA7jEu3fyGIPTlefQjWnmbxukaEDfvpbeF3LNMEOlXQjiE4IBAhfaIw4GQFJAODjANWtP0u8in1FdPjjsT5hkS2keSF43bactIFA24DgKC/OcEc1032fT9Stkur5xLAIxHIk/ESHqUZc4Ug4PPoDnpTLa2dtoiuormGJDGk0TeaVGSNrYyHUgICvB+XIw1Ty2Rk5GQs97ozqJX+0yzysVeSY2srsQCeH3RyH23LwOAa14bqO71O4ljkV5oh5JjA2OQrfMwVuq7uAcEfKauX17a2dsY12Koj3CDOefvEBeSeg4wPeqUNjFFYWyRm3ZFUvGsfBjckltjEfKpyfl9vQ0LeyZNr62OY1fTXfWNX0tYTCl+i6rYsPmzdRqFlUD0dAp57g1h208cJWXaGEiB1XkgexHoDnrWx8QdSu4ba1urGHbqGl3kNyXB4YDdxj0IbB54I79a5fxBJbvLBd6aJBY34N1bqMYibOZIT7gnOD2PvVL3k+/9f18zpwzs1F7P+vy/Jm6LtwAFaMKOgz0FFYsF0wgjALgBRx8pxxRX0EKb5V739fedrgj0nTdFt7a3iRtOs4hkb4oECeYedpIUDLlQOnvnHSsfW7ySw1Sa2it/9HvJMTLNJ8iOSDvj2gld+NpLcFsYIyTW5rkyG0V4sysJEVoYGClsuoKnJzzuA/LrXP8AiLTpbq0Mbh7W0i+XG9skkYztXACg7RySTjsDXz89FaJ48Em7yK9pp+rJ4q+3wNaTs1gYksirxxYDqW2NlsNtZcsPkB4AIyarX3iHTkU3L/a/tMXyPE9s8rLG+NyKMbDjggrkZWsjXNGSzvrSKwtrnVAIZJ1tZ5ACY9uxhEWBUsWAwGGTswOOmVNDJPpUT2Dh4ijCSEXEhZiSMAKAvlnORgk42nI6Cobt0NIrUseP/FC/2YtvYwmCLbIHZ0LSsZF2DplUDYPBJJ6dOnF+INTuNNlj+wpe/ZHh8wf2pkNCC+3MZ4OTtZSSOQT2FXLi21aCx+1Wl8R5Uv8Ax5bc3O/5hvaMkiJFIALZwS33jgCsq5v7jUb6CS5me5uZYo1likcPna5YAEfw7cjc3Q5HvT33FpsitM93qFs8senIbdpipiMAYRKSdqrjAIOO65JGR0zWVPJZPdOdRIhsVITda3LTKxONyGRCOV5IyPmweSOa9FtNAuZLKMXxb7XgnzJtuU4yI4ol5jBJbJySRjjvWemnS3sdtc/2nBYeVKGikaMmK3Axl2hCcq3TJJY8A+1c1iZU3I5ebSdPt7gyaYNQjlknby40hVIpUDZxuIIZRhRtJIzgZp9mdU02AxLPqMDXEEkbTMkSB7fzF3Ivy7wwBPAw2MkHBxXV6Ld3MSuhgWW1i3xBraDKMpBZFhDAHax74yO5xzUOsxoukX8zpIsMw8tornPmW8oICSsDyueBkZ527uCcDmxxoRsdZoenaVokM80FndNEh82BpbZljYHK7VJ5CkFWJwMnrUvhvDa8LiF5LgmNyHPBJL8nk54Xn6t0p6tH/ZL3S3SMkMAmZn+XyyCdrEYx1CcDIy3PPFWfA2x7i9mVY1vXZkicyKhQAKzgZ4XlgS2DhQcdDWcVeyOqmrJyOsZ1kmhS6jVUVxGY3Yk9R8vb1/WppbhrgI0QBicbYooGVTwfu7Tz6fnWfBai+kgZXlSGG3855Lg+WDHuxGEjHzKHxvO4FzhQDyTSWk101p9oiaKJY2B5RSxQsQAQ2VLY5wCQvfNbttGqgraboXUbG3ukkVSyMGYnqecAHjJx/nin2MUMMMKuVdmGCrMV8w7ScEDPtn8O9UdNvBNbXkmDInnsAGxn3yemOuT/AC75X9ox/bgVkVvLJH7tch2bG1OnUt1x2OetZcyvc3jSnK8H0O4WG2WxiW8JdjieLZjcBjkYPyhcdSRgDgAmq2txSy3sVyBaCVg3kSm1wI3LLj+IDHQFiM+1WtNMskqx3QBjhA85E+9NLwwjB7BSV3En7x9Fqf8AeTXkjXIV5JoisrQtjIwT8gIBwucc9zWu61PPqXu/6/r+vl5jr7In9v3GkEfbPJmluISwdmdGBZs44x5hIIOMOflbmuf1mWLVJri6guTHcGZLgJD+7lRim7O452OH4wBlg2N3THaHR4pRPdX6QNEvn6ZcxL91QN6Bto5zkAgjoSuBya4G01G6srafUbWE6kEhFrfWFxHvMtusRGXxnIX5XBH0yMmsZK9rkL3b2J9E0iw1LxJc3F/BstZCty5UPKwYqQUcAZeXcR8oGFzjNdbcr9gvIdS1+2ieGMCCBmkTzLfJPlhgAd7sOOCSDhRjJxzHhXEbwW4W8vrZ/Lkls4hHHFIWBwxkDLn5WAwT8xGO2a2tRvJrq4a1OlLaMsZEVqMObaJCC6AYA3scE87cAAAjJqU+rNOW2iOW126mnuvJmgvormQMYYbqNRMEY/MmSxO9sHLYyTjBwBWdcQWM9xYOlpchoGy9vOjyFj8wXaz4BcseNrAYB68CtP8Asuz33t3Po97cQOQAV8uOPpkRsM4JOclj9wYwK0bW7t7dZrZNMtIbhk6m9Eg2MMBMkKhUfNwGJIIIBJzWi1FqxljdahqKokcOk6be2cQa1Vp2tpHwPnXOOQwYq2MDBGVAFdHpF44drC9s1EDqkyC6dGjt5Coy2/GQSw42hgTgDHFYtkYtTW2guNQSUph4YltnkXqOAQSe56HA5960DDZWWm3F7HZXUKWv+od0lcCVs4R94yPmI5UAbT65BWskVH3W7nV39zcT6kt9ZlpdRgjBlC/IJYydvKDgkMABg7geCx5AtX2sz2l2scujvax3AwJFY3Z3kZ+4Af7ueA3T1qGx06W0txHEjteRt5j31uA0T8Y27TkGPr8mRtHIANXnuVkkltbiOVCkAZJDCn7t9+5GSRSFK5jHykA1O3UGl20NC2Ja3cWlxPDI7n5pDHJ5ilVIdkKgjIxlcDA4qWDULiSyjZbWQQ/8tHSRVcyJw5aNsHIK9ieMfSqa6o88yx3NsYI503FkmiZPkHJBBycgrx14IPNM1PXLfT5prXesc9xHI8YnTymDbcH5cFuVwcED7relHz0Mkm+mpT1m3hv/AA/PfI/nLbZMbouDKP8AlopzyMlm+hAOK5DGnaVpEEkv227tb55E2EL5QkXBjJ4yrAYOQe9dnFqOn3XhG9uLVled0jMwQYaVwAU4HUnIAPfofu8cJZbNT8P6vpwEbPG322FeT86MVkKk9mUo34GrpvVWLgt77J/1/mQLHCVBFnGQR13Nz+tFUIJSYY9ryAbRj5h6UV9lTwOGcE3Hp2Z3a/0z1iWeO8eOKdI2mWQM0nllohIh+VV7An7/AFBGBnPFYniFp9Uin0dYGLSKXCSkybiCNruOAqgg4BOSQDjaDmxqGpNGVkFzEsDlUHk2jOeTwEZ2CFuCScHAX8qM0iaa11GdWspLq4ZnCTEeY/vuBPQYAJXHbsBXxXNqebyFDTtLi0yaW9mv0s4Zfmu5IFEIMpIwWzlWbd8oCAZBPUYAc2rpFYqLSyhZVRVjuUkSAOFGCxEhwMYIDHIz0B6UX9xpds9rNcTadFKQQBI4uJ9zEfxAgbmI5x14AwMCucu9dkuZ7qG7e2aS7YtJN5qRI42qFDbckLkfdyMccerTsxuNyrftfNbxjTtMKtYzR3MYguBLM7g4j3n/AJaMxBAXnGMgdKgGkWd6IXtLpY7wS/abh3kXfJOobAZWPypGCUyOvJxSWEWjWkBnvY7O/uQQs0ZhDjcfmzHhSVXn2Jpyt4cl126jksZrq1eMSwx2gYG2YE7ztXB/DkjjFG3UtRs7tFqDUYk04m7uYI4pmaAG2VZ1kZCCfKKqHHBG5BhG/vHpWzp0WI2vWjjmMgEqtsS32sOAQgyowv8ACB3+tRadJe2kwvE0+TWIANskkQRwqjG0NIcB8cfJ1988HUj06G9vIp4dOs7sXMJlWOYfKx7vlgPmwOwwQMkmm7lWSKdxqNlfW12t7HHFdM5VZ8SFrdufmCop74AxwT1AGa5m2a5vIphIu6K0cyXc0qbo9zcN8g5xtYnaSQMHBFeiroTJbtO1wSjMf3ViSmQfk4bp0wC3GOcd6zp9OezMFtGsFvd6pMpuoS5CGFWyY/QjapOeDnjuaORsE4dDkYNBuG0CG+KWyvOj3K28cIROMthFTAjyq/MAPmZQTyc12Hg+2trqc28kJmglVp5VdtskwIChM9u/IxyBuPAq1LYx2+lmV5VeCHzPMYAqshc4Ax/slwP51hWF28eq3BlEsdtLClsHTr5+FZwmf4iVxx3IwPSkuV6m9Fc8XGOh1jRTZNpvJ1a8eOO4njUKFZ2YmNewCgbmYdgiLnJInvbi1tVMUVu32VEaKMCMAzO3O4H2AGemc55wKl0dhDr1mt8VthAsxWJGJ2EkiQk9FVSCNx7I/pk4+ta0l7btNbxLtKGRWLYLhvutg/dyoDbeoGPWtJJRi2XCMpSUbaf1/l8htjAsGlqqSmNkyFCjcZM4J/nx6/hVM2X2K509YPLTzVkldiQdny43D1bLjPPfPGKn06MzIHSFyz/u1cDIwo3cZ4IPzDA61U1C9ij8b29o6s0dtaNvWJQcF5AWRR0BICJz3bFYwWzOhOTk0vNs69N2mx2mkafCZpN6JjeDJI7q0hB9Sfnkc9APL6k1qyREXskrI7xsoiJYZLtjdg454yAcdMY7Vj6tbr9ubzmEbMrtKB8hVnfa+1gchm+SMEdFLAcg1rXhmspEtopGRbSNRlUAXzCpJCr0HVeOmK32bPPqK6TW73Oe8TutpdJaEeW2rRxyW+xwr/aI2AlGSBgkLG3oNhxXm2h6fcJbW2tacsl0biE/ardQQrplhJGOfmACcKcHcRXo2pOiyDW7vdKtiN2HcZWEoY3YHuNzA9APl4rAuoLeK7mgton00212shkBKOFMjK7KD1ABR+QTkEAcVzzXNqQlyKy/r+tDPEFjaWwbTneCaZY5YRaxKzMXUHy0Yn5G3OOSV4LKBmsnV/Ed5c29umrebHbfdMIlSMOfeXb3IcYAOOOSRzJbzNpF4b7T2tr63umDwi4JKs+NrMRkfNnIGf8AZ49ad7PdrJPZCwVvPkEk2ZokZB/Gm9VIQA9gc8/LWexai3qQ3dy2o2cdrFZDT9OQh2hhJkaVnJBcucEg7sfmauRaDo2jXNnPNsv4HDbYVAleJxgq0aHIIK57ZX8xT4Imilt5gkUkcavOJ2uTEC3Cjy16uRuPz8c/rR1G3u59WWJby3uEN0qfZXlaFlaUKJJA2AxDdGyDncWB650tdXLa1LmjXbpCYBZzabaozSRyrZkTzqchF6bVwOMn5icnjOK6ZRJEzPHBcwlo2kk3zi4EpA6kEnBVWbOMcso5PTNt5k0oGCTT7W1tkfFx5bssYdd212OAcKAOucngYzU9xrMU9pb26xGUMVUSSMVQoGzu4+bqpJY8AnnpTWmrBRu9ET2mny6LbRHzFEls6yx25EkqRp94JtJLKVXoUPI5Knod2GY3DebFpSASxoIzp1yRtbzGJ4YBSeeYyMjuKz7bXY1hlgs2hkukZZCIEMqbRkghjhScAnd1PPy1QS+Emtza1rWny3sE0ca71ywTDFWZljJ+bbyAegBwKjbQ1tdXa/r+vM6+S1e+t3dblrYKwiIGY/3igjBQjcAQSCBj7xx2IcjWS28cUdibRJZ0gBQfNBcBgFUt1ycgqx4IPP3qybHXEaOy03TDPdtHG0hlkDKxTd8uWmwpOCAeWxkYzUfi+6C6Y14JVST91i2imyJNjglpJiv3VI+VgOGIHzDIpPujn5HezKGlXUc/iA2ItPM1ewtYlk+znyTAGQLv3njooO3kgykAELk1dPWfStemNwitLHmQiMFRKhBVgN3IBQj6E+1X/BsX9lNePNDM7XUokmXIjZXOW8lv7sgyWQ9HViM9DTvFFreP4n002Ntv3mFQ2zaCrgg5J9yhzRHuirJS5Xs0VT4RvGJNoLaS2PMT/aSu5exx247UV0f2XTF+WW5tVkHDKLnoe4or6iGMxCil7R/d/wAEx5pf0v8AglfVYmuWeS9uLW1kbNvGJnJd0H3wu8q2Sx7Y6dOtZF9Z/Z7eaYX0YRjGpEflRZbIwXKrzlB2yc8DOTXWXVuq20SRWVu8zx7WLgOqKB3P3j06DAOScjHOHNo1ujWlq0SFWwWVIgq2yZySB2PPoO/WvmLNBCWpyGrm6kS6/s7UnZXRl+zRRM32lm6YCBQQpxkZPp8xzihaeHBNDOs1nEiSbF8l/wDl2XgeYrAAFclvTae7V2MVo0Qe4uZfkXOM/PIkIxsATB5PBJB7+1Zd7DLLdCeK2ngsbcEBYioyDwxZSG3FuRjOAB06mheZrFa+6Z1ys2j2yW0kzyvGytFdhm8xlA7YbluqcEgjBGKdd3umy3NzcXK+dNFbo6GXnIBLbSXAKHce5z8w68VMtvqUDQJayxXVju+e1uB5Y2gkKofqoxjaAMZGcYqrf315eebaW+n6vcRxgS+WoV97Z44wfl6EDbk+2c1e2w+Vvc0rAf2kypZ6jpGoyxYlk3RyLCTzujEe7BC54Kjdkd66+2aKbVLK3juHvZD5s74IKIPLKhQvRcl/uk5rl7HT3u9J33sFvNZORcm+keOJyduCVONygdOMHHHtXSWFpPZvNdX8/leTOIVdowN6ZwQqjgsSeT1OB9KqN2tiakUtL/1/XQ3REfKUu6/vCPlBwq99ox0A9cVzGtzyw+JQjoQonhlXaQH2yFFc5PTAXaMnPzA8YrpIb3/RI3MLu4Vido3bT7npkAc+pIArAvxF/p1zcOzXeYy4h2s0QC7ZAG5G7Em0ds9PWqbTVkY0laWqJLe4bUtBhmkLxzbnldXJIiYMDu299o3cHgZrL8O2r3niKOd1e5htW+0W0Tf8tvnDAHqFJPJI9h0GDc0FXbQZGDOmntK5yeWkQEDDc4wW3Z56DFaPh+OLT9ca7jDzyrCkfmBCYY3UHI7biQOxIHPeiKcmrnTF8ilymV4qcwRyWUuLp9sUcrFSI5XTcSnHDKGbcxAG5v8AgWcoWcklvJNK8jJG6vIRgHqFBJ9yR+gq3q0YGW3huuG3Bd/J7LwB1IxgdKluQ1t4PjVskalexqTG+H8sOqoAAexMrfUA9qUk5M9GLcIRit2/6/A1fMFppGmAtsezt5rp5dv3W3Hy8nodxIAHUYPHWuL0KNpNZub+9CEs8W+WQ7lQqGIGPxzzzlc1s67HG2pwBpBGiM8HmnJEiJIyhiONxwAeAPw61nWipNrWmQQsyQROXld8FnY7lizxtHPIHPqT1pbu3YKUVGLa67/e3/XyOzuNReBbXVJo9kB2uo2ks8xJWMuT/dAd/wACOKsXU7WNjYRyTS7sNNcfINzFinl7lHQ4+XJ+bjr1rGubi0lN1eNCEQlUcMwVLeJTiWTnhuCic9SeAQQa6BYmv5kcwXgWSNX8iZyZQVwd7NwQCoHp1xxVu7bRyTUYpNrT+tPld/1Yzb+xludEf7LAzxm3jikVgWDDeTIy+oywC7u7McHFcR4yvJWmtmgZ/NMbMqjczIVIVzwflJKscjp2wVr0zWJHk028so7oukwS3hmt5fKWXzWY5G3IJzuzg9FP1rlNcsVsNQaZreJraPSpCVBAAUMIxGoxuPTt0L5JPNZTStoc8J6+9/Whcg02zt9duLZdPt5rNLNbq2eGFMbS5VlycnaZMkEcnORziqU2l6VbwwxXdt517MWdrpHjVycghWbgt2GF4HBIwAazb9r6KGBZ5x9ris1tJTFFmRVfG3HGAAykY9TkHniWy1Iz29qLiTZK0rzC3SJRcQgISoRW+WRG6ArwRwealSu7JE8jWtyCF9FGpvPAgnnFmJGjSMQjcJGOJPuguB1I9BznmsO+hn1bTZrdooEiE3lkmF/MmcnueVXJJ6FsAduK6u2t7LUoCLaeB7mPBl1AgC4QLygdW5UhTjAX61zou76H7N/aECXiiQ+YbmPykeUNyysrHfzjovT35qrtblx8jF1XRb3T2i8y/gljYLIzyocNGCAELfe6HH3QSAMdc1Vtorqcxzm8imichp0STymUtlUB+VuuEYgggAjOOa6CO5l1QibUoru3eWNxbvIpKygZGYth2gnOBuOR3LdKlWyuoVjikvX863wjstunCYZdxJyHbdglRkHk54AJoWnoadhHHZJJ9thlXy1CJbNL9o3Ng9hwcEcnt1OatQfao0cRWz2sESGaCGAO8SMe64K45/ugg554rJ0/T7myvLK8h06W/S2JQzJI6XGzZtYZcEEjIOBg447jHU6feWVrG8c0SQxscSIEc7uOGJ2DB64PI9Cc1CfTYUm7t7mPLfSvate6VBZWd9bQGKaU3PyujAYkkXkFCeG6MrDGaq6PdveRC01uRoZ7i4hjnhOVG0SIxRPXgAnPQYIGM5k1bS3uPtc0G1Z4oJjHKOSgABAwflKgFt3JzjjHGN6XS5pdXhtJrdNPiVWcNajcHdSpEyS8+WcD5RjcMEZIpO8rMqU4ou5ikLwTXYL3e3y/OVo2Yj5hszjoeVJJI59TWPrLv4fvE1VRHNBahJJWiBVlUNw7IBgMBuDFflZTuwCuD0miWqWck8k0EDblLNOBzOpPDEHJD5zlckHII9Bah0+BJJsRvHbuGDxJgxcDP3T03dwOOD+JFW3OdzsX4/CT3Maz2U9nLaygPDIVzvQ8qc98jFFcOfAQQlbXxFrlrbrxHb299IscS9kQZ4UDgD0FFe3GVay/eL7pf/InPaX87+5f5mlPJcXqbIxbsEDA4kkWNn5GzcOX6E/Kcfj05kw6jHiY6hgyOrm3tBwT91sBtxzgcHp7Gujvniks4bWKGXy2Ukvv8ny4R8pOOvI+Rfug/TdUcawxvsFjLZq8qxzLH+63LGANu8ctgbTwR+leM1c6o6LYY9kQJS8l3LPlEUy3BIyTkk8YA5PGPy71lS6lIN7dRuitsPloQYgMfKOzc4GcA885FTWsphkhtWZcFC0O4FEZeQ3ViSQRntnI96itblnaEkC6WXDwszb8gccnvjJIbt2PSqsupUU0VNddxZSfaZ5opJiLcKkQLQrjkOF3D5RuekiuliubNLV4mCJtE3lticErkAcfMCBgcgjjipY4Lu51CGdrkSxwGTy4BGACzYA+bpkDIHOeT0xSa/Iiab9ot5Le482JrWVciQncPv8Ao2D2HTr7Gk29S9NIkeo3Hk6NezCAR2isy3rsRbvHI4wAqdDuYAMfc5wMkbd/HJJYRSLI5naMKymIeYF2ZkJB+6SmST6cj35a0kgttU+z6lcW06yJtmcSjEUTMqojn+Jic8jqCWxUlxLJJdLpmnQtBatdKrHdxvUbWw2eN2cnHoOmcUnO2rE430R1ttm4tLbTgzXGwlLiLOPlhwSGb3YBSBxhxmsCUtNczTWrQeRJNPertlAVmWTYG2gDKqEIXJIJOcZIrWeAWt3ctLLO0csUk/led5EWEIABJGMHAJ6n5TkVDpt7b6pF90yWkjIlxO4EcDKHO3ezcnOxpPl7lRim19lmVN295DfAemyP4dtkv0dkjnY+XIA4VMkjK9M845z07dK2/FVuWW2nBP2mN/spwPlwVL4HYEAKB2wxqr4KnZLSBbmMRC1hiVjPICsm4s6FP73ylcn8AO9aWqKkulQiCRLe24WaSU7GYKcrtZ8L37ZOMVtTXuicmq1/M5DUNOeOKFPMee4KM7Rp1HDeZ9dowck9F6dqzrxlSCzWAt/o93G5Vfl5G4kD14wT6d67jxFbXlvpjJ5Ya1ljCu0SZ39Og6q3JGe+e3WsDTUWyY3rRbZFDqmDzGxQhCDjqM5zznFJwakejSxHPDm3/r+v60Of1e+uh4asZLuUxSXH+kSs2N7bzk7mPJ47dOaXwnp41ovdfZt2wIkEK5XYE/5aO2QBnL4J6F89gDv6p4VW6eCfUBZ70Rttrckxwx8Y+Zv4mHBwhBGeBnpZtbC0c20V9caprDLt8rTbCyEFuM9OH+ZgOR5jduc1CpyT1NXiIeytDfX+v+C2vUa9jHda1BeJLHc3iBmiUwefFarkZZSoCsR24kIIB2fxDr9Ot5WjtluGMayxckP5qMuOBLI/JYE+3IbiuWl2Rxysl3YWEMaArHDE9xIzKCCEjYqhYd92/aO+K37mIw6PM12HsL+SA7t3lSGQvwqyZJSTk44AXOAOMVqlZtnn4i7SV/L+v6f4iwWdxe+ILq8e4D+WzQxW7qBtOSAVbI42gngZA7jkVhXK2114tisDLJCLe2klIIB8wcthD/EMuCR1GORgVq6bYnTkXTBdyTKVAM0o2vIoyqPnAGCMgnOc4znOaralp7xSy7XL7oJfss0ZKeTIuwIykDO7HmMMHnBz1rBrQ57pPf0Mi9gjv57a4iDSW8u6GZJMRhk3hYSFxlhuUHtjOe9VNTS2kvbjTrq4h2aZIltb3VxKieU6xKCcE4YMqpgd8SZ5xXULY20tnFZa5aQyRrcvtaQ7dzB0DEAcqxG4jnkfSsPTdOuI21KeZEuTeXbxPu2O7JsBjKs+PnVDgqx+bd1BFTysE/wMd/sd1cwrf2cr3Ma7S5KsbbPTABMgIySpUEYJ5Ip5sknvA99Da3DIFieRIgsjR5LIpZTjPPzNt9Pl61Zu9Ht9asrSW+miuGtozA6XMW0ugHyguBuDA5wQMjJznBzStdPtLKHZJpzfbQBGlqryOqK2cvjcQw4GXTI+bkDmj0OiNrEUthbW2mTwWVvtku5EWUBPMSNskkBQeAO5XGTt71rafCwnt1a8Y3Sr85nY8NuJxjB25bsD1PU1Qikt7xM3shspSBmMkqiYHCh+BNz0IOfVc8VuRGG2RPszl7q4yojJLFyoyMjkAZ9Oahbg9rDZLlre2ZpYjKkjOivbsFKSKeOM89hxz6elZl2ZZ1msCFmgkYyF1lLFGIzyDgLkg5H1HXGblqU1BLaYuLpdgWWVbfCMSM4wOSByMcNxSyoBqb3UVrESHAMmWJUfxDHOM5+vA6ZzSkaQSj6kkE0NwGkiiiCou5FYblQMAGQbsbuABnGOT9KsaSHi0yGG6RXjXCQskZO4L90kZ4OOD756g1Mv2b7IqxRp5agqw28sFOcDv3J4/Gq9vLGZkLSBEUsMMpJY9d2fT+VSnqYyV7m6rkGSIgooVXICldueD+GabEjwqCkjIsjfNGRnBGRt/qD7UyEtPsZLZpAHDxnkncpznJ6VPaOYg8LRlPvYVj82CeuB079KLmKLywptHyP0/wCelFWEhlKKeDkZ+8BRXYpTt8Rk2cXfD7VbWFxLMYkdmnEb4CuSdyjOeVPUA55+lRiAT30UuT5i/KN2QPmAysZyeM5LEde5psz6f5kkSyJMLR97ofmlUnqxA59R0xj+6OKtXKPLLuSSBpHCrI5G47Dk4IHIJBzyVxx1zWKWp13SRmXtlb29+lzG0cb7HAE2WOCVxzknbgHgDJz9TTLm2ECyJA04ubiMR7sbzM5H3VXuoz90AY+nNat7iwhtordAEcqkJ242YHIBznkHrknJ4GKy79o4bqTbe3MV9ukAhVwAsZ4KkkfmRwfajZ6lRbdjPsY7aS8WKPU7ydnR0Eyp/o6Lgj/az7g889RUxu1NxFDdxXc1zIojS4jzbxTMuCoEj4CHG0lQMcDGelXTJfZ+3mUtKih3cySrE6kA7VUjDFs4Hyjnoaqa5LJaabLb6mFa5QgRR3U3mSxyOQQTsbkAfMPlzhatWSL+JmJdiSymkgtY0j1N4JYLiNcO5jblcB8nd8xwwIHBPcV0uvY0bw3DcKY5Bp9zEVZCEBeM/wAHJJbqW6lvUYAq5Y6bZxai1wly1vbwRfZpJZFIaXcpYnBG4k7EAU4xzxzUfiiyjvtOub2cPDCIZY41jAbazJtRSO7sW5J6c9KTWjZjKom0jlvGUOp3lnapcX7S3d6+fs54SKIjbsVuhCqVBA+8xzyMiugggsbKA2NrMl3++KKqM0gZtuG3A/NIwGST90HjOaxpb641K8u2WSAIInSIxLvkMaZQbEVdyhm4GGXnGTgc9p4Z09dO09YbRViumgWIyKUafaOSGKAAAN2A692pRV3oaTThBX/r/hv+HL3hi3t/s1vI0UcV20Y/eNENyg9lY5IUcjA4GABW4s8UMCTGWSV0YMVO59qjhsBQ2flGMY5JHQ81TsIPLSHznZtuFIY7mduPXj8AOgrT2NNBLJeSOUYsrEEBSnQgj+IYz/SuunexwVdZXZm6vE+px21y20F0JxuDBVPHHvxyevUVzuuRpHZlI2AbIAzgAc+v4Vu6tdTm0jht/LS0TadixKrhhyMHHCAckABj7Ak1zPiO38+zcpKG5Mm0MQARkg+/HGPeqkdeEi7pN2RObmCzkSdnljkl27Xt7eOWUjjKb5SFBznghvbFXo9K1O9USx6WZEhOdmr3jlpuCc7AoQcnliD0HBrP0lpl0SMwXSxhVIk2B2cN1XCqyknoOT69eKvPFJJaSvFc+IEeT/WJpVgtsTxn5pGQuPU4bOc96zasa1Fyuy387/pb8WNigvobKQNqt7IE3oLSyiFlBHg5IEoVS4yPvKVJwa0LPSLOKWVoI0jgYxSqQxmllUYJdtxJPI7kn5c9q5z+w7W3lN3daVrU808hVBqGox2zMmORu88Mx6ZyDx2Pfc0WC1ijgYWem6a6EqRFqRuMoVYEbwoAZc4Bwc9Mg9Z0bs0RV5eVuDv6W/JP8bHQ3dvvDSy2KYtgfLa5KuckAqVHK/eA565wcVmX8TvqtnbRSW+2O3LyyL8pcl0G0YA+XAl6Z9Mc4rdhuI7qEhIYmmikAuIihBRuODjvzx2I5qla+Q2qm6VZJ5Jot3lrjgKwVSqN8w53c8DJPFNpHnxbWr6GfsQTNCkkRtbqM7URGDDnLtkgY/hzx1ArGhjNxbrHMziBpjFdtG3+rXavltuIG4I/UjoG64Brduxcy3Bu1tFjihDbpJWKN6MucEeh4x+NPgJhjVbjyXkMQVl8wsxI44XHIwccn06c1LimzVaLQzk0pPtCmSMRzIAHaNNzTAjaylu44B6+4ORWVdxyQTRzBHuJnOxQAZCsfAOfTIyOOefxrfNqV2H5FLMdsfO4kdxn0z6dayrnTHWV5mkG+HnmIK3qcMBuVhkgFc8Doaia8jWEtbtmZeWbbWgSOJ1f5Bk78IxBZWUqQVHp781VmsEtLmBLaYpaOzMMxhgM5PQHKpxyv8q23jMlxIrM0aEeYSq8yHGQrDGcYz1+ao4Ic7FKo/nIWZZVAkDei4wOpAGfSsbamsZW1KWmW7yXtwrTLJ+8EjhVKlCTwCQM++eauXCMhkaWTytjZ27ivm85OTjJGeT06gc9o7ySbzDN5aOYhtcshyVIGcYPHr8w6Dv1pLKOUNGqvIEkT54y+Tt6duBxyeKU9Byd9WFtDHHcLcPEwiuFx8+cZ74ye+R198elPAdLBW8rY854AUZAwR346fmfSkEcaxSSP5ixynCM0mV3DOWG7p/Ln2q5bxhEDgswUgYXnYzA5GfpjpURXYJNWuWpW/dIIxkBgBtU9emMdh/Krlsjpt2+aCcbWY5Bz1P0+tUlikl+ZpkydwLRjIGfUdj9av20yvFtKtvBIGeSuMEjj1IFOJzO5Y2E8hTg+woqeKNjEha4jUkDKluR7UVvy+RHOczNaxS2aiEySxqEY/NuA9wfrnPY8/SoXSfyd3lyEu2dqqM4JP3sAbun8vetJwhnlVElTGSWJHTAIA9jjHqKp6he+SsEYR5lclTIVYhR03BugHB4PJ7AU7dzWL6IpQtayxSTLI7xv/ECGfHZR05z349yainto55JrcmG3cBQ6RnDPHg7UyeQM7t2PQ8/NUloY5F3s7rIrFUGwj5BjqcfMOOe/XmiMbriC7M7xlSEVEjZzu3HcqoB8x6AknA5PamjRqzZcm0+AReZdebDEi7ZIzOIwc9GLnDAHIHy9e/pVY3NrbXhe1t3Dq4AmtrdilouBlmJA529CMnnqBmrsEPlSCSQCLc4G1SZJBgn52djhT15AzzgEk1I0Fu7W8TO92uNgSMt5QIHWTPXGO5Pvziqab2M79zGtmgvbefVVhVrc8WssrGVZcYAIyRk9fruPFUdfsrq5SSS6to5pURkWNWG2JnBVYlA4MmWDM5IwFwO1dcbaO81J0KK62qqGBAA3ttZAFHAwuDx6is/VbMtLEsb5hgYuVySoc5CjPVm5JHX6UnDTUI1E5WOb0vT47ayh09IiVijimkQp5XlqoVvmwPmc4GAc4zmut0faqstsAoT5XXbtVT3wCMn8uc96523heDU7hZPsYjKAG3QklUiCjP+0R8uQTnBJPBzXQWEzTWbI6sI4zjz0AUv9MfdA/M0Q3OmtqjYlYTMVgyowAWzhyvH/fAP4GnXUkcMNuJZVjRnSMM65U5PCqOhPT2HXIApmnhneHg7iMqrjCxg5ySPXH86oeJLua6tcWc0saxspcxvhioOeo5xnHT0OOcV0J6XONQvNQKOo3yXc++0mMikFjI3VeQQPccHkgZ4rNvonltFQncqqFAAG47jkHj2UkentVq0hjEkkESKUyASg2g+g2nhT0qrrpKWBVV3JLuBCKQx7KAe5PoOeBS3PRpJRkoxL3hiCK1iVC+WkAUFsYypIAHbocdT796kube3MkQCNefeYGCEEo+SOoibBwMfwjnHYmq2kb08pJvOiYlgAYOFPHcnAOMDABxj16WNRCXSq109s7n92X1C/lA56bIVyByPb6027KxnLWo3ff8Ar+rGP/Zdhao8h013kU7mM8PnljgEjzJJEHucLjjJ4FXdMktvMWSGbR7NISCz3FxZRqfQ4iV2yOeA4GR171l3MEESuZm0SM7xtdrISMen3BvJK5HUrzn8k03VTDdCKHU7SSJVYMF08QO245PJCYwccIe3fFZNnTKnKcL3v9/+X5npVzNJIsF7ZzSMgjZ3MCFjKo/5ZjGc5LcHJ24JHBpXs0SSS/v5HklaNVkBfbGMEkBRnJGegycnnHNVfD1xJdWbeaxlMWRxyCGxxkO2Oh4rRhiikBEUBh2vwQgznqMcZAHBye4H0q7X1PElHkbXYqvaxSNvdUjZvmEMgBVRjB3AE8k//XJwBTmhFz5kkc0zRBVCxKRGFKnIO7hvmOAcnt9avyxzOzbArgNvCg8j/HPHWq1xbJK8heEkYDBnBBGeDhh0x/n2q1gUr9SOT7g82QptAd4mALEnvVB4okmLnDPjGQRuwDkBsnPXP45q1ukjP7jy1idywkWVm8wYHGOuTxwfSoJvP8kyyW5Yq6kMDww5OOu4nv6VEu5cUYlxZZvRcFCfl2uEGMEDhsdM9uB0zS3VzFI0VsRt+TBVgSAD7Dn3q8JAZHkSRvlJyGO1iOxCnp6/jUCzJOryQsXwdoIbcWXuv0zjnrXM3qbNvr0MprB8Sol07eac+Y7ArnHXjGfwPtUtpFmeCKTDsxIRhGfTlR3BBGeTyKuspeHeJCFQ5ZAOnbofcD8az5SDLGJDIkpyHj2Bi+CBx2Hrk4HHrWcm+pam5bk1nAZJVkZd7qNmw/dyeuRjpwMewq3GF82SGMhGVgw2gHr046dQRjr/ADqSxWVLYyx5ChW2jdknvn1ycnpwKQ2MkJRjMy5JC+WeEBzk49cZH45pPQzlK9x8sQkt2+zyL5rkFCOcA5J+vIP8qu20YhhjUqQ2DhmbII6k+gHX6YqtFGYJnO0cuW6EgKDwBz3FahjSRhlQcgnnJOB2x0qorW5jKV1YLFlv7K3vLL/SLW4jWWGZOVkRhlWHsQQaKkUEAD7RKmP4VQ4HsMUVpd/1/wAORZmCEkMTRKvl/LlCpyUz168Z/Kqk8UckiMdoGP8AWlznkckentWtIgTLKhR2yG3KFGBwT7DH8+1Z1xOsnkRoyAbvmVsBs85Ccfp9au1tzeDu7lfyXR4REXPnMckjDlcFSxOMDofQ/lVuyjLxbYBIkKqoG37rAjIIPXBH5mnSQAgwtFzt2sAxyN3brzwBn61YjhJdAwRTg7FUltw7ZHGT0+nQdKa3HKehDEiF3RXMrIQJTv24b3GOuCOlXLlWht2W2XyycKq53sx9fm6DuSc+wplxNsmijGJlK7m8xsFVH8QBHHJ7471M8odVkB55YFXAX2rRWMJN6Mzl08xQLBFNcLli00m7czs3LHB6ZP5DgU6T5B5joBJuxweF/u88kE9fxq3NHIhXy3JMYz8nAyemc/jVC7lIuIhasFkBbG4Z6DJOe3OP/r0nZF07yZiJFv1K9l2wQW0d4kjh0w+PJXdsPUMSBknsTWq6MYUD7kKg4wNpxwR9cA8knA4pIRDbecy7lfcCzyvudiMABc9OAM/rTJbgSqGkfb8x+XG9mUcs20dueOueTgDmpudl22rGhJexWNk800xSJGC7sEs5YgAAAZJOeAK5aTULi/lQPYtAqKvkWikeYoBJZndhtiyANwywGOMklhe1TUp45kgs4Yp1CLKSPmkILfMq4PB2HHPdhyMVh3V6b21AKxNERveMMDDlcjLHP79gcHP3Af7x5rRvQ1w9D7TX9f1/lobNm+Lc3EjLNtTanl/6sLngJnJI5+9361zni7Upvs7JbB3kMO1TGTydwBUN1xjnitYPHa2hM05Zgu9mzy2B17e1eb+KfEBM01mN7+W67VzwM9csO3oKjm0O3CUearzdj0TQpt2k2yrDGkeFzubc444A9PxPqK6HeYIS6vHAsoJmWNUjkY/wjLHJwQT9DxzXk2i+IL5cPfeSkWGGcHABUDk+1dbpGrvcuY7htwlAVVIDEKOc+h5qucyxGGlzN9NyaRo7e5WGDUDbxAlZNkdvuc5zn5snqMnnnPsasCXdnY2tPLzh1hiKA85IaNzk4Jx0yMVlXa2u4vPLbo7ACM3CQRpn0HmwOuTnjkdevU1dTQEukYNpuh3U+Msf7MspgBxyfJmV8c9QuRxS5uhpUtBJydv69DuPDBmkilt7ldT8tuc3rg5XoAPn6N9ACOvNbzxpGGj3FZHPKn98WYd8c89ugrz7wbE+naq4udGgsQI9gaHSns0wTjIbJBzjoTk5HcV3yyRn931WQHHztu55GDwB371UXoeNioctR2d0Wg+YSJkbK5OXPA56/WozLEzOv389Iz8wJx24BJpxdd8QBAbbwdmAABj0xjp6/TvVK5uZEiKhvLcHJ8odFycFifu5A/DpmrucsY3Hb3ikMSRJh/4UJUIOABx+H51VuwI4i0ksbOwwELncw9Cc/KuM9MUy0YiObbM7x+YW4+bAI+UE8bhxn+ZJ4qtfSZIuAjtkquT0Oc4+91649T0AFZTkrGyjaRUmEDSsBDHG5AbYijLEDOAxzwOOn40n2j5klC/OQPMdmHQ98dxkcmnarcJYwmWZY4lUFf3a7myeeAO2QOM4zVLTRNNKXkZQzlioAy45yAT0GBjqeTk1g9jTlbjzPYtyMs4VAvzkFtuRjBHGfQ9eB6+tJcwqio21kiUsvllyTIewwP4uvU96t2EZWIyQJtZW5OVBLHkn27n2xzTfO8xy8aiSLG35V3YB5BPqecVm7WuZ3d7Ickri58vAxtG0dSwHXAHtn1P8qeIRLOiRlVC87j0LcDAH0Oce9TRxgNwitjAyq8AgcgfT9easxO+dw4Odx3DAHr+Y/HkfSny33Jcuwn2dNwYBgxOM+vGMg9qdHEjKMjnncScdD/KnDcBt6SY49Qe9W8b49yxZT+EE9R7Z7c96uMSLtDwikAiVsf7tFMMsakq0+1hwRgcUVtoFpGExOFMgUsMoCBwF74yTxVd4wiNGigtn5M5OPUjHP/6qtyykjARSuOcd/wDGoHYC+jV0Cq5ZnJX+HjH0HOMc5qGjRDlKn5BIV5xluWyOuMdj9abcy3SugIjiYkhnJB2A/wCyO/pzjufSp1RQXQkrsBJCD5f14qIMk0rGB0YKey5AIxxkdcHqTQmFxpt47mPbJhopBg7kAzznGe/NTMisMFTtPQN19uv86C6JkIGklLcHPQ8nIIOAKbtWBVUseScjnBPpk9fU1d0Z6sUmRdyMp37sKpQBf/rnGMZrLvcI7qkkaXewsC46AHGC3RU5wep56ZrTkTzQFIbevzL7duB29OfWs+W28oiJnLs5ATAJwfQE9cZHX8abTaN6Nhhby40eJcSsCfMPzYGMNtz1HB+c+nSsma6luJblxI8kWxZJJIufN7KA7Y3L9doA7Vr3MUUsW1tz+a205/eZ4+6T3IPYfmBXL6vI9iZpZdss+SkcrndFCTyML1lcDGEXC55zxkh3UEpOy3Ma6meedrqe3njjuVSO3i2BjdKvHyJ3GMtlgfXHepUle4271iitowDJjnoP4v7zfoOcVS1WZ5N0kjXMaXJWMyXMm67ulzyCRkQx5BOxeuags9Rb5+BFAV2xxBcxqMA4GOoznv25JqZOx68Kbcbpf1/X9dC3rupE6cxViFOSXUDkHPY/TpXm0Mqy6qygCSWWURqCSQvfP14rr9cuQtvOVxtZRzGNoPc5/X865jwZaNqHiMyhBtiXIxzyenPXpUxu2axSo0mzY8WWVzHaJdQMxMHJMWcHJOSfer3hy/zZxOrHJUBgTuHTk+2QeldReaQ9xaS+VmVdvKL1cjsoJ54PIHt1zXnOlSCw1A28su2ON2Xd0AAPTpxxjtRNNK5lhasa8XT3aPQNQ1FLK2jkdoMoDGEuMGKTI4DqFJIGOgIzVLSL/Tr9Cuo2+gp5fIWS2ghXGeSXZG4AySAOnAGSAM3xBcxySwQkOGVlfJl2YHccevI9c1s6Pqc2j6eZNPvTbbHWOMm9uHILYwGTyyhJIJ4ycMAB3BBuxrVpqNFOMbyZesJrC11O0ltJ9CRGCCWKzkj82T5xj93GqnBUg9OAOSDmvTLG4D2sMtqTImAyOUA2ksR6njtmvHrnWL46s8Wo6lJO0bxuzLpn2RgQeWYEeaeMEZ2846V6NoDMumWwjuiNobZIow33jwQePqDxwcZxVJ2djycXQapxlLf5/wCR1EguI0VRE2S2Gz8zZPVjz0GB0zjIqipE9wuUZxtb5WGN/HXPQY4z1zjr2p1sm3jzlZiuFYAsPc+g78nA9qZPu3tGTGVO1lEjNk+pyOeOT2GeOlU3oeWtLlyO42MpCrIU4yG+VeBgYPU8Dk96zZEd9/2l3Z87oFK/6vJ4UY68dzj6VakLSBwiqhbkY6lsdT9fU1n+cyq4V4Wdcqo+6CMZxk5x37c1nORC8hNSgS5eS2QRrE6/vsZWQoMDgjBAz3B79ahxHlyNqxHaAiqVG3PHPfIHoOvvUwbbjZ8uNuVVcEkdyo+vAPofWi1K/a2/exSbQGATnBOQWyRxnjHTn6Vk5NlJtImTlVkjgMUajB3LjBJ44z36/QduakiSQSSFUPllerPkZI4OO3T9an8iJXikkB82MZ8zHCDoTg9vc9fxqaGFG8qSba23BJUcAHvnpmgz5yeG3CKcBBwNuePqcDsOlTbQm1YVySMnIwCPX2qVFWNkQu0jkfKFJIX6n/I9qkMbH55IiqdfmbnjnNbRikY3fUitf3buQqqxH0IPp+PrzUzlVjHlYx0L5zj/APVUyr86EsQGHOTyBn/P0qK6iWRyOVCD5U3lRknj8OO9WJSu9RpaHPEaEdicZNFAAxy7D2DYx+lFPmKsYpZnZ2KhV/i+XHT0qMBZE8t2BHB2rnK+/wD9YdKCd7Mc7T1XZyDzn8P5UjMSfMQlCpyMHGKhmmpDOioEkWNiysSo649+eh/WjY32h2faCCAm7LZHcnjpzUpVnR1j+STjbuPB9z6cZqNJwHIlmKsvTkHBGOoFSlqO7aLCxpHErqx5OCD/ABHt0Hp/+uo55hMHDRhlwVMbLtzxztyenPU96ZuUS+dK0hJxjzGyBgYGFHQHrx+NOJYYGGZzjt1qrkWY7CoCYzv/AIgXOfmxn+prGeVTIsAaRJGH7xypCj/ZLHqQT91cnnJNajAhVj3MCwJx34GBg9s/zqvJArMqIp3NgsgchQQM4ye+c5NVvsa0pW3Ma91EMohMMzuzBIYoFIY46jjoDgEsPXqvWuS166is1trrUdk0s+I/NUKI27bIUJwVHByB5fAz5p5ro9UvGhZzGoEmXdmZEG/gBl5ySMfgccg1w+vyQQTC4dTHetEpeUtteQnBVjOwMnOc7YlHGRuHQJO+p7OFhqtDGvLuaWdVW3dyYzstZC0mAScs/cjJz820NySCBin2t04tvPnkEke8quThWK9cZ4P4fgKZbTWMcHkSDzFK/wDLVDDGX4z5cQPmO2M/M557gCp9V8tLaQ2sjKgj3QxSurOoOCCQvyJ1PyrmpZ7cZJ2hYpa5O02lzsABG2cH7uTnOcdhjj/Ipfh08sUV9dJEdgn2yS4yAqqvA7k1g6leO1gq5ARUKkMMnOex6/4YrsfhfN/xKJEdSVa4c5K8HOO49OlOC1OfHr2dJLzO+tFTULEtcIYBAxG5ASGTHp3xnrXm/wAQ4orPV7VlDSGXLMZNuHA6buOWyWJJJ7DHGa9Vs5o4bVy21VAJP+NeP/Eq9NzqVuY1Pkxhly2fXPf6HkVpNLlPKytv61e2n+Yk+oGKS3EYbcgCtxhmPQ4wOCBXQSarMlrKIbmRXEZjVlkLOR1ITaeepP3sD+LHfiLeQSQQoSTKX35J3dM5J9AAB/St9JEt7KSdy2GiMMQVCRcFv4MAjjoepA4yDWMUfRYmnGyTQ7Tmwm+OFvPfjDuXVHJxlFGN7ZGS7HYCa9T0GcXlrFHeGSRCABNvAUEHjaeNw4Cs3XpgmvJ9MSWC4BuJPtbKis0QkARRjCrI5UjA7R469s16N4Rnjhsre4kdEkeU7ZGO3ywflBRO2cdX5qW7bnn5gvcv/X9f1qd46kqsrqPMdGAYjJJ9lxz35P6VGpjSeRljBnOdq46E+/Q/09apyXoaXDbYEBws2fv5J4AP3jgdwB2AYVLIAkJ3rKrblVGk5kYDjn/ZwTjPHsKpyW58020tSS4nbbI0jJGygDy4ucKPXnnnn8O/WkVI4E2FU3qhDEckd8ADv7j/AAqm7rJkMEbYRl2UkyA8cAdsUyB1mvPJiTd5Y+UnJADHpnpzjr2rLfUhIvQxtLcksHaMDiJhgBu7Z/vc9T0xVu3jSJJTGvlsxzKy/d9CSfU46VFbmVfMi8td5XKNuwMdz1P0/wD11fjBIjUAFSepXnp1x9D9R3xQomcpEVsW2MmxzcMRlZOc8Afh0+lX4dySh1EZkHVy2ccc8nv9O1MjMVtyrgNIfnOTk/XufYeg7VLahnYMPkLHIXGCB2Bx079K1ijNu5et4tuEJZmPzN5nBPfn/D86tbd6q+Tt6kE9R/hVGXzGAeQvGCCWxg/L7n16+3U1L5xdhtVgMAKM8enX8hVoyeo1PvSb2VmJ6Y4A/hUDvzzRDAMjzFyNxbcxySeBz/L2p1ym1F8thuXOAvOOeR64zihI3OI4flVBtA6f5xn9aLjvoSi3uCMiQAHoGByPrRUZmIJAiTA6Z6/zop2QWkcyZGjDNEuSRtC7gvfrz7VFJ+7LLhmQ46f3c9AewpLO6imtIrgcwSoJEkRgVdT91gR1B6inR/OhGdqk7dz8A9+c8Vknc67Weo2Lc5JQDAycxk4x0JFOaIkySoixqQA+e59vbFMmmkihkk3qqxgllYhRt7nn6dunepXz5QD+YOeQi7mznHbk89fSp6g09ypasGBQIscrHDu2Tj0PuT+VPaRQZgxlJRgo+ct9M+orB03WbfUGiu9OmV4ZGZY5WQ7WAHTBwRg56dKtzxliTKzBo0x8rn5jwfy6073VzSdJxdnoX4pY5Q580sE4JwRgdx7fSoL4GOOQx7t3ozDJyOPY1VkZLQbUkckBcRscgc5BI/EikuDtSd1lDN8rDeDjb1bJ65z0I/GmpXFBe8YHiDVWtG/cZ3xnBEwOeVOSOPX06Z7815lql68U29lbJUoGVyrBMHowIYgc8AhTXoPipkjkZ7g27AAE73KsD3IPqMgfjXmuuQTyQCUROyAZMikMpx7nJ57cmhPXU+iy6Mba9TKjvkjlkWNJQG5ZVOwuP9ogEnr3NbcGoCW28iAkx8AhVCq3pnAz2/2vwrmNuSRJg7cnYB8wbH59P5VPbzeQV2gF8hWyo6e9WloetyJysV9RYkSAAAbzwvTHpiuu8D69b2Wim1UzvdeYxCKnGTggZ+lcpfk3FzIx53HOfWqtlLdw+Zb2AJuJyBEANxL9MBe56cfj2opK9S3c4s3TVFVHstz1C88UPHYzLcQGGbbwj4BGeM+/4VwGsam99KrNIDIxJbPbjFb9tpXim+sI7TWbq1tExzIkf72QnAIPYHryKi8Q6bE13pOg6SwB3PJMzLlo1B2+Y5HX+M+/AGa3qQcYs8bB4uLqRUV6mfp1tK0PnAJs3eWCcbTwM89sAgnPTNdVFbS6lLFFpfmFydk11GrfKCdxWMdEH+11PX0qK6t7Gye2hujIlsi4jtIj++cHBBIGSCxXP9elaUSX+oReTdzvouluSv2e3YmSQY/jYbnPUDaAScEcYrnS6HuV8VzpSX9fLr+XmM05LaxKWlqpubgMyskDbth5O9m+6rYyCSS2McV2untIljFPMgeRsLFOzErkDhABzIeccZx6jFY+jaTb21oBFbyJbgYSEruRSvILKSVD5z94sSO1dXp6SyxSmVSUbC+bKDk7cArtyDgngDgY/hqWjx8ViVLzLml26wWkcjACVYQhM4C4HVmAAyvPqc4GMVPJOJZgqBgysFYAYGBgdD9elJdQNJCqBVMERAEZIGwqMgEAc49OnHOcUhSCKA5eQsAFdjgY7Hn19MVntoeRKXM7sgkVlMnk7VTcVIZckHgfkT/Sr9rDINsy8Ruu1osdCP4iegx0x9KeP+PeNYz8j4TcWyVJHQnuetWI4pPOQ5dcHGznB4wB14GQKdhc/Qlt0RR5gwHBAIZjnJ4HHQdvyq4ZU8o7MmVQNoB25Y849h7fiaqtNsdY2OxlywGM89cKfX3NWICwyy/OmejjjJ5OPb8zmqWmpjJX1LUG6O4IILAAkNkZOf5f5FWbZlj3fIQhHQZGSO34elVnYIxhGCM7id+MnHQntj/PWniNhMjDJYA4Uc/5I/rVN6mdr7k0ZDbsry+RjqVA9e2efwqWPDSOynMgXO4HOMjAx29agg2b2LMq4+RiBj5fT9OPx9adIxUsZEKxb8FR94AjoOOnP60xNEtsyFh8yFFGBkjpnjPsf6CrEXyP5ZYYfOMnBJ/+vzVWEDzdrjAHAUfy9xinxyBXWIrjd0Zh8hY5O3PsB0oTJkrjjaqSSAhHqQuaKt707ISPUAUVVxc8jkLW2EUZjQbYwuAAuAoxjtwBUflPbyFRIoSTGOpye2B1zxW9MsXkDAHmFfuAnnnpjtVGW2ZgN/yqpO1Bk7lx0J6/hQoWOhTb3MbVrG31Wwe11KJbi1nG2WKQApIueFK9TyOtLZ2sdpbJBGAkSIEQDnCAYA47AVeMEaSh4UYAL8u4AbQfcDmqU84YbF81w2c/NkZ749v/AK9ZySTuy029EZUi20uUOBKjZ5jBwQcjt3FRTQsrs0U0m+Uk5cgj+XI6cfWoGsJP7TmuJLq7KThFW2bHlxFc5dMjILA8nPOBVl5GWJinJ2gBm+9np07fQVldvQ6L9mUZtziX7VD5kZ4EZHy4x0bB6H9MfjUsM8xs286WKbygTG5ONwJPylf7w9c/N7EHKSyLNGxkCsqE5G8fMM4Jx9ay/MvY1la4NtKI+Aqgxlj0AwBwc9amMmncHFtGV4ljFzaGGd5HcruEgK7UQYwOfp16+tcNqEDQhJEzCxQ4O0occj5sHH6d69Eu3aZ3aezKxkljskXIBwuMBck/5PauH1izFjcCFFjZZiWSRyQXXONp2nqCOQME1onqepg67XutnNJI5kMgYsi/KzOAwHp94DPQ8Z7Vegk024ljW6tYcscM8bYLZ/4Ecds4+nrVu50+BnFvLJKFlkG5CeCecfNyOORn61DLp7tIiQsjEMdpxkg4Hc46HpWnzO6eITdzQOhaXeRRxR3M8DE4UArL29wD+tT6R4Pk0/WLW+stasnkRmzBcRNGzqVwQDyuTnjGecZrPW1dlgDTymPZuH7xBkAdOe2T16HNX9O1X+z/ADEhnmdkAYQxPnAGDjCjHp7epq473ZM5Tq03CMr36HfNZGe3J1G7On25UK32bFxLKjDPGBhF4xuzntWKzNeSXNvoFhc20bgCSK3QNMx/haeZ+meDg9M4GK5bW/FuoTRKrENI+5VDNkgE8qcdcr/M4Hc1NJLCaeX7HLNaqxcOU2+S4zyo9cnGcDGByDWkm2ckMulTjzu1+nb+v6Xn1kmkvA72kkMVmhlIdgvnTOwwSQx5c5AxjcAORjrVzTLeNP3krus4diokY4aMnIOff3yR24FOtdft1s/KhsVshcfMrhTFtJB5JQZABB4GTjqSKv23mXW+S3khhjjUupdvMDPjDOd/Yjpkn6VDtsZVJ1EuWehf+yyOhjkeQ8MNmzKgfdOG6A4PAArcYKwjxukfYpjClwF46g9wPU9zVWBUSAMCN/8ArSGzjtnHoSeo7ZqaWKR3KWxeMbf3bqzcdzkg45PNZSXY8uU77k4kiilBiMoI5MI+VlBHPI6DoeDmmxxlpd7MJMscNgjbzwM/kcD8agL7Zd1yJIGQllXGApPAOMZ9enrU8SeYvkxeY7eWRsOM7cnDEDj0HbFZrsTa5cgy4BGCGUKTuweQc49s/wBetXoFx8mMRjBAduvTr3/P0rNtN8Y3NuzkA7RlZOfvevcj0q+ZFidXKHcC2OSQvtnp07AZxTT0E076EyRL5chdeF+bBbhjnj+tPE+2QoplLbflXIJJ7ADp/nNQjJnUupwyjagG4j16cY9utRNte4hWJDj5tw9V6/hj0yaq/YSV9y7byeW7IpG1lyoyfmz1H6dT1+laCyiQsFQcryMYAOeapKFmszH8uXBY85wccHP9apSXr2hUSwABplj3dN2T/d7KeufpSbSI5XJ+ZtOQCsvzuzqQQcZyf6gf54pXULDImQH8w/MBk/h+gx15qFd0sgMe5FRhuXONwIxn8OD+lELSFlMowygDcewyfmHuav0IJhKZnLQ/K8WQNx6kDB/PPenH99GRI8gZW5GOVOM5x71CiFWyZG8tuMZ/iHPNWXJyH2kSYCkRnO7jt27mj1D0FMUWTk7T6FCcUVL9sbtG598f/Xoq+Un3ynKrLPE06l4xwSRu2nrx7darGQxEiUSHknd0J9OD7VZlYyMWRyQigkD5j7FapSyo6ryxVeSpH3vw+tVJmkVcr3LAqzx7mjOTtDbhnrleentwMdMVnwvj/VlHhdAc8kfUA09Y3WWXzBuRjkAfw+wqveC4tXVoEURs211PX8+/bNYSfU3UUtEypfh4E2h5JFAI+Unfn+ZwM1n3s0PlBmkCfMQGVhvBHf0AHoRVt/tLFlklPQqCFCjj8z+NRQpCgIUsqAnDMoy5z1575xj35rndmapKJUlVVTzPIjViMFequM8nP5frVC7PkKxMc7OxK7ghygPHpyckf5NW7nKrGULKwJLSHlYznPIP+RVC/wB5g8uOSRZXwQd5yCw4PPAP3j7YFOLuWm76mXqOo3F1G0UNuHGdqkyjLHbjGR15BHHAPGTis7UJLe9tcsoSOQkKGGGVgRxgZAIJHPGQfetG4so0MUl3IPJVt7BcLxtwSAO/Pbr1qhcRK0zXMdqoV2VQ8kx3Ky/dIBwD3TkY57ECtol2WnKZ8kjiCQzmFRv/AHauQpJxjgdccYz2zWJdahJbXJWKPyZmJ2885HOTnp9fYVrX1jEJzFcoVbKj5MFmbbwFP9wlgefT6VnMVhJ+1tG1yoZXBBJQg4z0Oc9ea19TroxcvMz78hlAA3FCATI7EvyefQnPHTtUtvcSSEQxzAqUAIVNoUDPy47ge/JJNOWOWaR4bNCIYQX2dHwFJJGeo2g/N3GaY+mXkV1IxifDbSWMZzjg7sDgemTxSvpoerQhFRs3qX9XxFHHawWbu7Y5EfmY2htw2gcZznHsSc9rnh+0EX73Cq7F3EiScrlQcdeeSO/HTjJqO90uSQQXkjz+TFGFk2R7iAAcYC4zgep7mrOixuCYpoBHuXzFSP8AgB2jA446gYyM7u9WtgdvZaP1Na1tY4rxXh8mGZ90rF0V9zDHRCT83ofY9cGuktYYIJ3NzdQiOVgU/dkEOR82V6DnuM5IOcCsq30O3tfs7XC3KXqTogjZOUYkrt4Ge5PPIyfSuu0+72XiWtrp67PKPlgjaVXcQPmJ+U54wfQ1O+54+KqJ/DqOs5FniJZAGlAADnLhiT2+XHOT/OriuqqeArHBKgkhSOhAB49cDuOagvJ55YN/3FdmQFXAlXbg52kfMDzwCMDkZ6VWna2kdzc3YkDBQuxWPGM/P/ifQGol3PLtcu7IkOAJdmcMjZOwZ6E9xk/rS2MciS+YzttI25GCCMnH+feo/ND+WkO6E7/mC46EZ7HHQfWrAhXy8Qy7myMAYHA9QOvHceg9DWRSukW45Ch2EBGJxsDDBxwFyeo57cU7fGJX8xoRtUEDDEQ9cge/FMi2ujeVMDtwyBiM+/8A9cUk6N5kNw5jyGyq7sAn0PUkjsO3FUhR1ZfRmVRFsZnGGXBxsz7jjocfWnWxQlgqglDkEEhcDPPf6e1VbeJ4riSVGVQBk55KH/e6AH/PNW7WSLdvkRySDvOeAScf5/PmmmQ0WbBBIZl8pURv+WZ5VR7e3T86kuIo3YxlCS5+UYzx0OfUVGkZVUBbaTtCynkDjnPYirUSZiJQfvFYYBOcA/xD0yTVIzbs7kboo3hV+QJ2H+rHbH0HSmmQ20chkbCkA9OhI6g+uMfrU6/PbSKTuZmMfDAkN3zjJ9+f0zTIEka2ilUFQAdpT5iff3B/rTXkCemoq71ECKcqrblIOeozgn8atpGsMkqKu5Qo4x6dPY96pl4UaNoyNsnPzAjPPQ++KuQDazo2QxBwrcnryP0FUiXsU5YJPNfa8IXccAuQR+lFPl1GKKV4zIFKMVxtzjHvmin7vc1XPbYRSUG1zt54YtggZ61jzhmlJRm2lxhTwT/T6Vr3021UDRFiuW3dTjocD9KzLpAjy7cLtBYhuvsM1U2TT7lKVHEwkYncB0U9RnsPf/OKryNGYWxKUXncO1PLTBQGXcxIJJ5Y+uT0+lVrhJA8ZO0s0g2469s/QVyzN1Ho2QTM8Z8uGQqDjBBHG72+v86hvJvLjQTsojIyAFyfTA9D71akMszJEqICRl3XByOv4c1m24ijDoE3MzNjkne3XGTyfp2xUdDSKuriJMlzIRF80Q7BeG4OOeo6Hpj3rIv7d5X80lYcMxw+OgGASf8AvrB454q5dWscQDSxyJ5jlY3V8EHGeM9j16cZrKFwIJ3lkQnhYvKkUE4B6nPByelS3pqaU4O94hNHcELczjzChyFwZCW3DDDt9B2rOv0e2e0t5rgMUkT5VQ4MYXdwAOWBP8+tadxcoC0V1cMUUbTtYnaSRkEEAD9areTI1tJPb2f2eIx5BwZJNmTuPB+XkA9v0rSDvsVqtzDt4ZUv5DEReJhiyM4jDN6H2BIIA9GHtVC7giuEGpW9xjnaqPJuZiCcMwPY/MQSQcZrotTjhsNQTdBv3qVALZG0qR/D/vYqC8hVZJI7fFvJIPtA8zOWVTtbYFzjJAzn2POTWvP2O2hJ3Uu5DCskNxbrAII2mgMgkkjyJCFywQ5ywHTPrUsGh393PC1yWFyWWZUjJUDjLEHPYkA88+w4Nu4ZLTTxex2r26rxHCzchshvut0Uso7Ywxx7dPBdgyedG8XneayzBSGCowDZycdCSOMgY5Pciaehcq0oq8EUPCegi3lkSZIkLNuDAr8oU53j+FSRkn6cnjFbj+HYPNhbTbSU2Kv5jtIfmdshvlAGdgyCSRzwOgqro009nfTRvG45jlG5sxIuejL2649+K6W21BoHeKa8cF8yIqoHYjd82OMHJIUcnp1zxW8GrannYitV53JMydL0e3mu7qy8iOKBQZ45cHcVbjKjGfkZfzI9atizhMVvJKjrJOnnyxKAg3E8rj/e5xnvnsc608ogjW7zKzB/syMRxEHIAYn22jP61bnNtM6tD5cdugKqzxMAT93A/E9Pek7bHHKrNu/Qx7m1fyX2qgmTaCJ8/NxwDz05xnrkexrJvGTMcclq8hXL4Z96oucDaRwee3oa6K5gJd13YmULtCj5lUcEfgf51kXEM6wAhkuBkk+Xn7hHBx2X36fTFZT0FCVxsUE6wBY0jVC4xsGUbHPC5GPXtipbWaGMbYiXMh2kFdxzk9x0I61RQGQQukjNN/FD/EmM5HPXr+I59KdJMHncIN7lgPlIyGAHBI4wc857njpWO2ptZvQ0VlQXoVWXfI28fwiXjBKkdyB+nen3QG+Ly5HiVtqR5xjI4yG74H59zVIm5SCOSRoxBvOdo+71GdozwMc59jV1dr26POUcE/NiTO3p97qSO+T0+optglZ3Ra84ebE4kxCCZHeM4GDn8+3T8OtXY2RyHQKwj+4F4DY6LkjHY/r1qpaxImwhGSJhvCFeGbJz06defWrttG0kJyvIHyheOc8Hrwc/1qkYTaRYtlZk+V/LZOdrLkKPTg/TpUoVBESBuJxheuOpI/8Ar/4VHH+7ZnGVKkfLjtnk+h5z9cVZjQC34GArjlhnIA6Ve5k5CSeULkL5jb2UsMdz7HpxUiRhbfa3QEgheMZPWorYgRBlDJGGAYcjv/Ln/wCvUiSQwyiISrG8jZVWbBJxztz0+n1qrIhvoNMSLARsYE5Jfv14zz6VPHCFLgHAxn6H+VA+WFfLR3IJG0YG4Y4yTjHtS27OhjDblyOVLA4PoT3+oq0gc2Zb6c+9tty4XPAxnAorW8uLu0mfbgUVdvI1+sSKF4mQGAYEgKTz/nH8+KzLqNfniJLGLAlaQZBJ7D1PrjpxWy28Dl8JjafTB/Wsu8RI5PMaQEA8O64X6nPTH/16idiYXvYzJoxcR4ON6jAznnJ4OO341S8uWGZn2yNGx3AFsk85PTtW0wVxuU55yWB5J7H86q3QKAxKRIvIVMY3MevPGBiuaa6nRBvYz5Yylt5lsUEkmQhbhRnuawteF5Haj+y3czyHy0Z8HBJ5YD8D3xj8q6G7s0gj3iRzsViCvqBwPT2rHSzn8wx3MyElP3KBCRHwMn3Pbntk1LXQ6aTS965XeATEC7n/AHjqqsWXbuUZ4H6+lZMtqt1cOblYoURtqF03HPrnH+HJFaR06OOdpfMaaUjAfkqgHoPQ57VDdRO0SyXiROExGC5UEkN6HnHQ+oyaybLWj0Zk/Z4Y7JkZH8lW3YcmTGeQOc5P+FTwiaJ7eNx50Q+WZlG3zT7Y7BTz2GalleNLWRp32LCpQRxZzJJ0Uc4wc9sHNS2sgD+YskgV8I6sMu7Y+bHb73Xr19qpSKbdmVxBMjLb25hLzIFKcfIOc/N04xjP09DVG6hjsZI0iaRZ1lYxyMflQ7flYr9Vwc5yD0q5IVt5JJLlJBG7uY443+aPeo5Y55PJHB4x2qvcTTzfaleaOBXyspVywj+Y7SxxnHyjocCrvbU0hJr0Kl4V1JJ3kRxqMckUMy+bkoxcDac8ntgnghhUtrd/YoogGt7fzQvmRxRMQHBIUjIHGdxwvOWAJyOc+8mits3iPJdSw7CwdgFbbgiMHGcgkc9uK56bUpy1nPA0k0ykARMN2QAWfIxz83THTHWrR0RTkrHocGrWlxfGWBzcW8KvEZBG7lU5O0M2ct/ECQBwR71btPESSXe2a5SHbEWS43DZICOhHUe/0B9q8xv9QY6fFdiRUD3AX5JmQoCucbT/AA5OQR3yKtT3kE5t7KBke2aQSxbidkT89WOD1yR9a1V2jOdCPU9v03VYr9FRXimjTLZaMbiMfKQc+nOMenNaE16PNeACYxrGZXLAnfuzgkDpjHPfocV5XY69NBZSLHbokiDy3eKQcnpk9Rt+76j8+Or0zVoGthb225gygloiGXPGF3dievqB601JnmVqLi720OrukXzpGSd5FjUF2DAbSejN/tAZHPXngdaz5rdXVkcvKsXULxg852+i9OOetUYNQc6lB553yNJsjRX287jwG7HIHHfd68VaKPNLb3NsDsVQpEYADLk5XBzjHTHAzwMVEtTFNoybiGAtcIpldgNgkIBBOcDJPUcYB5APoatQxnIzL5iouxd/J4yNre4549fWlkv45LpHjnLLgBXdGDKpByxH14I/+vVaJRHI/nINpYFWBIyMYwe3bOe+KxOlSbVmaMiswf7PCki4Xq4Hbt6Y4/LmgSGIxTpMHRMhkiAQuM5IJI+Y8Ege3aoQyxhmYH5lD5cA5BPGe2Ov8+9WZIFwAHkxKCz7G3ZyO3cH37deKWwJpF+1uYnICkso2ld4IC7unXn0/lWlE20B9hLSMACPuAnuPXPrWUm9Xg/eLM6kqSB0GBnAI56/gR71sRxERHeuSf4sng/5xVxtsYVGi0EYOQycsMsOv+fc1NEmFkV43IwSOc4B7f5/pUcQkI3McSoxUk4yD6fSnRSMHCHO1Vx14PJzWtjlY5f3cYXaSQ2MHHA71KGYRnewbHOcEHPY/wA6hVstKVyY8ZU5zk9MYx6Y5qaOP5tuGAUZAJ557fhVIT8ydQGVJFkAx3zkMMdM96aJFAxIBgjIJHyr+JoRcb0Xg9emOfamw4Z3DEE/XOBVJEaEnmwnk9T7UUES54WLHuKKd0GhSuYFWIOVZmTnanU54wOlVdStlmgaFVLNwQzAjB9CD16961JY125YkKBjPTFUrqHETkAsmQc7zng5FDNIPVGRcRsuzzkxKpwuMHIHOB2qJIsqryPm4TrgcE98Z6YrWZM7pY0xHtBAYEHPpj1qrMoa22kkMwyVJ4P4+tZSVzVSZm3iGYA7SOQQVH+eorHudi3Yj2srOSBvbgj6+p5rpZFZbZ8dMjk8k5OKyGghihczHcsYxzyASf1Ht9KzkjenKxnsGjRYIX+UsN4/v/l1wMVUvYBv2CFi4UZEh2gsTkk+la7wNEzuXPmOcjjgZ9B/X0rKdDI+2a4+Q7smNcFuBzzk+3FYuPQ0juZd3aullI91E6xFW8vHQH155PPf8qqr5Nuts9zLcTSxnISQbSoxwOx2k/TtWkDMmmiVhvEa7gZMYYdRj1PA+hrPvJI/OhknLrKFUZHO4HkYyeOQT6nrUvubRvsZ9owns3S9ktke7YlkQZYKCT0/gHH1qOX7GYGTeuznbsUfvs/dOcghR0980+1xbXQgEYuzNudUYhii9fzxnkY9KzNUvS9onkRReaoBlKSBjGF4A2jCgHH1PGOMVaNftaFW6lVrwJCIEkjdGMKKEAIAVQz91GAfwrk575NshhnlhvIptzT5BaQnqeANoH1/Sp9Yu5bu4nkllkd33RCUIRnGAVT+7ncemT14Gayby9ltXjV4WTcWVN771yPlICZ27hgZJ9K3gi/a8qsQMxSW3WNAuIJCZZSTvJz83fAOa2dKvIjJZ7hBMiAAKY2TJxym7uf9r8utcfc3kaQyzsiyg/u1cAtnGQWwOCTwPT8uLGnagksUbb9yuCd/ylck88dug+mK1UTOWK5tLnotvqlvDcTJCZ4JZFxGobdGpxhg2ec4zg4x1Fb9trCWtoCqOQ+1QrSgxtHjaQcAAEEqcYrzW6uJbiFljlYgIfKIO0uRzjrnAI6gZ5OK29LmiuoG+yI4WVMA9CNwywcE44PGevfmlJGcpKWjPU7G4Oq2W0ERSt/D5oIcg9DjGTuHQ8jtwTXSzXfmxJIm3DjcF2kFn4xhuDn2P3h75rzLQ7h4neS7UT2syqoMEiqDKPuNg4Ab5cHnHAOOa7F7xor1GhME/AkEbELIYyTkAHPzAknjnnHOKzvY5ZRvLQu3MyzS/aIi0m5huaQlChIJKtkdyTjIOenuEuoo0ESiSRAoJcbSckYKnH8IyCOvpVOxuZWv5IsESKv+jebGVbnJII68Nn/vongVdtAWmZIChG8rjI2jqcDd3PrWT1LScSUOSVadVCquzcD0IIOQOn4Ecir1pEySbdh8kFW3becAYySSPl75xiqFtBEkuPOBaPqGU8gZ59PUYrVs1LttiaPKntzuX1wajcblZWRpK2JYZdojUMqk8AL2B/8A11pxkqwXJKbcNjt19O3SseFMP8oLqOflGOcY69u35VqRHYh8qMgLgkY6+vPp1/OtYnLNlqA7CgZSQTtIPTGO+fephlUzkYXjPUkZ9arxSGQja2xgdxAHTnn/AD/OpTjC7sln4OTz+Pp/ia2WiMXuKpR1XAXaGI4bofQ1dRRuyu49j7+5qmqbl7DAzjb96nW25dxLsVx904+X3HFVYmWuxbXIcHlhnqDSeUM553etKCcZHGefrSrvOcgBvY8UzK7HZ+n40UtFBNyuNxjIZQe2BgZ7Uy4hUqF2gknPXqfpUipsdsKFUgHA9aHVXHmEchcf5zQzVOz0KEsJZuM7RySpPzHpVGT/AFkaSQvnkYA+UhT/ABHtnHStVyOFG4bT1ORx14xVCaMhHEYZS2SAVJ696TNYyKF6sgg+VHRHJAUckEjrx6VQkdBF85fA4APVug59f6Vp3KhkILMhzxleT74J4PNZbK0kbR5V06cdeOeM9OayZ001daiMcQh4iFJbaQT8wHpj8MVk3ITdEsfyryJGI5OemO9WLnbJpZdVky6feZckZPp9c8e1VbsRwR5hjiLRsNnPQf04zWbNYxszPeEtLM0e0lm2qrnCqD0YZ74/+tWTqrJBGx5IdgJJ1T/WYGcf7Iwo5HXgVoX6CWB7VAfmAYs2Q6D+8uDkA8jPP9aydTkV5Am945QvmZh7bV3ADnDMWA9uwznNQkaxbMO8b7TJcCxgNuWGGQkKV7levC45JJ65HSs7W7q3/s628oMELbnwhKLnAGV98gcAnp1JNX72ADAYxuX3XEiAbgwC5Yc8nnGOw5PGDXP6zO0LeVaQQu2fJhkk3LJKgILyBcH5e3bjseTWkYhKpskZOpS+XCqN9pWIghS+PNVMjMmOkecjC9cnqB05i9Y+a0NiIk37Yw6sQI+nynqT7jB7Zx0q1NfytetZRBi+4vLsXdtHVQAeE+8WPOAFyeap7Hk1BI4IpZGcEokSM7TDJwdqnhR2B5PJbmuiJzTnd2ZlTWN6sG6SVo4hkhwAHbPUnBz0z1GBnGBkVlWralDfzeUwkl80lowPnBPJGBgAjuOOa6S/luvt/wBmUxRyhjmSRzwQe7dznGcYXOOaWKC0sb6e0WaZyC8kN2VMbSy5UENnJwQD375qkc8o3a5BdJvmu3SLO9wwcKAjgkZ4I7Hjoe2K6jwxJuvbSO3dZ2ifyCk67AxBIGeMqNhXDH8cda56CC3uPMfTLW4l1i2lOFeVSksITcWVevmr6A42joTmrWiXtyNRjeR5T5wHCtsaN8gA5HqMcjsamb6nRTbvZnpOgzNsNoGjMEj7QhClY34OXBJUglcEcj7pHIrf1CRoEgjjgjDpK8SxBiSORllx7AAgnkevNcLp88f7pHjlDBsyuy5MhU5AYD9Pr+FdTp0bXcsk4jR41ZpQkPAdiCGUjrz6ccDisJM63FRakzptOv5oY1xLLJcbcTCQbmA3HG7AOVzt5+nrxqBY/MMMmGugeXRtyvjJHPGWHB+vHUVzkV0V0+BGjKRxFVhmdTvXdkBcgc8HIPoea247qee/jkudjuxIaUYJkI6Z9Dnpx3rJvUhxe5qrbskaldwkb5vMY4BPfBPXPpitG23SEgEt8vJQYJBGM/X/AAqr/EAS26TBAPOTxhh2x2/Cr8OUfymOCp2ZQfiefr+lFtTHmdtTUttonDKAxGGweBnsf896txR4LOFUOy5zyMjjj8McZ/PrVGNcNGkhQADPHTGOvWtC3ZVwhKhOgHHT1rRI5pMsrGjqjpkucjc38Q9Pce1SbV8tRkAY6BsZHpVaeUwozscRgfLg4NPOAo/ebgeQR3+n0rRGZaUrkBW38Z+b8MU7Dl8rgjk5HJH0qvECpY5ON3I5OTjr+NTxjaA2STj9PQfSrIZPwVBXoO9HTknaT054qM/eIUDp1Pf2/wA+tOGHBGOeMiqRFh42kZKke200VA27J/eN/wB80U7Dt5k4JBOB+dRAqFwrDnJ/X/8AXUjEBgM/N2GeoqCdQGVVGW6qPT/61JiSuR3ToPnZwu4beTjH4d6rbwxQwkhFzluSRV3YQwBJY/eYmqc6s0i7uM/Tp6VLNYlCfcYwDEDkYAPTj/8AXWVKqo+5WO8ZU/7P/wBete5O0AhgwUkKp/MkeuazJUIUHIEechuOT6g1m0dNN6GbeRkyLsYPEFwwA5BHQe/UmqN+pmA8pvIYYDFfmJ4wMDp2ra8lPMdoiGKrk+3Ykf8A1qzLgRqI1+UDOWHfHT/AVk0zXn7GTcPiItcB4mX5jExG7gkckZGMYOP61zd26LalYbmGOSeRCCuWZhk8v1x9PX6GuiuRM8BtoJPLLqQ8p+8oAPboD6DmuOvgLSZm3+TF5bucgElicZBzksD2J5JPGABS8zaCurGVqFykEBiSRobiSPygytmRkYYYZ5IPUADnLAdhXJa7B5cBt5oXjYqsciQzbVghRSdrAE7gOSQCT16nitudwo8/bJCmQFUuGkkxznnou4Dn1wMYFczq8sYtpi0CFo2IMRPLEAn5j/CoJOFXrxn1rWL6ETjpc468mFsI2tESBGBlX5CQ6bs5wfvKdnf72D6UR3kkbI169w9qkcf2oQSCIsmchFIBALEjlge55xSi2NtYyz3OEkbLjccOVIVlCpyRuLKBnsremKyr4iNAg3fZTJmRioyr8g9fvYAbH/162RwTdy9pMCQ6UtwZs3dwrBY1BOAvygscEYJJx7Iema6K7SKz1gRpM8giQKJCSodic7vUd65zRjm6uHihDPDEZxvfbhQ3C/XpVy1kJu5hMNm47svwWPU5P0PX2qt0a05xj7rLlgiTale2M6gSNie3Zm5bZkH6kD88cVo6nCkcVvcq7GRgVcoD82M5HPBDKewAyOnNc1DPJ/aBukLRzIFljGfukEnOex55HT1rrw0V0jG0leNpI94x8pgmA5HsP6CsnpobR95Grol68M5EI8ySRAATna5P8YB4y2Rn0P4102jSvBMZ7tri3uJCQECZ3rnGRzhh6/gevFcdZsY0NvueOW2kMkKbDxk4O0+hHb1/GuoGo3V9e2rBnF0RvtpSQPM4PyjHAJIPt9OawnozshK61OjilcXUbxTfa3BLMvTKt94decDOR+I9uhgWLMZij2DIwRIe459eDgc8+uec1ztiJoZWE1uoR4l/dt8pXvgAd+AQa3tJiCwBdyXEe4uq42uF4wDjg9xgdqykwkzpLYqXDLcNIoIB2EZjPX/61aiExyQkMHiYEHYec54Of89KyLOCOF3mhjCxS5wOx4J4OM9M+laVqxGMqVcn5CRkHv8Ah25q0tdTmZo2wkyN5YRKNuWGcf09QRWjbhAm5SQqjA/2R/n0rFRikqFi7q3J3cfj9a1A0u3FuylSQWDAkYrRGE0X3EbIpd9yA5G7HT0+vUVYCL5qsrfKBjZgYx+Wc/jVSDGx0YZPHBBGasJnZu3MWU4yeD+frWqXUwehMqgk7c5xnJGdvPQ1KV2q+1hnPzDpjjmogzErtwegIGOvrUuEwMZztxg1diGxOH2A4J9QcA/SpYSSSHTbjgHPX/Co3VVAUsQCMBc04fugAQW5+uKZLs0SeSTyCMGimfN2dvyoqtRajyed3459KilJGSM8c/Uf4U4jOAMbSMEc1FJkqQPfg/56UmCRXuZW2tjcSecgcAeh9qhdmK7+QSfXPBqWULGjlmA7fL61C6qI41HzF+fy7j9KTRstiCVQZQ5UAEDrxWfKCjc4Yc5zzz04q7MQ0zLtyQCBz1rPuRIsO8HkHr/Djvis2bQuRthYS25ePXqRWZJtUu6hUwBgZJ57Y961Rlj5KleRtJHTn+Waz7pXkeONCdwBbce3p/L+VZtFpmFcyqkGwjaxLYc+uOFUDjjP61wurtMyyxqqqzfu/ObK7Fx97joepz164HNdpqoyQ8jHEal2c8cA54A71x+to09wsBiIUuSkSgdcZycc49vbk1k9Hc6IaI4u+uYkuFtdqPN90NIT0PPbpxyMZ7d+mPq/+ulM6SytI4jiRRmSVzgiNU6kj5cKOAepzxV14nXUbmW9Bw0ZWLy2K5j9E7hjj5m9sD1rD1VoZpfMtbeCJ3RxH5SHbCv+znpgcDuWJYnPTWCIrNnL6pdNPcSb41l2xbYmSTJwCxL56HkED22444qtqjLfXZjiURwrBsJUYHy/OQPXqvPc1fh04tJNbxqyqsCGWaRcBFYgs3sOqg9wM9Kxb/mW4eNimJBGEIzgHORnpwFA/CtjglpqWdNVI9NMrGViHYOQOGHTbn/gINaOrWwbT7J42aS4mBYqcADYMk+/BxVOxfZD9hBbcLnzzHxtZQgU575P9c1eWVP7JkeQCQmLylBGdil16e5x+H41d9Bwiia4tpLa61KEGOQFI9rqOhKK2PxB/Sug03a9hYOJFWSVS54IbbvIIbjBwcH6H2xWTqXmTy2qMxYt5TswHJGwJz2yQvX2rU0CaONZbVHkVnLFCgwe25Tn8j2NZVH3OqluaVlG7q8cm3OzJm2knAGAR64xkjGeCeRW7ZpdWepwR3ZS1kQkOzgspRl3Kx29uRyOzA+prK0mYKiw+QJ/Mfy1UpvBk/hyMgH5uMf/AFqmtJ7oSLLFHI6cCAMoZwFbDRtk8hNwXn5gu3rWEmdSR2mhwy3EiRM8ZdYx5a4zgZJwrD3/ADyQa6/TIkCMFRAxYneWOCfT8Mnr71y+jIokVI4ptiDfJCkhPl4ONynsPm/T05rs9M3m23FlUBgm1TgZHBO0dD1/GsluFR3NWFmR48k988j5snrj16/nVyPeZwc7kHKlgM4HHH0HFVo4V8zBLDcCjKwwR7jH1q2JG8qMKFLY+VgBx+H4VokznuW44sXEmQHRjjOQRjj1q1ahvnPIAPJzyc1kqzp5RUBgeM4OB9M9fatCGQsq8YBYg5U8DP61pEiSLsL7SzlX6ZwDzn+lXB+8AJQqcAYPp+HFVlGXIXO0kKBj7wq1GxcBQ23HDcgH/wCvWqWmphIt7vkAYjaehUVKEDctgt0z0qvnzA2QevI6f57VKhIUAZUjjn+tWYtD8hmGcjHTil25XaflphyCu4HaByOuPxpwJIyR8vUdsUyRQcDG9fyoqPah5MZJ+lFGo7IecqoC53Zzz+tRvjbgsAen/wBcVMfvD/dqof8Aj+X8f5VVrhHUJgpX58+uQOQPaqNwxUEzlQe2B0q7c/dm/wBwVUuPuR/Vv50NGsGUJhvkBLgKQRjJJPHXjvWfcsvzH7rNhfmzhQOn+FaY6/8AfP8AWqMv/Hw31H8qz5Toi9SvvLysWJyEAUAdDjvVO6ZlO48uSETcMrnn+lWl/wBaP91v5ioJvuWv/Af5Vi2W1qY17EyoQgwwXjA6euf8+tcVrCKWkYmaTcMRgdHbocH05/pxXfTf8fzf7p/lXGeJP+Xf/rjD/WspKzaNqOrszz3UbIC8NmsYuZCVjKIB+9Yn7oPUcf1965eaZfMeS6kE0sjjKBT+9PQhOOFVQAM44PGSSK9Du+sv/bz/AOiq8/j/AOP2b/r2i/8AQWpwY6nfsUNck+y6Zc3e8NeXUryScEbwPlQbfQBWbH+2o9a5a6s0iWCF8hndWduThicH69Ca6bWf+WP0i/mKqaj96H/r9P8A6FJW3N1OOdNJGRHDv1nYyyeYqpHIeMqT6+nGPpWhfwr9jijeJlzMgBz1xkZ+nSo4P+Q5qP8A11b/ANDarEn/ACB7P/fH8nrVamUdEl3bLyxt9njXO+RUSPOPukNgY/M/ga0LDT2kvI5TuZjFIZFx91g3U/gP1qG2/wCPS+/z3rW0D/j/ALn/AHZf61jJ3O6MTbUwwQiPyg/KvhWPGAdy555I5BHQjtmrMUEirNJCr3CzKWkTYWIORiQMORu4555GDUKf6qb/AHR/M1r+Bf8AkJxf9tf5xVgnzK52JWuavhuOe2kEjuwuBHuikRvlfGco3sw/l0xXfWJJgjZYdgYK7pu+7g9sdRz+o+lY3h7/AJAB/wCvb/2pXQWX/HlB/wBcxTUbOxhVd2SQO/lgu48z5Vb5doJHoO1aECqIlbaRJ1ZWHQ+mR/Oq7fw/Vv51ci/10n0H8zVxV2kYy2CNT5rB1Hy8jHBx2xVm3cfKrHJHXoTTbT74+p/nUdl/x+L/ALx/ka0SsRa9zSAR59yfe65A68/lWhEql1fknOCSefyqov34/wDdP8xVm2/5eP8APetUjCaLqsu0FQMg4I9PeljKquwfwnt2ptx/rG/H/wBBoj6D/PeqRhZWuSsAQAoz2zSHG3K5DEYyeadP/qJP9w0dx9f60WJWwAkgH5/wZaKkh/1Sf7oooJuf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The distinction between the labia majora and minora is lost and the clitoris becomes buried under the fused prepuce.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Ridley, CM, Neill, SM (Eds), The Vulva, 2nd ed, Blackwell Science, Oxford 1999. Copyright &copy; 1999 Blackwell Science.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.blackwell-science.com\">",
"      file://www.blackwell-science.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Severe lichen sclerosus (LS)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 263px; height: 360px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFoAQcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDtzu807dxOamVWbjJ496sLCTIPr1FWIotpc4r1kRKRXadI4dv3R3yai0XULS8ubyK2nES2mPPdzjnPHWnzQxzxuSskgMixlI8buf6Vel022mvDp39mq9m8X74s/wB89Nrd24yc9qu6SMJO5e0yKFoTBBuSHDPLIWLED6/nnFTT3cGpG2t7fMatEZINynoDjJH4/rWZDqUFnqI0/T3i8iGIjYhJBIGMEnoB05PNVfE3im08IaJ/aN1azyz3chMdukgOW2gnJP3V9uf1qJK2rFGLk7IwPiLqVrYadZ+F9JlZdwDzbCcJHknBPXBODj0Fee2WlbJVEM0qnd8w3ZGO55q1LqBu766vim17py7KTkjPQZ9AOKkR1K7o2w3YDvXlYiopy8kfSYSg6NOz3ZtWumWsUqG6nlkwM7t2APfHQ102mwXF3In2SW6FpjhnAJP6YzXMWALtGHUbMZwTkZx3rtLZpzBFaQ3LwgY3SRqTI5P90njp37VpSd9jKvdIoatZfZ7C6lkuTGAdgVj88j+56/8A6q5+G9mvJkS2jkWcRgSzb+QfUehPr2rrtde21PT44LK3kKQk75nOEXHXB/iOefrWVYCDTi07hHsrePd0wWJJAOe4P64rVxvKxFKVoXa1Me6t2tbRJ7q7+R2JWFHLdPfPWqdvLeQiSaXdG+zCj7xVT9e/bPvT7i4uNRu/PtQqRksyiXkA9Tj8KmignlJWeTbgMVDdG9fxyDWDs37p2q6XvGDdM20ouc5HGf8APvWHrzSTgCMsBnHydAMdfr8prpigmkkdFG7YDn1xXNam2xZxGQSgJBHpuA/r+lYSWhumU4Ea209TLIScfKB6nvUkIknwzswHQHPBqtqdwkklra28gk8tBuK55Pp9RVia5W2gjjYgEjPPXFKStoZ3vqSK+JG3MQFGBzjPvVO/1NpkS1Du208lRyBVa6vZJDsgXYv94npSW8PlruAJHU89azb6I0j3NKG52japZuMA4ODxyef5VFdTO8kI3OFchTk4/wA9KWyuEuf3DGOMqOGfjFNuolSeAggKpyC3fjijoa3sXlYh5iCcMf0B/Sh3aNj874JHGenrSQjZaEnJfJOcdabMu+QBHwSoPJ5JxTZky3HIzMQrHDf4VfsZAblQzn5sA5PT8PwrHj3BslslWz04NaY+WFZcfMWOB6DpSRk0bNzck2iYViwfJIOAfbFQW8rTTsQzB2OCO2KZCxcLuGFPUduaSRkgmUKyhm6mqk9bhGNlYsmaMK/mg+xPaq0UsR58xwT6Maz7m53IyjPPrVO5R4oN7SDcfu80+bQv2a6mhqFyy27sLhs9styfaui8JIiaDbuoy0m5mb3yf8K81nuxITGxbzDwMd69O8NWraZokMMrEynLlf7pPOK68K+ZtnDjIqEUvM1Yg6vxgk0UyAkuCp2n35ortZ52p3H2cIenSq0rsFkEI3MBkir17IERj0qDQ0We3llA3s8nlYPXjmtE7K7OO47TVt9Pige4JG9zuzyWb0FMvVe5hubua5TTbd4n/eE5YZ/i54459qneS3nlaN1YqHwiY+77r/Wk1iMXFuokQuAAUUDIIAwQR9aFvqZ7nBa/420vS57uPSNLe4vJNu67nO2NscKQAckEc9s15prF3eaw0z3szSMoMn3uBnsB2FereNfDcWq+H3vLK2thfwENEVj8t2UdUz0PsPWvJrJGaKaQg5fI245GOK4sZKS0Wx7eWwpuLkt0b2mW4aPkqOODU62RWQPAuc9cng//AF6htS3kRZUqNo5H0q9GCsZGGHfNeez07lyyjluplt442R89GOMD612KeajxrtlVmQfMqnAXHUn0PtXMabbjdG7sWL8cA9feupT5rcW0Ex8+IEgbgqpkdXJBwOOldmHWmpx4h3aSKt7ewxg6bHd2sZbjyzHu3hj90HPB71y2u6pPdXFvZWT74Lc8sBw7fT0FReJWt/OCQSC7vWKs9wr/AHOxA7YotIYpYYYLdQokcgOuMsB3+meKqpJy91GtGkoJTZpW8ULLZLCAoRd0mWxuY9SOuDVLVZ1gaCHe7SEPk9RtPQj8a12gig02MKihNxVT0Yn3PTnB/wAaxdSeN4oHYr54+8R7dRSlGysVF3dzE1O6NqqKp/eNlGAP1zXH6jflw8YJ899uCRnAB54rR8V3cMRYxYLZ4I71z1nA8hMkhOG+8Sefwrmm2nY2burIntXELYjAZz/EO1SsGlcu+6SQ8Fj6elWYbchAVU7RxkCtOC3wqkqQP4iB2+tZXb0LUOrMxImChlUHA796mhOxDjLEDmrs8axKytjk9uMVUE6KrIgJKjJCjtSZolYrSIPMJHAznGOv41a06W4ivkliY7ovmDYBxnjoeO9VZPMIJOVP90jmp7DeWJUjcw2lfWiKJlsXJEkSRQysuRgDpU8USc4Bzjr69qkZpGgVmIZhjmk8wBmxjcOeR1qmrMh3aGeXtkYs8ZXGCuelaMMW9oiTnAxj3+lUthRiS27cMHIq1aS/6MRvDMsn3T16DnNJambRZuZ2hiW3kwdrc49+9VrjDOrIeQOh71PAgmdjK37zqM1FeBI4i4++v40ncqNk7GXe7oxvIwq881i3940oCq5A7Vu6peQywhR8pP60nhfw4l9KLy/+WyjbgdPMb0+lEYSm+WJrKrGnDmmWPBHh8vPHqmoxnykOYEP8Z/vfQV3mchjk8nv2podB8qrtxwqjoBS8NuUYBFetSpqnHlR4Vaq6kuZliHYpyMj8aKn063LuHk/1Y4z6mitrHO5dje1q6PzIpPHWuh09Ba6Jp6qVRmYh/ckEjmuNuJV+2QRyEMZZOV6kjvj3ruIZI5raOJwAnQNjlX9/wqqitZHI9EMW3Kzt82HPOW5+tRhiXW2iDdciQfw/SrXl3ECMqoZAOByCD9aqyvcy2t0glaCQodsiqAQfSpTuQUtQiZoZBIVPBHmIBkHtkd68f8SabJY67OzQGO3uCZI3x8rEjLAe+c8V6H4S1u4utYl0WfzZHg+UPd43zADl/bnGAO1ZvxKjf+w45xt8uO6UtgZ2EhgCPr6+1TXjeDXY7cFN06qXc4fSsPbRFmKhUB+tagkEq7F61g6TvaBFz1B/ma1rDi4j4Y5I4AzXkR1Z77R01sJbayij8nc7HK4OMepPtj+VM1WJTB9mglfzJM7pSCUC8bmJ79uOe1SXk0nyrB5kUTfK0khBYjofw96iuphbwH7KPNSKJoYEKZG5j3B6813JWVjjTd7nPa9Fa20ItLB1Z2tgrMrZO7cSSf7vb61ctIV07TNMmkm8yQ/OVIGF9BxWFMzQ322I7iCfMk24Z2Jwf/1Vbv78RILVh84CldzfdH4fiOfWs01ds6mmopXNsXGYTvmDHcDhjwBxuPPTPFcVr2rxwyTy7h8gKA5xnOf/AK1WdS1n+zLW4jRUlMy7ogTkc9fqecY9a4N4Z55jLdOWY9ic0q9SyS6iprdiLHPqE6yyD5AMqD/Otq3t40G5mBfHGegptnYNKQGyRjPyntWza6XEI2DFIyAMA965Urm6VtyK0ZGYByCQNxHan30piKBAyxOOgPUUSwRCVTFGBJHn5umahFrJMvnPKvB4jxzTb0sjSLW7KM13vRgpbA74ziq1lgzLKBubI2rgjd7n2q7cxAusQGARlgPSpQkcUQRBt9Sf/r1FuoN3divfQySTOWkAbqdtVlEkDbsgkcEd60GCJLF5hVfNIAZicAHucfnVSVVkOVYdOnuKdupLZdsrjzHiiJAy23npz057VrNAJJshAoHBUZ/n6Vz1m3k3BIYHH3cYx+tdV5iLEHVw6sOgPIHaq3REtNircxgMq5ye+Kr2m6K4MhXemNpOO9Tkg7iMjGDgnH+fpTY4w6nAPP3hU9QWxDdyyCQN0yPTGaSbmAM2CStLesqSFScqTgbhyKg1C5VLYnjIFJ7lq9kVrCwbWNYhtFYxx9ZZP7ijqfr2HvXqMcCQ2yxwKFhX5UT0Haub8JaabLTY5pVP2m4AlfIxtX+Ffy5/Gunxi33N1J6jtXpYalyR13Z5WMrOpOy2REke1Tgc4wD6U63gMtwqKAVx8zZ6U/aPLVEO536Vet7crstkPB5lYfyrqSOGUi7ZRpKy4BW3jyAP7x9aKr3F0FkWGM4QcUU2zPkbNTTLFp75rgSGEDKK4XcT6gelb0H2qD5slrUcIjkc/gOfxpljAREoiJ8tF28DGWPX8STVjcZ9qAZ24BwMAUSdzlYiMcF1t0Ejcjr0/nU8hw6xJcPbu4ZUO443YzwD/Wm3c0drbyzMcwouX2jJY9MCsW/juIwLeKSKS9jmEyq5JCAnGSPUrnA9aSXMIsW9rFb3KXWrPE2oRBraO4GFMgbpwON3H864vx/KbO1sNNiC5ktis+ecYIwfzBNdf4hvLS0uoprsRCVSBCH5JbH3jweAP54rzjxNcm/1S4uWZpEZ22buCEzwMVlXqckH3Z3YKm51FJ7IwtMYJaqmz5gxwc9OTWtIscSRywsW5yQeDmse3Ls7qgIKue1bbWvkwxMQZ5WHzRg8rg9D6V59Ncx7c3bU2bCWN7OSe7PlIRtVUYFjwfxH41l6pLOA5t4jEuwFm9AfTjitS3BuFVba3MDHG6W4ZGCDpkbeh9/51l3NxETLa2siktIxe3OSyBf7x7jivQ5Lx1ODntLQpXlrHYWNvcybWVgWUsepyM5/WvPtU1Pz7iVkBLSHLN61o+Jtamu/Jt95KomAB0UVgKqjuPqa4q0le0Tuop2vIk3yTuGlLH0HpVlI2KYjjHJxuaoopwjqNjH6dK1UglnhDIo2A54NY7nQopFiwMqRfu41B24OBV+aya4i84Dy14wAehrMjhmgBHmMATnrW19sEUEa7SxA79qSXNoxvTYpragZ5KnNMmDJDz90ttBBGRV5Z/Px8hZj+ApsYGwRuw/dEsOO5rWNLQj2ncyL2CWNybUFFA5dhkmsW5juXOTKxIPc10F1NK7hUYBRxyKvR6DcXFiZoYt5U8leSv1rJ03J2ibpxjG7OOkupPJCT/MuRyfX1rThtrK5jkk3jzcABORn3FN1DTprZm3rwOoNZasFkia3HkOg5JyQacXZ+8ZVFf4SwIzHNkZY5III5FdTp11/xLgoCKqnDLg7iOeemK46aa5LhmdWOc4QYJ/Gtiw1SFMZ+RxztIxgUKyZG+hr3mCoEe71LMOopIhIkO5QfQn0pqXIlxxkf7JzxSxO0xcRqwHQ59KlrU0Wxn3rkqu496j0m1/tXW7W1cDyF/eS9hsXk/nwPxq3fQNHHhyOOMnscVt+BLEQWs9+5G+4cqo/6ZrkZ/Fs/kK0oU3KeuxFar7Om7bnQlw8nB+UMcEc4+lW870RR/CoLfWqO9N5dRz1yDV23g/c4QBSxya9SKueHJ21JYf3SNcYG4/JGpqWWdbW1I3DzX6ketQ3JB2Fiwjj+7g4yff2rNeVrqck42DFW9CIx5tWa+nRh2DSnceTnFFRxTMjDbnaBxgcCipckinBvU71GIZfKLLu/h/r9auOhT91jBfh8nkfWoo4mhDHkzk5z3pzymKHzOEyPmduD74Hp703rseexs4ZJl+zQmSRSoVC4GAeCxz6DJxVWY4lkKK0hPCOe7dhnqfWkE8HlwSCU+TICyOvzlwPeuL8ReLZf7RNvp6gxwgBZQ2QjdyB3I9elV8Kuxwg6jsjN8QaodU1dcvuhg3RocEHOfmz+I/KonWOQjJDN6VjjBl6lQDyT1PvU8TnzSVYZ9TXmVZuUmz3KcFCKS6F6ytNss5KEMwBB/Srzrth8zzHgMZ42kc5GORjnPSore+JaVFEagKAxY9/XNYPiHXPsiyQsLedm4DZJf8ADI5/Ct4QjGNyOacpWRsXmsQWliLYX0Aklf8AebFcso9T6jHTFcFqmr2trdSvpjziCQbcyYDYGM/mc1n31zLeSqRujjH8JOf0rMuLViIurKpwN3OATzWdTFdEdNPDW1fUihSe8mJjBAJ5augsNHyoKhmOQWyOtSWFhMFV0QbMjd9K9A0GyhSDzHYAHuMH9Kxpw53qazmqa0Mu38MRwOqzMrvwSAOORnFJfxRWu+O3QoD1BFbs7RxuTA2AOhzzWS26eY9WHctz+FbShHaJjGpJ6s51TmQlgxPsKs/Z/lO5SM9j2rpbKwjWQMVUlfxq1LZecv3cKOvFaU8MmrkVMXZnHtE4QsOFTpnqazrjW7aJkhvN0O48MRkE/hXT68sNrbFUTfJ2yc/pXnmq2e2CWacfvHznI6Dtir9k1sEa3MdFvguFHlsGx0YGt7w1dzWVyGV2UEYwejVg6bah7SP920RVRz+FakUUsYUls/NtGOtcifLK6OvmUo8pv+LrW21GJJ7cKrFcMo9a8v1awaJiQMYNemQ28xjOQCAemcZrC12x6oybSRnFTWXN7wU58q5TgC26IHcNwI+X+dXrP5n55HXceaydY3Wk8sQABb7prQ0tgLcBixc9T6Vihr4tDrd8DAfKoJRQDgcnAp37qIN5efMK8bSMZz14+lVo7TzzJhSAuDyR/wDWz+FXntYYbeAMEXzI924/w56ZPYH+v4VpZvUu6iZN1NcTzfZbeQhroiHAOAckdfbPP4V3BiS1gRIc+TGixxDPVVAH/wBf8a5fQYPO1YyPGCLeLeOP424UfluP4VsXE5SRULkZyB3rqoLlV31OLFy5pKK6Fu3zPcKATtzk1sXDtAigMA39Kh0qy8iEPKMNiqN/dN5hzgrniuyOiPOb5nYTU7uU8K2QBwB3qDT23sCxwTzmqeS4LnucfhU0MkcKnzAFVyACe5PYVN2WrJWNWGQ+ZtyWB7GimWrlZAGx1IHpRUWLUj1tgiSNFvw7EM7Z+6KwtSuvsibYUe9ubmVYYrc9F3dfwABJ9a0JmeO+EYAfZGGVj0LEHGfp1rhfHniFfDlvHZ6Y2dUuBveXvCrDk89CeB9Aa6FaKuzyYxc5cqNDxbrENjC2nQTIb2MFH8tcLEnHA964OSSJIwo5I7nv71g/2mRvmnPmTscsx5Le5qKK/a9J2BggOCa5atZNWPUoYZwLk9/h9oBY5wQOaikvpIoy4jkGT0J6j1p0cCjJx/8AWqwYPMjCFct7Vw8x6KirGTf+JwIFgWJg3P7wEqd3ofUVnW8hupQzNvkb1rdn0VZGXgNg5yKdbaB5U6vDwevApOcnozSmoQ2HR6UjQbhnee1JbacpYEr8qnp1rsNN0/dC3nrwiFiQe9UHhK7gOh5GKJRtZkqo9URaK8dtct5i4TdlQ3INbFw8Zz9nUJk8BelY4QxxtvHzMQQM1ZtN3mLklgewNaqdlZmcoXfMXraxkbmUZA6EnFW4bREUgr82TyOlQfaDGVyNyj0OfwzSi6ll5AwnTGMZqoySMnGUjQt7fDbgMCq+p6lFbfu1ZTKwJVR3qR5J/Iyo2LjqRzWMLaC2mmnZ5p51+cOxwEJ7jB4I4xj0rtpbHLKN3qVfLDylrne0xzuQjG30FYWvWSzXccZXEW9cgema6BmcOZ2kaR3O5mY5Ynrkk96m0wW91exlk3yKC8jMmDvY8DOeVAAPbljWk5JRsXCLT5hj2Y2AoBtI7VEIi0qAH7vGc100kCsjAALjg/Wse4s50kV4xkZ+YjsK82rTd7o6aVRWsyWG8kto2WRAw/hLViapcpLnzCAwGODmtS5kDwl3IULxkd65e+kBlXbhueaibdjWNnqcd4uRftUMoBwv3uKmsFZY49+3DDKgMDwfp39jWlrdt5tlLIyklRkAfoKytOuJb25jhJRZZJAuTkKrdMnjP14rFK7sawa3O/0Oza51WMRBnjQKpmcbRlgRuOTjgBj/AMBp3iiZ1hs0/cgGFcIp7KNvzDAwOCBn0+lXHi07RNNgtphLLMHF1cxSlBuUEKQMElQc8A4bGa5fxD58NhDduLeO41TLRQxcFEzhcr23E8Z7CuqceWNjKE+eal06Gl4aj8nRnvZJCGuZSQOgIXgfh1rS0C3N/qHmPzFEe/XNVb3KQ2enwsHaGMRfVh1/XJrptEt4rGyVW4fGSe9dVOOy7HBWqNpy7ljUpAsflgZZuMVgXS+W7Bsl+hX0q3qVwsrkryO3aqKgDe7csRxk81szmjoiOZ2Rc8FSMAYpqXJUgkcHouMUp3FQy8DrtI5FMmRwv3c9sVDNEy3aKxZC2ec9RzRT7aIoyFmbcc8HtxRScQ5jv/FWpN4d8M32sSEGdISU3jje5+UHH4ACvn97y61KaS7v5Xmu7g7mdzkkf57V6J8e79pzpmkRTho4282WJeSxHyqW57DJ/GuFS2AQSouUUY47VniZtWiisBSVnNkH2ZpISSuR6+lR6HK1tNJbTAhidy/StASB5FBJAJAPtUWtWbwXkUqlWOcZA7VxON9UenFdGa+wPlcEZHWrVgEQRh2wcYIqhZXYcJE2MkYyahEkkUhz2OKdktQ5W9DqUhEqh4SAw6e9WbCZIZczpgqefesixnK7NvORllPb6VbkOW+diCexpqPUTj0Zs3epxlQsYAUdwKy4njkmJAJ/2aosQCQ24ntgU0XM4QrEjKp6kDBP403ruUqa6GsZI9ylwuQeM1Yt1jxhRj3ArGgtHZTI0mMdcmug02GNowdxZfY4FWk5GdVKKJEhV8RrDk92J6Vow2qIo4GQKmRbeOAKIk3d3bOfw5xTZJguAMY7VrCnY4p1G9iK5RDGQ2FHPGaxrS2tLi8kF7ciO1iQuVCkmVsYVQB74z7UusTyE7U4PpXOatqNxbW+1SVOOSRz+NaOaiVTpuStfVl6+KQw7eDtHzmquk7xemYDAY+vArlra6uL1im5vLBBcMfmc/4V2mlNhUh8rbzyehFc9SuqjSR6ccM6MW5bs6KORHUh2IPt0FQySrDG32iXyyPu7uM0k+I41Gdg6cZrHv4ri8uAIU8/jPzcHGfc8VsmcqpqXoZGs3EkqsbSN5wWx8o4rktSvZLSdI5ElSWTkDHB9q7CWS7hZLe1spWk83JaPknPyle46jis6bS7mdHllBA3ZGV7j+tY1oRtpudVJW3tY5bUJtQ1O2FrEGRGPLE4x+FQ6RZX+iXkdzbSo80WTGXXO1umSCCDXW2dkA25sYzj3Nay6dBMhz1965bNO6ZU4xWljzu/1zU7i+ll1CNTIU8slYlCBQOwAwOO+KvaLeXGr+IheTMZvIHnOSe4GEA/HH5V02oaHbzROGUHgjjvUngrRPJhmKyZd5MNu52gdBV0rynZswqtRg7LyN7Q7BnzdzLy/KZ6gGr19MXQhOTGSBT5VKJtVWATHQdPem3AFrbFFHmZ+99a9VKy0PHk23qZN1IkJBMbMSuTx1psRcqHTbjBzkcg9qiudzNESSuG5JIqf7rEIpIP3c96YXRHJkbME5Jzg/zqzDF5gVWGVY9Sf1pVg84A5G4eg7VoWyJGhAzn60rX3E3ZD7a3WNxGwLEdSRz0opbeXbOxCqC5JJx3op2uTc4bWtureJLvUTGwknYZbOeAMfr1rTttGMNm+07o8fdx0pkCgT5C8buRius0pVmljhjILP8AKF9a81T9pNyke3GmqcEonnF3p8kLnhlHX60oEsluY8A47969M13TrSC1MLFWmIyQeq+1cQ9gXkP2YqF7gnmrlS5NjWnONRXaMm3ikhkwwDVdWASzAor7s8jrWvpujXc5YW9jJdY+95Z4XPqTwK0f+JhpEvkXunJGDj/lqpYZ6ZxmpUHbYJ1YJ2juZq29wkYdkZVPHPWp4LV3KmIMS/AAGSa22lEkWNyKf5UlnbTxpI6MIyRgMR0+gq4RbZhKraN3uUXt2hOJRsZeCG45ojthJy67l9DVxbB7qTbGJZm9SMk1s2+hLEitd3MVuD/CzAt+QrZxuZOqorV6mRHYxOgLAgdsf1FalpY4Tcpwp4PHGasKltHlIUaV88OeOKvwIybN2AnTkYoXYwqVW0UzaOR854B44qCWxKPuXcTj61tkKVyoOe9NYqARj8apHK5s5m8tmkBGMD1rJ1DTkTT51i80zscEA4RkHPI7ndj6Y/LqrsIjDHX0rKJSeV4y2056jrmtLJoqE3F3PO7PTjDMZCuG7j6V2ujFHty7hCcYye1PvdKGw7X3DH41DpltJCQrOFUnoVrh9k4SPYlio14eZemhaVQ+Y1QdNx6/QU6G0+0OwLnsAdox9far0dvGqEEc/TmoJkkW4EcSsMruJxwP8a6YabnG6l9EOupLfT0SHCPGfvDdjJA4Jxzx2rPvtatvLkUR7lbqvHP1NVr+wmP71InkbO1jnaD7cc+tSWenl1VntkiJPIEYYfgWyc1U5N6IunGCV5O5HodpYXt0iyGSSZ2G2NFwpJ7Z/rTtc0mewvHiwCGJyFJJHpjjnpXX6PZ2+nrKY47e1CYBklHzZb36D8BTr14AJIJQk9w7x+VIORuJxjI6etc0qPNGzF9ZftPd2PM7iGZEOxXyeDkYP1rMsnurK7NwgbcuA47OvoRXea1bR3cs8trC0bxylZFyCq8ep/iOfy/Guenjm+Zmj+UHhR0/GuKUHTndM7ozVSNmjprGWG9hWW3O7I5HcVm3ltLHLuGW29iOv1rKsbw2UyqztboWyjHgIT1B9jXTQXkd0hW6jKMvHmDlG9816tGqpo8evRdN36HPXMHQSAFR8x7ZNNjbKZYOuMgDHSt27tGCYKfIec+tYjEQyjcw5+7u7Vs2c61J4kwMnCYHAzU24gYU4bP51H5kcbFmdWTrkHIqndXAZdqA5PQL0A9KUpKKCKcmXI7tVlVE5fnLhaKzrCZFkbeCFAwXxnn09TRXM8TFPc39hInhtliZlLBjnqK6Pwxp6T3Xm71jEI3ndjoKwdOjAy8nLMc4FdRpNsDA8gLnZztABU/XNc8eW561VtQsYeqPd6jqk092Q8an7wGBjtUUdjDM+bRJGl/55Rgsx+lbFzp0ps5ZonCt1KgcVB4Tnm0+Oe+mjKRMwhEkgwD647t1xgCtIay9SJz9x8vQt+HNOkcTRmVxEACYtxXk9mxgjGOlbJsYfs0ltDbJNaADzcgDn2PXPvWdJqF1NtnfchYFU8zksOwz6061vmBSOQHIbmMZBH1rujGyPJqc0ncf/YUUX76O3CR9QN24gep9KrvbpI+1pQoz3PFdFBDch5JLmFEVcYC4Ab05HH4moSjXR87ywsbHAOOfrx2qbpCU3fVkNppCqm7znIbjKIHB/PApWsbaJt8zsBnA3EZ/IVJJaQrFtQKWz1YYI/AfyqlLFBGx5LMTjIGOfTFQxptvcQyDeViiVE9R39zSyTLvGCQB0HFV5wyBSFwM45NQO5XJJXgZyazbZajc2oJt3fGeDTJHAH+eaq2F2gKllySeCe9Wrk7hkDB+lCZm42epmanGxXeoqvp1sN2WYdutWp22fK2TnnGay0uCbspkLnoM1tTYpptWNGaEFH8sMcHHIqC3h8zcpBXvzVG+ypLBQQvJxU9tPKIVe2PmKw3bSefwNKomy6Ssro1ZIp2wUbfjrnqaWCaISbZWx2Oe3pVODVEJ2yho5B2ap/OglI3AYJ5YHBrJaF2ezNQyIVWNR+7xkAkcHHaqr3B810LbwBgOykb8/XvnvVN5DF/q5S6/SlWXcPlKnjGT/nrVuVxRjY2bfUY1imUx7mbG1CoKqfU1ma3fRiwciNySRtfPKnu2KrpIA+HyB9aSe4VlI28dKiT0LhFRlc888Q65c2kkLHasTOS4C4MjHox9+a29Mu0uN0crxplQy5I5+nrVjWdGTWGj3nYinPPetyLQbK10qOeNUeToSD93A7f41xwozc3K+h6NXE0vZxVtTm9V0iaQSbraQxqAWfacKD0z6Vzwt76xufM06eSKQfw7iVP1U8GvQ9P1dLLVDbzowsJojHEouPvv/EHT+6Mggk+tUL3S5FXzniJiLYWXghj6D/61XKn1iZxrSWk1oYula8sAFtqOIj04GUP0P8P0NT6zJbxxCQyRLb9TKSAPzPSqd5p/mPidQoA7dq53U9HhKMZYY8dlGG/GtFWktGZPDwk7ovJq0F5KbbS0F3IVyChxGB3Jb/IrW0/SUkk2yzG5nxz5bbYUHf3b8a43wy4t7qS0XyYYFbzHkkYL8o7Nnrg4wK6m61qFgsFsVhtmILPyQo7n1NHNzR5pGcqfJLliLcqovRBbKXYE9BkUUS6qvlLb6LDGoJy11MTvPsCMYHsKK5nGKZom7GjZGQkIIy1eiWwGkeGS0ykT3IAA6dT0/KuJ0xQjfu5dsgOQSa6KW9edooZnRvLTKkHPJrWKtqdWI9+y6FtmX7Ci7sZGT7VjappEMbwT+a4jwHw33Q2eRgdOe9Mluxztcu5fBGOB7n8a2ZLh9QtUikh5TDNIrct1J49K6KSV7M4qilDVbFG7jjaIyTpugfPkliVP+8BUMCPeSBIJ/OmVSdsi7hIPQEYIP51FdLJ/akQnctbgjAxxt7Y/wrTW2a2lFxpbt9/KKYzyO/PtXXJnNoh+mIgQySShVdchDIJcn0xxj6GtV3kaOKRyRHkdRjI+naqkbXMCie70qNWZtxlI2fjx0qx5jXk26aSPawDYLZz7DjisW0Q027iTsfKbylUuc/NnJ/CsK+v2tbiBPKZmlOEUHgH1P5fnitSQmO4RI/nbzMLg4JBouYRHdxYhR5ChRSWzgdee1Lcum1F6q5QV5pS2QWDHcH+7t9Rj1qLUYpPMETdB/CBjH+J9zViO7zEAq4zzt24wOuaX7VD5fzffJ45/Woa0sXre6RXs4tjgnOR61ozzBoj6gcVSlkA2lQQD3IqOUS8MxwmMkVF7bA482rKt/OQwIAz0xnrWTHE0l+u6YMOuVGAKbqM0hmZLcb5CMD2HrV7QLYQn5tpkbksw5xW1L3twqrkjoaD2qLBgqG4zyetVYYTpjorurrKu9Sp3BQe2fWtyVA8SARIfL+YsAcn681m3UUl5A8dsgdRltgGdnfjv2Fay1MIOyHSxxSxDO1w3G3HOBWXLbSxnNtIUUn7rjNJBdNDO0EudykghlwfxFaAcggBgV65I6Vm2nozeKlFmSJb6NzuUMuMAJ6+tKl4zY+8D6YrfS0ExTyhlxyB0q2llEmBfJ8x5XKZJ/D15qfZ+YvbpdDAgupDGfMQBxzwe1L9qllLFEDqO5PStJNNtmu5AqIYyf3anKg568A/Ke+M1HPpUAUrETHCWIGDkjrxnv2pezY/axKJeVWDMqDHbAIH1pFlnkhmW3jdDt3MSuRjOBxnPUj86qvatKfLLHepxyfyqfbeRxfZpobUrk4MilQTj+IqQT+JNRZml0Zd9oEl8kEN/JFcTGQOny4CHnAJPUHJ456+1droyve2cceVXy12kyE4UDrjsOew9KybWC3W1QyW0aOMok6DIRuDuUg9aSW8i0/VRa79m/DDaP3cmeQT6Z/pTUVBXCpKVZcq6E2rWm21N1cmNYs4jDKfnPrj0rk77y52zwoHHSuyn05dYjlF9cTRuxAj2DIT8PrWLeaWlmTHOWaYZHyjjANc9SMnK/Q1oSila+p5t4g0nMD3EcXzjnI6msbSgJnTzLgGTjduzhR6Y716F4gQSREQxyBxxgdhXAx+dpWq+fLbKVY5TLY57E1k9JG8r8tz0HSbS106Nbm9BkDL8kWSjvk9eMgDHbI/Hmiq51K4mjD3s0CPJgFFQBzxn3IHTuM0Vq7p2icitLWRr6fPK0ksUSFlY4BI6c1t2U0hmRn06HzIj9/cQp9MjvVeFIbUhCTt+9mul0wm8QNHAqxJwSB/M9zWkb7I6qk9OZoryW0l3cvcyeSryfeCLtH5e9WbSN4ozIGVnjb7uMAjuKuShD/qot+Oy9RjvVO3+S6KuAofue1bxVjhlNyRZ2IxinMasGGAAATn6Go2t5eYgxRMkmNuM0+S32Fo5oypU/fTB4qNL3ydsTZfDYHvxWl2c1uwsa7Q6IH4XDHHzfn/SlW0XIYcE8A4wNw7EU58hnmiPyg5ZRzwamLbIEbeWicgkDqn4VNhttGXf3DI7yQQqJAOY1+bPqADWdHqbS53qEYjAxwAKu6lbG6hlcnaqnOTgbvpisSGNYZQHfPGfpWUrpnVTUXHXckkuiryIqsrPwGB7VXimYSfNyegAHGKlYosuCpKn9KJQFbcuDxx7Vm9TdNWNOAksrSdMYPeqWrXLCNokJDnsKSGZ0jLHngkEmsyaR57gyAgqMkMRx9apK5i1ZkFpa3FtMZZmV5XGQOp+lW7K/wDLnX7ThSThhnOKxNW1uO2/cwqXmxjCdT/hVLRbmWaUmbiXkiPGNvpjNbRv0E4XWp6RNexCJhG4yoyeaxbS8xfuFcMrn16NWebwvKxu4vnxjO8jH4j+uarW1158vkOwcqPkZRgD3A7dKu+pEadk0besWMrj7ZbMTNCN021cBUGBuPvmmWU7TlWEioT94dmpYrx3heKRSrYx/wDrqLUDBa3cM9ouy1uix8oDHlOpG5QB/DyCPr7VEmtxQv8ACzp4ZNro69varsLW91IsbDYTwJM9K5m1vVIAB69jVlrk9UIxS5jN0jomtEjAZUJQAk5YZIFZ2pXlrDGHeO4Yg5VUixntnHb8TVGTWp402lmyTkDPA96wtTmubsFpJWLbv7xIb2pOp2KhQbfvFuO6hnmdpGaDLckjJx9BVnzhO/k5LRjkM3A/I9Kx7CJzcRqEGM9zx9RXaJpVrHHG1zIFLfwEHB/4EBVK71KqOMGQ6ZGk0YZQiQglSuCwPHOPf3rJ1+yW4sxI0bb7ckxOMAsoBLA49OvqAa7KSFE09BBFBsA4Xf1+lc/dafFcXbkxqFVcKh5HPXAptXVjOlUtLmKnh3VLi6t5zIzLO7APkADgdeOuf896vXemtHAbh2juUbl2zllY/Wua0+U2155Py+W7fJKBwT3GO31rsLa6uUhkMcKy4XBTbuO3/wCtXNFcyszpq+5K8dmcpqVvC8THyiQRyuMGvN/EdnPJvKoIyuSuTXrlwGm3MVRSByg4rhfFtvJGxaNgQ47jisKysjopSvoea6bMVlVJ2clCcqvOMj9TRVcQzR64XaQoxzwnDDjsaKKesbsxqtxlZI9bsLhrq4YythcnFd74cWSe3aOGMsFB+Z3wo98d68xtCFkwGJAOBiu/0DW4dO0yZLhJGUHKspHBxwDV0XrdnfiotwtEvxavJplyPIkiLHKfMD/kVbt1GoSPhgJcbj2A9q56aa31dPtBaRLgsCqxxgKfdjmtuzvElsZEJW2mjwuUBDOPWuiE7s4KtPljtr1EmL2Uu19y+qyHFNhEUysXm2Sfwqqk/rUl5aWsln57Xcks39xySevTJqqUEgRkO0gcg1q32MEk0Paea1TajCWPngqRjPaobq+mYRfZZipQ455AHpzU2+5GAr7gONnWqFw8DNt8oR5blR0NZtlRir3Fid3jczNIUJyNvGf8BUO9ZMkrgg45qT7GNqEMR9TVqOzCjLMGHvU6luSRRMRU5jzzUE6yBdu8LnqR1q86rCCA7Y6n/Csm9uNpJ5yOlRLQuF2U9SvWhXyicR7Szc/wjsa5nUdfe5QWennMn/LSTsvt71D4nuWnhdY2YF+Gx6elc2NNubYxStDMkc24RuQQH24DYPsSM1UJW1extKmmtNzdtLSSObdMd8hOSO5rd0Bd99G06IFmyiEdu4rlLPX57PSpdMa1SRPNEqTtkPGcEEA9weOvpXS+DJGuYIpG/gYsSa7HOMrKBwxhNXczfvdPmEq8ZYDt3pkdlcTNGLfMLo24/L8pOMc/hWpZysHWQIfKY9PfPWtiG5MTFkReQQQy5HIx0NRvuOUpR0Rz8+bbHmACUDAx3qvc3CT6fNCyfK+H6DIYA4IP41sXypKhEihlHNcxeFbcSkZIAJWom+XUKa5vUqWl8u0pL95Pzp6azcq+0shQHj1rnJLl4pvMXDCTnPvVqzmMoHI461zxszslBrU6iO/jvFCnKS9ee9X7OPCjbHvOfXOfrXLwvnACkMPSuu04ia1R/wCLHPamlqYzdkamm2lw03ms0YGORtyMDoMVuOqJaMy3k5nA3eXG4KAjnbtUVnW922FiAUqeQJDt/U4BrQadoLcgsIt5xuU5Cj321utjhndu467kIjDrcRrHjcrEEZ+lYupXcaFYlmVpGGMgYwP5Vb1a7ht9PUuYnDEkAjO76/nmsnR4VkjvLmeNpI442O5CACTwOece39KHroaU42XMynawxy3RVggQZf5jjJzwCfT6VtRw3unzxTQyxtJHh1TfvP4Ef1rC0+VY3lMxKsoXdhSdvYkj0H65rYiuFvr9JLePyYWBCpnoM5/qay5VodM738i94jaG8maUskUhRflVh1Iyffg1xOtWoa2MboZNvKupzXaXOnZUySrkA964nxbE1vbvJZSKkijoRgfjUTskxUXtFHkt1Av/AAkQDAvwxbHrg0U7QJFu9anudSfyyWYdNx/Ad6KiikolVpXkd3FMtvcOWzt3Zq1b3JuNysxEefTvWDPJM87+XGzKepPAWtW0mSKEKD9ah6aHqU5cyueoeHZdN0/QbZ53IEz7maReNw4wKbJPA/mJE0LRh90bgE5HpmuQ8PT209xGuoPM9qv/ACzVun0rqJZLGwme0guTJC3O6Plk/wBlh61vB8yOKrSUZt6tsqX0+yRFRsPnlSP5VoQs8iq6oMA85qrPJb3ICwvcS4PMk4AJ9sCtG0tWiAlSXIPVM1qjCppFA4BUbeCD0BxioTFDISZE5B6+tXWhjV8jdyfypp2t8g5z0NErHOmVpF2R4QDaP0qs7MT8pwAKWUvE5U5A7n1qCecGP0AqbopJjJXKKxbB9a43xNqKQQtyQR+tbWq3yRWzuW4Fed3Usup3oOf3QJ257+5rJ+87I7sPT6st6fvuGWSQcH58H1oMix6xi4VplKMI0MpCxOcfMB07DI71s6baxQonnfNu6gHtXP68nlawFB+XOM56inN2joaRSlNh5+zUUnnt0eOKTeYiPvAdj7GtnwlKsaMYlX7O8sjKFOQilsgdO2cVhTzosbhj0H41f0NGg09WLHYck8+tEKjTsTKimej2bYU7SpTGRjmpvtC44ySetcjYXn2PDM+UPJGevNWjqoDthQUHf0rqUk0czoO+huysdvOCM1gamTvLKc7TninG8Z1Vg55OcVKNkqH5cf7WeDWdT3lYqEOR3ZxUkISV4pc+UfutUtopjYgnK/zrbvtNZx5hOVHbHQU200tZ2Kr5icAoxOQ1c0U1odM5xsVbdz5gK5BB+tdx4ciD25ydoY9+MVkWOjIrlLjdJjkAcV0VqojCqigYxx6VvCLW5w1pqSsjUtkWEMJsmFSASRlT7/rUjAMPMt5FjcHBAbCkZ4NR/bWhAbygWUbTk/Kw+n41TmumMRaGERA/eCkE8+npWt0jlUW9TL1SaCe+zcu8kQbbheNwHYemcfrVb7ckkpWRWWMEyBUXhT2yOPYVPqMcCwxjEjuWBdVAGV9j61VsvLVJjNCCSdwEv8I9OOvasbtM7opOI6ONjI6LhWI+buK6bwv5Ylit5woLudkmOSx7H0FYWibJJh9q3bAckKcFvbPb613msWbNZQDTrddyEEMv93qGqo92c9eVvcMnVjdwl0lQspbJKnpXA+OLu1eyaJ96Z6g9K77VtbjfTTFIuJyw3bRwBjn9a8d8Z63bxs8EzmTcDwvasK8rKxrhot6tHN6BHBFeSSSJujLHbkc9O1FS+GwkmwwozSsD5SlvujuT+H86KcE1FJCk05O5qzMyu0crbFY59h9Kjl/dgbWzxzzWlq21wbZwshUlo2HUrWXECkbhxu3E4U9hWc0rnXQqNI1tJniiAHU+/avSdI1TTJ9FMd5DEsyc5IwWHtjvXktpjci89cVtafNi62O3A9e9KlNxZ1VaSqrU9P0HSRqLG4yscIYbUznaPf3rQ1WyFtsXfkH7hIwTWL4e15NPk2IzNbkZ8sjkN7VbvtWGoyBpOR6Z6V1c55M4VOfyBGbIYNlTxjrSsADuHT0HaoomCnAP4GnvIocjcM+lMyluV75HZMLj1rlNUumjidfMJx+FdJfXBjXLdOnWvO/EN1Jd3rW1oGZmPzY5OKwqPob0FfcqS/aNYlKx8W0YLOx6ew/E8D1qOFI7K7jIwNjZHGeR0rZ0/SdSFiwtYVgjGDJJK2wDHTr3+mTUNvpe2QvdHzGA4XsD6/Wq5eSNkdVOopN3eg6S5ZpjI7kysS7MepJOa4rxTdMt/GQScZ/Kurvnhs7d3bAYAkn0rgLnXIJGvy9hFM8yCOKR2bMBBHzLg4JIBHOetYS973TXnUPeRp6RGdSl3SKfLQ/99GuuXT2+znywwJ7Cq/hXTVGn27MGBZfmX1zXVLYnySXm2KOQF5NdNCmramVSq76HKayyWWn7pSQ65H41ws+rXlxMwQttxgYOK6fx/OsYWJXLLj9feuTtU81kMagsw6CufEOTqckT1cJBKnzSOp0LUJXiAZWmmDAfeAwD3rurPCouwAll59jXIaRZpEijyizY5x3rpbWMxuO/TjNdcY8kdTgxLjOWhoCNihPUbcEeo9KsWcKtGN3HPX0qRI1WEFl2yZ3Bj0K46D3qOWVre4DDOx+ce/tRa2p58m3oWUnXlGx5oOM9DUytK024MvYegPuayLyfdMsscLbujH196eLssoIjbI6gc8etTfoyeU2VuQI/LlGHU8AHOKrvcmJWXJyx6g1nG9XaUVBv7E9azrnV7fzPIaZXkPCpFlm/IZolJWHCm+xsSykklsZYZGKrTSxRH/SJVVT6nGKzUa5n4i/0eMcZPzP/AID9atWmnwGTeys0396X5mrOUmbJJGzpV7ppmjXbM8WeTChP69K6V9Xh0q2a3ibUDARuVXCALnvnkiuXtbJVcNI0gj7+p/Ok8T31rb6a3lllJPLGXJPtjAque0XzMwlTU5pIq+IbyJbQSwyb3Y45JOBXkHiScz3DIQjyOwC8dea39Q1cjT2KybgW24zyPeuNhb7VqIaeUwQISPOCbyoI64BGfpn/AArjb55HW7U4WOs0hHsWVBPbEKTmVBkZx0JPb0460VW0eGCW42XMMyLsyiyyqm/1Zyi49MADPqaK6otpaHI2r6o7jXNKWa3MqKHaFtzxqOvrj0qnL4fiuLBdR04FrZ/lOW79+D0I710tzAYZcbgquePb2+lZs8K26Ga0n8vzZBFNbN0YkcOvv2NXaLd7DTaWjOSTdaS72BMYOA1XY7kMY51AQH71a2paUssJa3IJJAAHb61zEjNaSeXIPkz0PaspwcPQ7qFfm0Oos71zJx8y+netu2vGSVQysMnmuEttRRJAVkQfjW5FrzPNFDEqyySMERVGWYngAVMWaVV1sdz9rVV3ZyPes+71eFVYiTBH4VxOo65do0kYjKlWKMr/AC7SOo5rnbq/u5fvEoM8heauTmtNjmhh+bU6vVNdmkBggk+Zzj6VFpVlKk7PFIeefmGc1zlnCHYEsx3Hhv8AGujslniUKX3c9KIQ5d9TScLKyN67+2YRnkDsBgFuePaqFxLOBsIXeevNF1c3BUKUYAD73UGsG/uiIiRuB9aqo0Z0oNFHxTciOzkR3BY8ADvWFoFgupXEaFCIU5Jx941auLeTUYZNhUqhztP860/DI8iQSKpKA4YDoPepV4Rv3HJKc7djs9NhaKIoG+7wv0q3cyCOLAJz6561BaOWkAA5PX0qSaEtksWzzx604y0uh211OR1ay+1TEuuRyeaq2Wkp5ZDbFZW4AHJrrJbNRkYO0+tRWmlASFhuDY59KOZnUqlo2uQaXCVYDoeoHaumi0ryUVriRI5mTeqPxu9gemfY80+wsUuFUOg3KOGXgmtcxr9l8s3UQBGSJmHIHQf/AFq1jotTgrVeaWhXhZVtY0u445LeM7VAfayE9WwetQahLDJAwgZlRTu2spIYjvkHj9aiilnVgIQmc/efn9DxUdxHcmPGzMYbovJpe000MfZ66kMkiSRhdpJ9RxWI1zdXUxjsHQRgkGR/uA9CBj7x/IZ71sXcke6K0DPE0vMjLkFYxwcehJ4/M1LCII53W2i/dLjy0wAAB2qHLmGouPQxX0VpADdXNzOxP3i21f8AvkYH55qxY6fGhPlhV7bV4/Sur2o8KHYpYdqzpnhMjShQjjgADgj396JWQ4TckElrHHAxjTa+RyOQR6VWkQwxLLOmwZwCeh/Gnajqhj0+VmRsIctjkAetczJ4zWNDFbPIyuMSc4yO49KznON7s0hCTWhrz6oqxHzJuVyAua43Ur43crIW3YJ4z2rn77U5pNQbG6OE856fkKjNzCSxgkZ5Mfd/qTWDbkb+7BGbeSTSzzWsGEBk43MAD+NbNrpUVkzNd3MakDMaBSzOSegUEnd37j3qHSdLvrz/AEiRoIYA/wArs3c4/Hp9BWjPcWGjq8kKyNIx2R+Y4aR/oAP/ANWfxqopRWpzyfO7obMl2koldZoo3O1RMeWIBzlR6enaioBp9zf3Std3K5Aybe1LTMpP8LOo27sc4B4+vFFPkuLmPXmUS2720qZPQE9fwNV2sftMMkM0ohukGYnzneex+oqnbail1BIGYtMvC7euau200VwDHMxLAYAIww+ldEJxZEotEdujyjcvlLMRiRB91j3x6ZqjcaMs1xM1xayGNcbMqSIwRyQfr61uk2+VSY7JW4LjG1vQ+xH60thZ6pBBO9o5+zMT5g3BlP1BroVnojO7jrc4C+8OusxNr82fu7h1PpWf5U8TBld4JYG3Bom2sreoI5Fd7NcXMk7rczYhGGCCMcn1B7Vz+sWkQj2RKoQMZCxHPPv3qHBJNo7qVSUmoyIbX7HfWbfbmnW5LEmZjuDE9z3zmnQ6VBkiIl4Qflk/vVWt3Ty8OcetathJHj5s7B3qeZTVmaOLg3YgbThCheIdDyPWpbaURsOcfrVwMMMoPynkHPesW4BSTODt9qwcnFmkY8yszQvbxlypPHbHesC/ufNiKjGMVFfXMsbhWwYzwSRULlVj3MCF9fWpdW7NPq/KrlKzmmsnnMQVldCuGGetdP4QG1Csij5gS2RXO20qTRuqgferqdDMcTgPx/WnKV+WzOdxtzaamuhmt8m22yLnhGOCB7H/ABqcaggIW6jaFv4fMGAf+BdKjjljSYHIx9alvNStRCRIygEchiKrS25i277E8gSfIY7enbINS2sccbqGPCjHXtXE6jrEdgGbTrsxnr5Z+ZD+HUfgapf8JZqhXdFbrID3LYB/Os1Vt0uX7NtHq0E6uNiOhx3PFRXWsadHGWeW1DD5SPNyM+vpXkTeIdUuUy9ugiJyVLHaf8aSHxNrc3FvlI14AGf5A1ftZ2+Ey9jG92z1O01axubxQznyiOHibKg/QH0xWjPcwQEOskUkbdirKF9jn/GvEJL3UZLiSQfZRcddxDRsT9eCfxyKv2PjXWIE8ua0t5h9xiQVYH0x0BqFOUdJIJU4yejPSbPV7GXV7+a5hZjlIl2HO0BAeM+7GrDz2dwhKq8ZUn94Oy9RkdvwryEeIgL+cPbSQSysrBRwc4we/PQVpWuo3l2h2280iDueDThOT0SuXKlC17neXV1JbRl47rzlcfKcbcexFctq2ryQys3mAqeNw4rBubnVPI3ZSKDccb5MkYOD9OaqrH9qkXzr2JgvO3eOT9DSnd9BRcY9bl2+8SSkiKLLOynjPXAyfrWDb22oPLK32aYAnJ3qUwTzzmt2G1QNH9jSBbnPEmQXQA8kHt+AzWzDYRafCH86OWBslkuSygf8D65Jz1yPpSUb6smdR7I5WHR5p51EzrJ8+1Vj+Yk9uT0q/p1hZo90+pteBY5PLjSKNXDFeMMS3AzuPGa1b/XrS9t1aWOZ5CiqI1QLsRT8oGTz3OQTXN20txPZwNCiRIhDBmkC/LvJ3k/dH4nkjvTuk/dM7Nr3ja1TWIXg8m1tmlxhmSNMhSThRnJBLZAwOaLHw1dmbzNVg+zXDZYW53jy0H97PAGSOpJ9qr2+rafa3MTWVq17cxh3eSc+UNxPytu3AkfeOcZzjtxVme5jks4pL5BfyBMsm+RY0yf4m27M/wDAvyzQ5x33YKL6aDvs9vuCQGbVPJYkxRoUt17Z4IyeccsT36UVHbeL2vZYLKx0yaV1yTDDEHjPHZVJH5AdqKn2j+y2i7JfEddDEmnXDzABEUBHGeSD3Hr71rWy75Qs+BG3zBh/Q1gxXZuN8VwQsqZV8jGfQ1d0ma4hVrSUCaLdmNu6CtIy1CUdDbEFrdqy3U5Urx93O70xUQuJ4MQTMXQZZZB6ejetRRp5k0jOrCReNv8AI0OQI8Ac5zz6V0xk7GPKmy7JcLJ5ER2rAoOZFjBLZPeuY1NRJiJFzzwSeMVoG6kkcLyB7DpVK/WQlJh8qg4GBxVOfMnY3pR5WZ9nAtreHdDHMxUqUlH3SeNw9x2qw8AidkzlTkgLgnPvUgD3Eu+4bJQYXAxj2FIzgNiUceo60muVG/M5Mj2ywEbxuU/xDpVO8EpJIK4zxWqsgKhVw6Acc81RvkDISkgXI4zWE4roa05O5iXgKFQQzEHPPeql5MpiYINpPY1rMfNGzZ84HOKovYknceWPr2rGVNvWJ0xqJfEZuijZcNuUEFu1dkLRDEX3CM479vxrF0m12TszKPLDciuwNlGEBm5OMgdQBXTTo+6kefiKtp6HPushYKis+OM5wP1qnc2pzmdGVeuI2Un+ddMtlbbs+Up+vNNuZLe1TMaxhvRVAqJUUkYqrJvQwbWzsZFKJBIsx6eeNn5E9fwpZrC2hUtelXA+7GBhQfp3rQvbi4vbVlMYMR6+Yf6Vi2sMkl55Ll5Rj5XY5x7UQg2xXdndjls2v2IXKRjjPtV6LSYreJ+hPbFbltZBYVCngjJOOtV7oxhgjlQuOSDiuiaUNzBSc9jAuoeF86NXDA4yuRjv+NUTp6qskqRblA+dOu9B1A9+cit6GaVJVRYxLBKhR0YZDEdD7Hrgj/61WBZhI8xbgGGVDYG3tyf8/Suezk7muiVjkL2xgmMCviQfcLjqyt91h+O0fjVu0vP7PmhspgrMRujKjcW9jn69/wCnLZLeRIrm3kPlpb5+51KHkYPt2/3aZepGbZJrVyWlG9c9WIBPJ69ePxrFze5so9DXLQ2sY+0mNmGCASMHPJwPrTrq8gSMyu+8YJO9CcfiRWQmpW1vZ+akSeTLlfNK7T/uk+vHXrUxtr26iEs25IkKyJBIV3EEZ3nnJAx0xx1ODxRzSlsS4qO4mLp7i5uLmFbWeT5sSxsGB6hdoA25znJ6ehqjdxRzg4+1S/LkPknJzycEYH4e1dHb2Qt75VuLkMqqTI+3cBx1APJ49cVnatfR3GTpvnNHHGUaOAgBEPZn4HP4mnyq2pKb6GVMwtrhYtPhW6uQ397KxOO5ZRkkdeDUMpkutItru8cTP5YeOUkiANzlAn94Ej7vAHeuiOmiWxMl7LbqZoyiQrISsagADH8TkDoTx7cVg61qcDXK2sUVtHbxqUUsnI3EAuPTAU49NxxSlZaMSu3cfb2FnZxG7uj9tvJVMgiEZwsnZBnpjuR045p0N5a2IF7qrR37CQrBDK+63ml7NtJBYg9yCv0qhrPiOA+fa6VDLd3h/dx3ch2gR/x4jyTuZjnc3bsKqafpUt5dLfak73dzIfLBbOWOPlVegx2xwB7Cob190uKurEsc18NPRbeK0soSWM89zP8AvpzkYGzOFwRn5OcdTjiiu40fQLeC4jnuks4VEYVQp2bRyCQSGJORyxA9Bx1KbpJ7sm5tatawyyrcRkk9JE/xqtaJF56JsZFzt+Vipo1aRUeQlisgPJ/H0pq33nQoXYME+6VHSnOV2aqNkbkBWNx85x90qTzx3qdGhcqGIDg/MAOKw0ulkdSHB6HrTNsxu1KN8u4jd0wK2jWfQydNbmndY3kIAg7gVUmuJrTKqA6nkZGQDinQ+a1wySngcAmmaiu2MKxyc8Ef1rWLctS42Wg0yBrckEMcZ44xWb54yTIRz0Jov1MYxnaMY+XuKwbtnEbAE46CqqSsjoo002ba3EDMPnUkepqpdSIJFAY8++a5uORQ+2YnJroNLitwAXGVPc1ye0c1Y6nSjT1J7dSkjMOQKmkwITIyY7gGrtmsSzkx4weK1Es1k+ZsbW/Ku2lDnVrnJVqcruZek2RmeEq4ZXUuygfd9q1rgi1AO0sDwM023LWl4piUEYxgHtV3XLmw+zqd2CQCc9j3rdpKLuzk1c1ZXuYHmSzSYT5EJ59qJTbwgdJJvSo31G2YMkLLnHUVnrKpl2qATnlvWuRWezOhwtui95D3T5kOF/uj0omhWCBmhUrImHXA546/pkfjU9s5jZSxOTzx2qQyAy4Yj39hWrioq6OeV72JDeqVG4koQPLAPUetZLZlWNiCSwHOeaLcBJ/smN3kfMmf4o88Ee46H6D1qey2uVAHAZkGeuAxrnd5vUFaC0LMAWGRYsDDLvJz79KdNMArZxhvlwetTXEQjjLAbHjG4E9vY+1YNzqklxIpsIVZQR+9dsJn27t/nmt5vkViILmdzM1i8MUzyRQSsqKUdiNqnuOT17/nXNQTXcibdot40LBTgllUknoeD6c+ldBJFcSyNLduzSl8oMbVT3Cjis5TG63mxt7iRowoBxgnLkewAya82a5nqda0sTaBa20EsYuVEkjqdkjkkoR129l6jtng81vXF/cXUEPlMiOy+WfMGVHQHb7/AOc1gKZEMDs5jjJMhwq8cfNgfiK07e/uhFFG80pONwWNVGzPrheDTjK2hLhd3HyaZI0rJO812IhuKhtqbscnZ6euc5q1calb26bbpkgwqqsSI7NMB/DxyM+3FMZZ/tayXUrAyuMswwcevT+lVdU1a00+ylecGW6ZPLUsAzY7AE9Bj0qrpJ30CUdjJutWu0R7aLy7dCMLypITphmOQuBjPXpXPWVvFqUkMj/bZIskXTK6hpiWIVIOCSCMckHk9KN91rdz5t3O0gjRYwSMBVVcBffAFdhY6aunRRWqWtu1ykX2kTZ2yRMMBW3E8AZLAA8kDPSpj1bMpa6EGg+H7a0mEktpPMUVzIsDptRsLtj3E8HLYPc8DHPHRw2F1JNFdXDafZnazRiNWnMUK8nI+VQRgkk5J+mKx9OubLT7mWbVJZYTEoa0Xy9zNvyxYgNnBycMQ2ORTb3VNQ1YiKKJora3Ueaso2GXnKrtJDHntxmnzbaDUddyxPp11rWuGOC9lKNlljYrHsTHBYJjknsenqelFaug6SrlpNVhuri53nNvbMgUZHor/Ljpzn60VpCEbe9b7jGpN30bM24nubOd4dT+aMnCzbeCff0+tWI0W3lmK7trjO3qv1FabyJKrwy7Ww20tjIIqK2aMpJAIyQhAGewNY2Vro7XJ7EVrcQyROgQFgM+hq3YzNEC7MGTBAB6j6VCyRxynzP3kJHyseoqCaN4pA1u+5eu1uR+dNOxLszdeaNEQxNvaTkKOo9TVTeZJmD5wB0NY+nXRFxOWO1gMKpPQVNDeYu1VSMe9axq7AoPWw67dlXa/J96oXMO6BsAYHvW3c7GbbIBz3FZV1AFk+QnZW0zalI5e7gYZJZQwq9pVxtARjn1OelJqMMctwwU9OtQ+WttEHbkk8CuWyT0OyT0szVlvpIUPkdT3qpH4hu7dts0r7P7oqxZxJdR7w+3HUGsfU0JmKoMj1rSUZKPNEwhKLbjJG5b+IZWkDQKF29zyaj1J3ubRp2kcse2eBWPYWUobYjEBuprpGs4008qT8oHNCcpL3maPkg04oydHKKhMmWNXzKCVZeoPPHaseNzHKVi5U8VfhYoVJXv1ojL3bE1VeXMzfimjZCFfkYJz2qwknngIB8+MZPYfWs1bkO4LRjB7Dv71KkwmnkdgAqYQcenU10Oeh58ohf26ySgGVUEZysisdyn2IFUbe6WCQbrlCWdicAgD5z1OOB7mpNVnEsLRoSGZlGQcd6zo7d4cm1lk4OQJOck9cmufms9ClHTU6tnimVBJNaSye0hK+3JGPxqlq11EF8y5gVYVOGkgcFgPXPQ/j+YrBt5niZhb+XFDOdpYrloX9R2G7oePT1rPu28u4cCQtKnHmyNu255OAOM4p1K7sTGkky/qN+0KA2qLc2UrhknIwA2PuknkH1XvgHkc1z9tcNMEmuJxHCA3IUAuWbJ7cnp0FWQbmOKQpK6RuCHiPIkHYkdAc9O4PNS6BbWtpB5zwzLiLIkQByWx05PAznkVz6yd2aXtsXba0lnkVpkZFHzCKRuSAeAw9yenetO2eGwtpEuVWNpWDBR99wD91R19/wrJhup5NzwpKFlPyNt+ZsdAPT3Jq7bxG3LTSEGRh80jDkewpp21C/QtXIljWZ76z+y2wxIyySjzyM/dHXB7YxXJw6Pea1qwhhigjkcARxPMFEY6fMzEDccgn6469Onu7kizW/nx5aMWhTgyGQD5XPfqRj8e4p/h2z8i2ma4QTSyxtvlY8q5BO4Eg9CefXnp1qtHKxnJvlMS2tmG6HyUcp8qhWxtjU/MFGfmLMQoHJ7Crt0+ogSQapF9mFxtlmeaIieGJMhEBb5lDYbjpiprQWsa2F01pA0VuW5fdmVQDgtg8AAZGMdSaGsLjVp75vOYLcCN7iPeSsgA4z3JJAYA8Ank+pyr5icrPyHWV1aLdW19pdp5puFMIAi8tIiDiNi/wDFISDlhk/Njrmtqz8P3ltezLc2tjJLw0kk8rld5HBYEKeMZwTgnFazaTZX2nRw3LefE8aq9xJdtthbBJUIuFQ8Z2EZyBg5rL06xg/4R4Xl7bWMtw0gHzbVYqgKsSRyeVwM4PPfrVSaTMottHQ6fZTXSKPtUoVUAWO1hSEKMn2Yn+dFcwLZx5s/l3trGWwYbZ8oo4xu+fB5P3QOOvPYqXzPoPlXcsXFhsu7iW2b5W5ZT0zWdHcy299IJFCho1OM8Hk10dntLTJIRkuc4796zLu1SC6kEvzpKRsI7Y7UrXVzpvbRheRvHal2G75c4HcVnx6gEtx82ABzn0rVL8NbDO0AFc+npXN6rpskF35e4rbOMkY7+maJRe6CLXUs2zxORLIMO+SO3FPiIWdXUfNnvWXdLMUjQNtGc5rSto2WFS5Bf0H86Sk5OxtZJG9KnmRxMBhz2rPuF2Kwwc+9WhFNIIETkg5681m6hemNnQ4ZgcE+ldc37t2ZUX71kYFyzRzMx6k1EjrM2JTkGpLhxPI2DVdk8pAwBLVzW6o727rU2Y0jtYCinG4cVkzPIrsW5OelTzyPLah2OCvQVTe4Lxo2fY1ve+hzLR6mppt7EkLGY/OOgqtdahLM20kiPNZ0cgLHp74prrKzccCsp3aNYuNzeitWWIsiK2BnJNEd+sThJoWKjqV5rHSa7I8qORgPrV+xtrxFBkjLR55YdqcXKT0QqlktWb1pe6fLc7VmXeRwG4I9uamt4d00qKRyxNV7XSdNvW/0q/hhYDO1oyzH6YqqYG02YtZSyuoOCWHGPpW879dTz9L6El7C0E8TsMKJBnHpzS3EbeWDCkg3c88Z/CtOeVprFXlVSMfMYx198VC00LwL5TiQjuKz5I6oFNnOzKFF0txE+wqCf8ax7BJJHjjOWYMCMfx5yc/XpXUS4nW6kJxtAU/hWf4fj8q3SfIDeerJkdckg/lWDjG6LcnYPskrzhQFwJG5HbaMY/AmptKsTd21sHV/sqoN2eN7eg9hWpfP5N3FbWigSsrDBGcEsCT+lT6XbzJYxQkOEjJXp0GTRbXQnmdiERRlRMzmNYmIjCNjgcZJHXntUMlpdXTEeQzqOir1UZ6ketXfD2mfai0c2dtsz9f4mDHH5Ag/jW3PNHEkMaTQRFyAQXAJPrzQtVeQr20RyF1F5t3Yxr5bP5vmfZdpztUcZHuSPrWpqNtKywWEUuFuWwZNhGIwMsT9T8v41urFEyEXe2Qqu2MychRnPy+n4YrBt2vLi7nv1/eQTKfKV2OdiMQcHtyD1z06iiy2Q+ZvVlLX/wDTbu209HEc13Miu4U4jU/eY47AAn8K3dBt0/0JWuGnjk8yMcJlCCu1sf3Tx1/2q5+3uA+r5e48maFWkYSNtKudqKuDxkKzfqQa6ey8+WASqS6RpJBjPysxd2B44PODxx0pxaRE02K/lFpkEUUi/IBIOVdgPwyoJ/MCsvw3axz390s0sq2lvKxVA+fNbjgHHQEkn1rTEbTwwrLKgZUzI0jHCJnOMducjI9+tUvDrn+zJpYyIkupGbaAcKC2QPUntSV07lu1mb8toNR1CO0t9yGIF3IcHYuMADg9Tk47Yoq7oFtNKJZUN1BbTSlVjRgDuVcfMe+AP1FFdUFZao5KknfRnGQahp8lzcxrclTnKq2VPPsaS8V5LdjHOp2fMu5uhFXNM+x6lOzMI5FaMAkj3rO1TQn3udOnZVDfcblTXJbmXMmeinbRkIvX3xyE4bODzwR3q5cyrqEccOSBjcDnvWLNbyRRoLy1Pl55lhYn8x2qKxnaG8Hlzb0GSBnqKm7juFkzcu7F47NFmCkkYJH86ydNuDFO8chLbG25PcVsz3om3K33QMe1YU9qBcyNZj5hhj6UO17oI+ZsXAkkUPHMyguAMHH4VX1YIrLHGFJA5wOtVLeZprq2hIIwc59/Stm6tFRWkYfORXRbnjdCi+WRzqRbWIwoXvRcQjy2OaiuHZZyGPGeKL2QKm0Hk9aVOWh0yuUpGJiKjHNR2EGZWjlbg9Kt2cPmYkfp2rUNgkuGjxuXk10xp6XOadTUwYbZkeZG4YU5CGO3OD0rTmhIjkY4Kjv3FYsa7rvAfjOCcdKwqXi0ka05G5plt86s+NvUk9hW8Zbdrd1y6p0GFJH51Q0y1GPNDxlFGSXPWte3vknHyuuxR07V1U4pLU5q0nJmfBFbxDfkSRnrjqPerkAgY7WKvD0IJ5qpdlZ4wYiBKh4I6fjWS880U4cqV4+dP6ispVOXYjk5tzZM0VlcExOWgPRSelNFxEkzFEXzGHBxWLcS/ddPm5496s6eCLl49hlmGMbTxj61zOrKTNfZpIlvoC9tIsbeWjDDsfXP86z4JhPFujRYljC7VB4XDE1rai0iW+J4HVVYEYIIHPWqfh2GI2j3M0YkgaZyQRwBk4NS9ZWFeyuTWF5AdekuGuI9kabFYt/Fnnnt1/SuvM8ckKtbkOmwDcpBX36Vl6fLDBoce94ollBlDdPmJLD+gpqizu2+0QL5bN8xeBtrIfQkdfxFHMlomZtNu7RLJcRWuosrsRDcAHepx+8UYx/wJRj6r71PYSCU3CZQnfhd2PusAefyIrJuROITHeE3EDjImiTEkWDkFlHXGAcr+VW7CJbh9zsoREUyuh+WQ5IDJ/snrnscjsalXbG7JFHWJktrTzNPhlMm5gWXiE8DjB4z15X1plpqN3ZQwI1vbyIhjQKmV3gEZ59TznOPrW5qdhFLc2UKgeTnDITkgAMcfjjgVFqWmNDpDTtGgMWySUn+EBhnPoPU01Fq7Q+ZWszkdOVdS1R7q4IA/wBZI7dVL7mY5PuRnNdzYQQIFW4hSN2YszgsgcBcnGOAcDkfl7cjbQx2eotGGVoXVInf7yysq7XYMMgjIIHsVro7iRJ7JrRvMEyqCGlOGb5gAR67QRyPb1Ioh7qYp+80W7aBZo2IuJoo1BnlJIJ4IIAyPTFa9nYyBopYUjyxYAM21U6E4b157etZtmHkC214qGaSQeZs/ujLbgPQ4/A5HauuKCPy/lIlGMjaVC5PAwevY+lbQfu6mE3aWhm6EzGzgW4ghZfLymzJJPAJII5PXnPeik0yb7NZsoLCSBjCWUgd+FHXjAzRSc9h+zcm2eUaLcPaXN6tmGkeFygHRWGe5rodOS81a3aVp/JAzlYx/U1y+hu0txcKzBWB3H/axniu+062WztTIudkhDD0PFc8Y3dz0JbGU9i8Qby5ZRxklzkE1x2txpEVnh/d3IbHy/XFen3bCe3wdoJGSwrz2+tRJqu0glEOfqTVT20M4t7Mq6df3LztBKBKSAeOCfwrTt5QDNLEM7jgAVkSwvZzvcJ8pV8Ln071o2Em4t/AGOc1C912KequWNEt5Zr2VVx5hIbr0PpXQPMSGhmTZIDjB9axdDhmiu5Jlxw5UkHOa2LxWkikl2/ORkc9K9Cjb2epjN++jl9cUQNn+IGs5AbmQZOKt6wZJowz8nv7VlWsxFwwHXoK5FNcx2/ZsdDYxBmES/dHfFaE9o8MHmK27PpVTSI3S3MhPDnFdAiM9o1uo3SKN2K9OlHmjqcFSXKzlWnVSyOcb+Of51hzO0F1+6VhHnGWHJrd1GH7NOZ5cF0ABXtk1HJHHqO0gYwO1cdWLvyvc3pvr0H2LQNaN5O7zcdCa0tHuYXjaAIomPZuKxYYZLO/jRTx1+tdEsNrMm5wI5QOoODmtoyfV6oidrWS3MiRri0vpAhVlzkA96S6u0uRskXa2Oh6g+1VNVnktLgI7B1J+V/8adMivbCdjkLzkVxOW6RtyqybKXlXLyNCmABzg9hV7SRcrKNwIWI4AjHzL9an0kOryCfl2w2fbtV6QNb3UUqj5H+R/wChrPTchvoV9SWG4gkXMjzMNoBkPU9OKrJbpp2l/uJbiLMbKy8kbsdwex5rdtoo728LyIrxwjByM5PesLxAvkR3EcEkhwcrGDxtPr6Cm37vqZ2970JdLUrGhl2SbVHyscbfYZ4roraOyucLbk293j5SgG7gZ+jCq2lT3MMfltBHKwVWJQ44OfX6VavBaXLDEJtbvaAQy43H19D+FNWiJtsLfUZt4iO2O8jITBxhe+4e3Uim3myxENxbt8gz5sYGVUHGWx3H94d+vUZrLIkmvLZLt/LeMmNWzllJI4b+8p7H8ODWu5ntGBYRyQldjSFiAc9Qcg+4zUpuwNISyuZGmjE77J4GGUznKnPzL6jmtjVJft4eCFA1qU23BHyc4zt49/0rlC6X2n25llt40twuAj/OR0+92OPSt1JRawtHZzo0BA656gdSRyTkDsee9UnZW6Ccb6mJY2Et0bvTgMXDMNszdI32jBx6N8p+q11d3axap4fRsr506CRBnDRPjO4H+EhuP51gWl9NBqQT7FJPJcIPLVWXJKk8nOMD5hyfSrFjPqcd2bZ1NvGwkkRVQMxDElgWPvnt/FxVJ+7oiJJ825JbX0tpfWN1d5kK741nUBRKrICYmH8Mn3sY4JXjGSK7G4kili/ct5qyhCOuNvBJJ9cH9a4kwzNHNC00jzq4njSWHIKnkgjAyPvd6i0S9u9JuI4JGiis3LJCJXOwAnO0ueV743Z4xzSV100HyJ6nfwWhmvFg8lGiTc2EYgsenUdgMcexorOtdbhkmAuAbZSAoDAL0Geo4NFbKcSZUpHl9tYPYa/t2ExMqu2Bn5sdK620uXCtagFljB2cdQaKK57W2O5O+4gd2mMPzC3GPMx1+lZsyJ9rDheDMT064GBRRRfoZPco3VoJnG8MwVN7DHctUV7BLDCGiQgk9MfpRRVvVahsyfTWuLa33BW2N98AdPet+TElkTkghetFFXTbinYiSuzkdUicQZCt7cVhxQutwpCsSx6YoorBrU6YvQ6b99BH5cQJBwTgdK2raaWK1JjP72RcEkdBRRXp0nZXRyVNTn9V8yRblGDO7HcGx7Vi2JurQLII28snGcUUVhUXM7sqMmlZGvaSpPLK0wYHHGRyKkkeRrcoylj2OORRRWMpt6GsUr3MWdJCcTKzr64zVmyR5AkLqwjzlTj7xoornNpu5sm1eOdGKnCnDf7tXtXKCApCjSMcFSBkZ7UUVTdlZHO9dSxpyzQWEsjQulyCVKqMbmPYfXNZ2paeyRyl98gZMylRyTn+Q7UUVpOKWhlB3NHSreU27vhvlQRMpHOQTn+la8cIntt08DFB97cvUCiimlqFzL1TS8O2yJ5wo2nHXHcZ9uoPqKNRmuX0e4tJDvvCm0NjAcEYDjH0OfcGiiplFKFx31NS1gjmtyVjAhmRWRfYgf8A16s3/lRxPaWC5lA2lguQuR1P9KKKTk0rCS1C20yJI4mtAJrtCtwvz4Ziudylu2QWGPpSzWn2iOG7iVzhPNBT5WKnofryPyNFFWnczvqU5Wa1mUyfeG6Nm24DoQBkE/8AoPatO5tn1a0S0EbhCo+bIOMHIKj1B/lRRQvi5S27RuYVraXFheTgsolSRlkilbEUmfuspBG0HGcZxxgUUUVkW9T/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Long-standing vulvar LS in a 55-year-old lady with severe pruritus for eight years. She woke up most nights scratching. Clitoris is almost buried. The inner labia minora and vulvar trigone are thick, firm and white with two biopsy sites visible on the left side.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD&nbsp;and Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lichen sclerosus (LS) adult 45 yrs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 297px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    45-year-old woman with purpura from scratching plus loss of labia minora. The white areas of LS show a cellophane-like shiny surface.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD&nbsp;and Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24122=[""].join("\n");
var outline_f23_35_24122=null;
var title_f23_35_24123="Causes of delayed gastric emptying";
var content_f23_35_24123=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51417&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of delayed gastric emptying",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Anatomic",
"       </td>",
"       <td>",
"        Pyloric stenosis, duodenal stenosis, duodenal web",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Metabolic",
"       </td>",
"       <td>",
"        Hypokalaemia, acidosis, hypothyroidism, diabetic gastroparesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Drugs",
"       </td>",
"       <td>",
"        Opioids, anticholinergics, neuromuscular blockade",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Neuronal dysfunction",
"       </td>",
"       <td>",
"        CNS disease, vagotomy, intestinal pseudoobstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Muscle disease",
"       </td>",
"       <td>",
"        Visceral myopathy, SLE, myotonic dystrophy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Infection",
"       </td>",
"       <td>",
"        Viral, bacterial toxins, post-viral gastroparesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Idiopathic",
"       </td>",
"       <td>",
"        Slow-wave arrhythmias",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CNS: central nervous system; SLE: systemic lupus erythematosus.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Milla PJ. Motor disorders including pyloric stenosis. In: Pediatric Gastrointestinal Disease, 3rd ed, Walker WA, Durie PR, Hamilton JR, Walker-Smith JA (Eds) B.C. Decker, Hamilton, Ontario 2000. p.415.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24123=[""].join("\n");
var outline_f23_35_24123=null;
var title_f23_35_24124="Secreted and circulating pattern recognition receptors";
var content_f23_35_24124=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F53389&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F53389&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major pattern recognition receptors (PRRs) in humans: Secreted and circulating",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        PRR",
"       </td>",
"       <td class=\"subtitle1\">",
"        Recognize",
"       </td>",
"       <td class=\"subtitle1\">",
"        Functions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Antimicrobial peptides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Defensins",
"       </td>",
"       <td rowspan=\"2\">",
"        Microbial membranes",
"       </td>",
"       <td rowspan=\"2\">",
"        <p>",
"         Microbial cell lysis",
"        </p>",
"        <p>",
"         Opsonization",
"        </p>",
"        <p>",
"         Chemoattraction",
"        </p>",
"        <p>",
"         Link to adaptive immunity",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cathelicidin (LL-37)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Collectins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mannose-binding lectin (MBL)",
"       </td>",
"       <td>",
"        Microbial mannan",
"       </td>",
"       <td>",
"        Complement activation, microbial lysis and opsonization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Surfactant proteins A and D",
"       </td>",
"       <td>",
"        Microbial membranes",
"       </td>",
"       <td>",
"        Opsonization, lysis of bacteria and fungi, efferocytosis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Lectins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        MBL",
"       </td>",
"       <td rowspan=\"3\">",
"        Microbial carbohydrates",
"       </td>",
"       <td rowspan=\"3\">",
"        Activation of lectin pathway of complement, with microbial lysis and opsonization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ficolins 1,2,3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Galectin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Pentraxins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        C-reactive protein (CRP)",
"       </td>",
"       <td rowspan=\"2\">",
"        Bacterial carbohydrate",
"       </td>",
"       <td rowspan=\"2\">",
"        Activation of classical pathway of complement, with microbial lysis and opsonization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pentraxin 3 (PTX3)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Efferocytosis (from the Latin for \"to take to the grave, to bury\") refers to the process by which apoptotic cells are removed by phagocytosis.",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Reproduced from: Liu, AH, Zasloff, MA, Johnston, RB Jr. Innate immunity. In: Middleton's Allergy: Principles and Practice, 7th ed, Adkinson, NF Jr, Busse, WW, Bochner, BS, et al (Eds), Elsevier 2008. Illustration used with the permission of Elsevier, Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24124=[""].join("\n");
var outline_f23_35_24124=null;
var title_f23_35_24125="Troponin T in acute ischemia";
var content_f23_35_24125=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 500px\">",
"   <div class=\"ttl\">",
"    Plasma troponin T and mortality in acute myocardial ischemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 480px; height: 296px; background-image: url(data:image/gif;base64,R0lGODlh4AEoAdUAAP///4CAgAAAAP8AAEBAQMDAwP/w8KCgoCAgIP8wMHBwcPDw8FBQUBAQENDQ0DAwMODg4LCwsGBgYJCQkP8QEP/Q0P9gYP8gIP+goP+AgP9AQP/g4P+wsP+QkP9QUP/AwP9wcH8AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADgASgBAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wsbKztLW2t7i5uru8vb6/wMHCw8TFxsfIycrLzM3Oz9DRWgsHAQcLRg4B1kILBd8FDtLj5FAPAgQCD0YC7QIKAAXu6OX19kYRAgwADAIRRQcAOGgXT903cfcS1gsgIAAAhg6NQBCAoGADAhIgCCmwrWOAAgpDJoP4sOGRfv8cSAiQbl08jywjipw5bMI7AAoETCiyIF3A/yIEj2yjSVSVA41UJiIogECARnoQzhHYBiEAA5b0hMosyhUUxnwCEE450BTBT3ry5hWI0FQfNq1d437yRwDBAwl0hsrdq0lAgQYrCeTdyrfwpAdNJ0gQPEev4ceR/j6A0GBnY8KQMyt6e8ex5s+ICBD4Wccz6NODcgoALDaOadSw/1Br0O7BP9eYY+vO40BB26aM4bzeTbxOOgQKNEIg/WZ48edwJty24xy69TULJnRkLjz39c8GNtDp5y447u+xK1y4YGDOO79TB6NHXYHCgAvi5fhtUNV89/mgYTDAAAm0N0cDBzCAwEXyAZhZBwN6YOAcBxzgQAMNtPafg49ZMP+gBbFUxyFNBngwYAd2iKaiaPBcNuJeBiQwIAZ3zFNegy9ypd4AFFSgx1JCrIRjjjTVd5+PeugkhAL+NecdkfYISOCEeaRDwDl4uQilSBAOIGEfC5DHAGfnbamQhwOAiIuIZjpT4om6sNnmMjHOuIuccyKzY4+84JlnMUZegCQg1GxzTWlP/nmMlAUKcuE8GQ6pqDJdfimIBIBtg2mWcvg5qS9oqjlIfEOwJOmnxLw5AIqFbKopYKeiGkydA9BoyKPuRKqlrMPsOaghhVpDZpm8BhPor6IUemgR2nAjBATaTWeEp8XKwiiVwErAgEroDGsOOuqw4w48lDVwTovTJlr/bS2VYmuIarS1o24S+eyDEkACEZTTTrR5+9C868YSaiN1MaXAAgg06QRJJElEEQDpgBTxSx6RGjAuqrLKiGg4BcTxFAybZMS9E0/MUcUAX7wKrbY2EkADnME6hU3w7MuTT0Lce46GQlCrsikfXMAjsot481ZVPDuhFFNOAQCVVFQdoE8+FcH18ywgDCioK2RRdJZgabkDkgK0PZD0v1fHUoGMabqLjM9pe5LBgBRwAA3ccWuyAduWPoN33pd0YB8FLVviAAMqokss4KRsoMGAGuSHSVvtKNzG34xHwsHgGmeiDx6YZ96IqgkQfQkDiscqeiabD5jBJ5gmrvrqlRiQ/zWBpmeSzo270o4JB0IPAILb5ITuuyCOa/1BKAUs4AA44cx+PCMGzO068X0VsHvl0k+fCPCQSx5KAMt5xJ2T3kOS/H12o/L8Qd2nL0j1Aw6QAfagqMZ97/IfAv4AkVvFarYTv/7xYX0XaN8qEJAyNRjPgG6g3/VY8Y3FgONsbHggBNfwvwC2wkb761QDNxgHBCqwFTAxVAFJCAcJ2g9/qTgASAAQAWltiIV56KD4YkEqJq0Qh2rYgInYV4uwuWMf/ANiHAQ3wVo4gAANSBgBtvVDJZLhA2zTQO5kIUPQjdCKYLAd3Tpni+a9D35JBCMaWte2XcBnHpbL4BfVqAUELv+vT+UjYBrpKAbr2S8YEUAKdebIRyoELXzCaEkAMCjHQo7BAGiqGzEiIIG2IFGEjgwDE4UHw10sIAJWqmImnVCBxxHojsVQDQMmIMjFjfIKEqQAGYlhJVZaQVn+8gZSvHFBJGhwlNULngd2aIzenOOSUpBKuIpQgH5ExIiW+2UhN2AB+xBxGcupZFakUC9++AMo8tqIQaJntVdK4QOmJFDhlLG7B9gSZCZpGBEaJo+LZGQIJ9uGxczpBAwEL02obIawrhAyzDRMJVhxCcX0SchpZsCaFAABMflCM5woqQjyHEJQ0sXPJVQATffpQCe7srSmPIUxBZCAACQAEqtgJZr/DbUiB9KpgROCpmtmEUJWbERDS/oLbR0lggE68E8LbDFP0vTeBkAA0QxMlBwHiNc2XTnKD4D0AutMCG1kt0c6YoBtAAyoSBqQuq4qMZh0s8BTFaIATiHKkR+t3wXu1xUQTvWGYMQATbNKlBVxFZNWROuHjnq1pAYsrlqjK2R6iEy8QlCv9dMAX/dSlYRt4wFxXINhUSXYNBE2LkYMp1lFh9j7KBY03rgLGkcLOMhCbrKgOSMjHRhTWXXWqM/R313RR7vSznWkmrlIQ5AjSlm5FoCw1Y1fBLAAqxT3TwbAQDXrh9v50IUBmH2umSrQgXSaFrixUUAAwHI+N2wWOgbg/4AF/kmgDHz2Og6YLW2rtYEODJFuHsDAWuezACYdzoa8/RQHQMDeBIBArFAiT0obG+A5bQAD941QB/abI50QgCOZnW+bPgACsN4HBDZVFF20x2Dz1vY00fWANSE34XVhKooCKO/lTpyZCmTAwxewAAfA26YwraasDb7Og1VcPwJ14L1BTcJ5Q5JeAheZAhbAAI8V5VcWaTcuH7hxkQF4ZNHZNcNpWPI4uEvk+hk4xKIDEgCExNq4RHe9Rc6xlPt3UR+2mSgD9jAFPNDlDVoJS1cec3e3nIAMIBiCPnZLoI2xgQ98gAMZiLQGJr1irYF4yknugphv0dktb3nP+s20FP9weQRdDgFa41UyjX1BzSdPWgORzgAHHE1hUS9BmQrFpzOfhaFz+XLVu5ipmZPLT/JpoZv3IoI7ImKzfpXTTf6k7qFFDR8aF3RaIiuZXzaCsmcsFaIStTUSohjFv0bh2hjN9rYnttCYNMOqcp2zuJEQVRuBGQkVtVm6I6KzsDx7UWCt6byboAAZQ6GkTctKSlcKEqkxgGq/XpmHPU3xildcrQOHAjmrgNOv6XQeSyrb2TaNCFpZ/OQn/23Gn4CrB/y0kaioU6NW3gYEMJBsbnXsKGSOaZpzYdsPufcZSE4InvvcDQhgwFrusuhHGP3obZBaO3QF2J3LaOZQb4M23nn/Z0s8PeumIPofvg72Uoi9D2QvOynOvoe0qz0NL9e5JurEp7e3QTQGN/En6I5ku4MBXhKQLxrYfge++/0Ns6kNgGG+CcMfXuu+aQdwqp4Jxz+eDcdJDgCWQ3lMyKjul2eDdLy4CQ+BPvRrKLgQtNN0QZi+76jvQmpZ2kyhm4HwcUATsWMfhtCutPV/0D3v2VDZqQRgAnHXcCWEP3yttxL4fGB+8x2YRxV23RDSn34a3si7zj/idrvXPhjMCD3BDx3YeZBS+MX/Bej18vqCUD/72fBl6NtBSqKaf5hTmHflNwL/+ocKuGcGABiAa0AAvbEiQDZjjlCABqgG3BdCVHUI/w74gGaHfnHAAR9igW7QX1O0eHqnCEaSfxyoBtvzTfCXByNYgm5gEguQXVRAakWAarfBS6uFURjYBkaCdSxogrdhKlSAazPYazcBTRF3CDvYcz2IBaKBGKKRdFSAbCi4JErSL/LwADc4TzmoBkm4hGtQf/DkEBmlbd+wGhghSPnkboXQhV5oCOgmBGSIUC2BT91GCGzYhtihHdYnBfl2UTnzTTujbAJwhMhjHzyIh2lAHhJ4cBTBNCcFAA4HcS4VSv+2BgbQSSZnZkqIiFnwHtoTUx2nU4xBNuogDmzRDmNCiGwQI4dYBJk4IK3IiWewH/1hf1JAK7EIAG4ni2yAIP8KwiApuAUyd3Xusou8uAYVciFUN4FlwHNkZ4zHuHZb2ARPV43EGI1y4ADnQFZvlQbPSIzQiI1pABznMI1VMIDX6IpXl47iCAcoiDi22AQDQjy4uInt2AWq9xAlxoBpMCBKwIr2eI9aAIbeRwb++I8BKZBZUGUEsICMdwYHqZC2MIARKZF64GPcGI9MUJEWiQd/JjIFOQYc2ZF2gIJ2FpJiMJIkSQcN4BBhso8PaQYquZJyoFsgGJNlMJM0GQcT8IHdiAY6uZNuUCGkhwYGEJRCyQbw2BnmiAQyl5R1QBbvh5JeEI5QaYJwpJFHYJVXmQbVoEdyEAIhgHJkWZZFlov/XckGG1cHYmmWbnlyaJmWcHcOu8WMcikJUvMA59B/mtWUdwk6LvEAfkkFA/iX5sVAAWBZfDl4g2mYeQFCtlcGhemYa5CGe2iXlPk2jZmZrDCZnDkKnvmZ47OZopkIMkgENHhq0aJqpdkKQoiaREgusamKrXkKUigtzcZcuekvoVmbfPCGELNubyQxQMdtLGF8KZScyrmczNmczvmc0Bmd0jmd1Fmd1nmd2Jmd2rmd3Nmd2zBDjACcZEiGRHAyouGd6NkR55mezbme7Kmc7ome8fme1Dmf9Imd9nmf27lPitCHlvGH/7Az/ZY0vdkEA4h7S1agHLUHCgoFDcoFCPeI/5H4MBNaNQuqBwdKmqVijg+6ob+poVrQoVsQik4ziiIXcqVIm0zpf5LJoSC6MC8KMjFKUDM6CN/woSxKBglao0ogopW4BzeaGUGKBkNqBkXKBUcaB0lqB0vqm076pFAapVI6pWlzmkRgalxgpQBgg2vpBV2aBaiGfHPgfnmwcVo6pmJBpqdwpm3wmuW5a1zgpuLUfV2gDXV5BduTa2/AU3Zgp8Ehp9nIEMHBp6YAqG1wm+AEklmAqPg0TuYnBbsTmU4QAQuAMMW5p37RpG8QqULAqHPAqR8HDrb5OcnWHPGkqD2DqgR1qltRT2fYe3eaBSalH+igdHggD4wBnHKAq/8aVavguXas6hrBum9cAJxyuEztF6tXUFFycBUqxR93wKslIYaqCgfSyg8B8KzPNz7D+gb+iW0Y+K1HsFFeqqxVkBM5JwfsVgfSKq50cK1DsK6j4K5uEKEluhEqxVJbYK/0MInmWgUOYBNYmHxR0A+I+attUACC+awEqwYBaxALYK908LADq7DZuhoNmwkSCwckulMgN6Jl4XGnqGhfcIIIewU2wqOoSZdmcwcmC4khmyJqERW18aiZQKJUmrM6u7M827M++7NAG7RCO7REW7RGe7RIK47QE68O+QcniQQQ4H4nOwVtxQTeYLM7CSni8K8oK6lSUA1LwBCEWgUTMS//8EqZBGET+wAVi9GQ2OCB8VENoHQwi4EQTIIRrSE1DFQ+0KIRPflwQlAN2iMBb/G3P3gAPUm4kOgQHEFJBCAtUSuwTWoNifu2i/GdpdI0izu3C1C3BeG1K0kQvIoWU5GvALAgAeAbwWlzZvgwp5u6UUQEOXERT7QafpETCkAyK5UT+4C791IbTYEX6VASwqW5jZpZwPt756JSMgGFcEgRTSFcFXG2jikve3mvkLgY9IAhK6ERwysPDjG88cAktAEUjJEOb2EuW/o54nsOAKC+C/A59BC/gjG8DDE2l/q5SjC/6CAPeAG+nTqF32sSAwy6JFk5oyGKFqUAvHo40QsB/AMcvoNYLxHgvsp2voOowPcqvsO7U4LhwcFZEi2Vv9R7waIIwAC8Zg1ABBEcwiX8l+S6wf4gNfUrQ+lQuwUhwdN6ikCxFBCcwd4UAQyxExGjtkE8xNhLD/a7bffLTNvEADBjwiUav0uREy55E/E6iAA8wIi5mFkLxAr8KKFEHjnVwsP7gtALxiURFuK7pf2QkcfRLW78YxqsxIPYxE1cntskMxrFGPRQb+ngEDbRSmasxVmZtFzQxmQwENtqBDLUTN+UMIgcB4o8BkLcBCpFES75EZPcyZ78yaAcyqI8yqRcyqZ8yqicyqq8yqzcyq78yrAcy7I8y7Rcy0EbBAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mortality rates at 30 days related to the plasma level of cardiac troponin T measured at baseline in 801 patients presenting with symptoms and ECG changes of acute ischemia. There is a progressive increase in mortality with higher troponin levels.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Ohman EM, Armstrong PW, Christenson RH, et al. N Engl J Med 1996; 335:1333.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24125=[""].join("\n");
var outline_f23_35_24125=null;
var title_f23_35_24126="Determinants VO2max";
var content_f23_35_24126=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Determinants of VO",
"    <sub>",
"     2",
"    </sub>",
"    max in the Fick equation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 361px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     VO",
"     <sub>",
"      2",
"     </sub>",
"     : oxygen (O",
"     <sub>",
"      2",
"     </sub>",
"     ) uptake; SV: stroke volume; HR: heart rate; PiO",
"     <sub>",
"      2",
"     </sub>",
"     : partial pressure inspired O",
"     <sub>",
"      2",
"     </sub>",
"     : FiO",
"     <sub>",
"      2",
"     </sub>",
"     x Patmospheric; CaO",
"     <sub>",
"      2",
"     </sub>",
"     : arterial oxygen content; CvO",
"     <sub>",
"      2",
"     </sub>",
"     : mixed venous oxygen content.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24126=[""].join("\n");
var outline_f23_35_24126=null;
var title_f23_35_24127="Vitiligo2";
var content_f23_35_24127=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80058&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80058&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vulvar vitiligo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 228px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_35_24127=[""].join("\n");
var outline_f23_35_24127=null;
